var title_f22_21_22864="Labral tear MR arthrogram";
var content_f22_21_22864=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F78773&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F78773&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Superior glenoid labral tear",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 399px; height: 456px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Coronal T1 fat suppressed MR arthrogram of the left shoulder shows a tear of the superior glenoid labrum (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Shahla Modaressi, MD, and Cecilia Jude, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_21_22864=[""].join("\n");
var outline_f22_21_22864=null;
var title_f22_21_22865="Patient information: Heat rash (prickly heat) (The Basics)";
var content_f22_21_22865=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"11\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/86260\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_picture\" href=\"UTD.htm?24/58/25512\">",
"         Heat rash (prickly heat)",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?4/60/5058\">",
"         Patient information: Blisters (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?23/20/23874\">",
"         Patient information: Sunburn (The Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Heat rash (prickly heat) (The Basics)",
"    </div>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H504077919\">",
"      <span class=\"h1\">",
"       What is a heat rash?",
"      </span>",
"      &nbsp;&mdash;&nbsp;A heat rash is a skin rash that can happen when a person is hot or sweating a lot. The rash can look like a cluster of tiny bubbles under the skin or like a cluster of small pimples (",
"      <a class=\"graphic graphic_picture graphicRef86259 \" href=\"UTD.htm?24/58/25512\">",
"       picture 1",
"      </a>",
"      ).",
"     </p>",
"     <p>",
"      Anyone can get a heat rash, but it is most common in young children. The rash most often shows up on the head, neck, chest, or anywhere where the skin rubs together (like the armpit).",
"     </p>",
"     <p>",
"      Heat rash is sometimes called prickly heat. Doctors and nurses call it &ldquo;miliaria crystallina&rdquo; or &ldquo;miliaria rubra.&rdquo;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H504077934\">",
"      <span class=\"h1\">",
"       Is there anything I can do on my own to get rid of a heat rash?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. The most important thing you can do is try to reduce how much you are sweating. If possible, stay in a cool, dry place. You can take cool baths or use a clean cloth dipped in cold water to cool the areas with the rash. Also be sure to wear loose clothes that let your skin breathe.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H504077949\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Heat rash does not usually call for a doctor&rsquo;s visit. But you should see a doctor or nurse if you have a fever or think you might have a skin infection. If you have an infection, your skin might:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Hurt, feel warm, or swell",
"       </li>",
"       <li>",
"        Look red",
"       </li>",
"       <li>",
"        Ooze pus or form scabs",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H504077964\">",
"      <span class=\"h1\">",
"       Is there a treatment for heat rash?",
"      </span>",
"      &nbsp;&mdash;&nbsp;No. The best treatment is to cool down and try to stay dry.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H504077979\">",
"      <span class=\"h1\">",
"       What if my child gets a heat rash?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Heat rash is common in children, especially babies. If your child gets a heat rash, you can:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Put the child in a cooler environment",
"       </li>",
"       <li>",
"        Reduce the amount of clothing the child is wearing, and loosen his or her clothes",
"       </li>",
"       <li>",
"        Give the child cool baths",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H504077994\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?4/60/5058?source=see_link\">",
"       Patient information: Blisters (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?23/20/23874?source=see_link\">",
"       Patient information: Sunburn (The Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?22/21/22865?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 86260 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-183.1.191.153-07C1274D5D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_21_22865=[""].join("\n");
var outline_f22_21_22865=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H504077919\">",
"      What is a heat rash?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H504077934\">",
"      Is there anything I can do on my own to get rid of a heat rash?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H504077949\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H504077964\">",
"      Is there a treatment for heat rash?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H504077979\">",
"      What if my child gets a heat rash?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H504077994\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/86260\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?24/58/25512\">",
"      Heat rash (prickly heat)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?4/60/5058?source=related_link\">",
"      Patient information: Blisters (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?23/20/23874?source=related_link\">",
"      Patient information: Sunburn (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_21_22866="Recordings suck swallow";
var content_f22_21_22866=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F72871&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F72871&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 537px\">",
"   <div class=\"ttl\">",
"    Simultaneous recordings of suction, expression, swallowing, and respiration from an 8-day-old term infant",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 517px; height: 200px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Time markers are in seconds.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Lau, C, Schanler, RJ. Oral motor function in the neonate. Clin Perinatol 1996; 23:161. Copyright &copy; 1996 Elsevier Science.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_21_22866=[""].join("\n");
var outline_f22_21_22866=null;
var title_f22_21_22867="Bacterial colonization of biliary stents";
var content_f22_21_22867=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F54167&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F54167&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bacterial colonization of biliary stents",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Sections of whole biliary stents are hybridized with the universal Eub338 Cy3 probe. Bacteria in orange color (arrows) can be clearly identified by their form within the yellowish sludge that covers the inner surface (Panels A and B) in partially occluded stents. Bacteria disappear from the stent lumen with increasing occlusion of the bile duct stent (Panel C: stent center; Panel D: stent wall), when only yellowish masses of cholesterol and other sludge can be seen. (Magnification x1000).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     <p>",
"      &nbsp;",
"     </p>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_21_22867=[""].join("\n");
var outline_f22_21_22867=null;
var title_f22_21_22868="Thoracic dermatomes PI";
var content_f22_21_22868=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F74926&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F74926&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 559px\">",
"   <div class=\"ttl\">",
"    Thoracic dermatomes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 539px; height: 447px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAG/AhsDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooqG4ure2XdczxQr6yOFH60ATUVkL4m0F5vJXW9LaXONgu492fpmtZWDKGUgqRkEdDSvcLC0UUUwCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoooJAGT0oAKKwNQ8Z+GtPlMV5rumxSjqhuV3D6gGqK/EjwezbR4gsM5xy+B+eKnmj3K5X2OtorGsfFOgX5UWet6bOzdFS6Qn8s5rZByOKaaewmmtwooopiCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArg/iP8TdI8EBYJw93qTruW1iIBA7Fj/CP19qz/jJ8SV8GWkdnpyxT61crlEfkQp/fYd+eg/Htg/Kmt313qWoTXmpTvcXs7b5XY5JP+e1c1aty+7Hc6KVHm96Wx2Pi/wCKvirxNNIqXr6fZngW9oSgA926k/5xXCzJJcuXuJpJWPVnYsaRC5IAHHtTjI68L+Zrjcm3qdailsJ9lgA5bB+laeh+Jdd8OTJJoer3lrtOfLWQmM/VD8p/EVkSu7D59p/CqzN9KE30CSR9BeDv2hZUkS38X6cpQ4Bu7MYI92jJ5+oP4V9CWN3BfWcF3ZypNbToJI5EOQykZBFfBeiaLqOuzeVp9s7gfekPCJ9T/Sur8GeNvEfhORYtP1KZoLVihspnLxYycjaTgc55GDW8MS46S1MJYfm1jofaFFYPgrxJa+KvD1pqlnwsq4kjzkxyD7yn/PIwa3q7U01dHI007MKKKKYgooooAKKKKACiiigAooooAKKKKACiiigAooooAKKK8j+Pfj258N2EGkaPN5Wo3qF5JR96GLplfQk5APbB9jUzkoK7KjFydkb/AIy+KvhvwtdtZ3M015eL9+G0UOY/ZiSAD7ZzXgvxM+Kmp+LZ5LWyklsNG+6sCnDSj1kI6/ToPfrXn7Fmwqklm5JNIIxu2gcep71wTrylp0O2FGMdREhLfdUk+pNTbCoAlTA9RQoKMd3CjjIrRaM+QHT5l/iBrBs3SKptV25VuvStzw14z8R+Fpl/srUpkiU828h3xMP908fiMGqNrDlXXqoGRVUKTKVxkgfpQpNPQbimtT6k+F/xOsPGNuLa8MVlrScNb7uJR/eTPX6dR+teiV8EsXgnWWJ2R1OVZTggjuDX0j8DfiVP4gJ0LXZA+oxR7oJz1nQdQ3qw657jPpk91Gvze7I4atHl96J7LRRRXUcwUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABUF/dR2NjcXdw22GCNpXPoqjJP6VPXI/Fy6+x/DbxBJz81q0XH+2Qn/s1KTsmxxV2kfI2t6xdeIfEVzql+5kuLiQyEE52j+FR7AYAr0Lwn8N7SWGC81kyyTuN5g6KuegPc15z4RspNU8RWNsmVRpNzN/sryf5V9MaZHkgHoK8WrJrQ9ilFPU5+L4d6A0MUTWbFVOThyC/+8epHtW0ng7RI4hHHpNmq4x/qh/OukiCgDFTDFZpN9RuVuhykHgjQo5PMOlWrN/truA/A0XPg3QC/mHRtP3Zzn7Ov+FdYcYqrcGiSsKLuzn3sobWERQQxxRDgKihQPwFeHfFjw/8A2XqY1W0G23uG2ygfwv6/j/Ovfbkbs1xfxA09NR8M6jA+AfKLqT2K/MP5VNOXLI2nHmiZf7L/AIgMetano0smIrmLz4lJ/jTqB7lT/wCO19KV8XfAu5Nt8SdEZTy05iP0ZWU/zr7RHSvZw7vG3Y8euveuFFFFdBgFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXx38bNSbVPiPrLliUglFqg/uhAAR/30GP419hvjYc9Mc18KeIL86p4g1O8Oc3NxJMM/7TE/1rlxT0SOnDLVsS0QMxyAMLgU6GMb33dmplqxBBz1qSFwjfN0Jwa4TuQ+SMbXB6E5FSWEoW3ZJOnSkkYHgHNQ7DkhTwTmkMuW0uxM+vFRbtriQc5ytMjO0hWPSkDERN6ZosMqXK7mep9B1ObQ9esNQtiRLazLIPcA8j6EZH41FckhSR9aqNnzMn6irWhmz7z066ivrC3urZg8E8ayIw7qRkGrFedfALUW1D4bWSOSzWkslvk+gO4fowH4V6LXqQlzRTPMnHlk0FFFFUSFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXPfEHTF1jwVrVi3/LW1k2/7wG5f1Aroarak1ulhcG8kWO32EO7HAAPHWlJXVhp2eh8ffCCPzPE8m0cQ2zE/UsBXvWn8DJ6V5f8ADzw42i+I9d3zxTrHtiikiYMkiHncCPoPociu9vP7Y8orpNtakAf625mKgn2AB/UivBq6yse3T0idMsygDmpFnB6EV5Trl14stQsZ1PRIpCe0u0n/AL6FT+GNT8SDUo11g2r2jD/WxMpGccYx/hS5WlcNG7HqPm8VBcOCp5rNa7bZwa8/8Sal4juNUc6NdQx2cRAbcyrz3JJHSkry0Hbl1PRG5BOawdfg8+wuosZEkbLj6jFc3pt54pnDf8TPRJQOwYn+QFbttNftHs1KGASY+/A+VP4HkUnFxZcZXR4z8F08v4maEki5xdBSD2Izj9RX2uK+aPhf4btLH4s3d7qF1BDbwOZLdXYAySyfdUfTcfxxX0uK9nDaxuePiVaVgooorpOcKKKKACiiigAooooAKKKKACiiigAooooAKKKKAGygNE4PQjFfAz8Pu75Ir72uJ4reMvcSxxJ03OwUZ/GvhvxJaCx8TapaEbRDdSxj8GIFcmK6HVhupDBzDnuDSyn96Bjg81FbsVLA052Axg9/yrjOzoTMpjjVs96kjBKbvxprDzrRgv3hyKjimPlqo6mkUTTDDxn1bFFw2FC9M1G83mSJ6Bs1FezCSdQvQUCuOmYGAiqM5w8WP7vNSSOcYB+tV5AS+TxxVJEtn1F+zIc+Bb721Bx/5Djr16vM/wBniwWy+G1rJkeZeTSXDDuOdg/RAfxr0yvSpK0EedVd5sKKKK0MwooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5P4nNcR+FnltfvRzIx4z6heO/zFa6ys/xBaG/0S9tlxvkiYJns2MqfzxUVI80Wi6cuWSZ4foMkv8Aad4blYluGSNpDGMBzlgGI9cD9K6sx/arIws7p7ocEj0/H25rhfDsjP4gvy5O6YBwD/dz8v6EV6NpS5U14UtGe5pynn3i7wRb6pf272ZhtLdJ0uH+TdIGVSpAc8lTnJBxkjJroZtPtijNZW62yY5RPukjvjoD64rr3s4mGWQE1n6mFjjA4UCiU5WsyYKN9Ci0ZOmiX+LbXOaXYWdzZTfbYPOVw688hCeN2OhI7Z6V2i24OmFT1xXNeGiBeXNo68rIePapi2titGtTB8MeDYbTWtR1DUmjuFuOUiiXylQ4AyoXG3gdu561vNDHbp5au7gcAucmuse1jjjJCgcVymo8XLAdKcpOT1HTUVsc1c3F49tqi2yQSW7TNC6KuZS2zg57cgYr6NgDrDGsh3OFAY+pxzXz98O4HufGLFQTE96AQRwSjs+fwC/rX0JXq4ONk2eZjZXkkFFFFdhxBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBx3xAQtNppcZhxKPbfgY/QNXyL4niaDX9RVhgi4c49iSa+1PFVib/RZ0QZmiHmxY67l7fiMj8a+S/ijp7WviD7So/dXaCRT6kDmvNxEXGtfuelQlzUbdjklYGLcalRQ8ZNVM/usVYtWzCw71m0WmPgkeLcoOfSlUglmxj2qJWw2aRWwWB6E0rBcl3BF44NIEXys96jlbhaV2PlgCiwXIyuAQPWo2O6U1ISQhq74bsjfazZ26ru3SjI9up/Sm3ZXEld2Por4PWLWiaLFECrIkrSkfxLg9f8AgRWvZK4n4b6fsinvCPkA+zxfQcsfzwP+Amu2rtwkWqd311OTFyTqWXQKKKK6TmCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA8L1Swk0jxCtvNEytG0kavtOGiJ3Ic+mBj65FdXpDgxg+tdx4hsRqWj3NtgF2XKf7w5H6ivN9GnwNjcFTgivGxVL2UrrZnsYer7WFnujqCw2Vz3iGKeW2It4zK+5SYwQCygjI59q1w2VrFvde0+0mZfNM9x08qEb2H4Cudty2NYRfQzpdb1WNWR9KlXd/q8smWH58VFo8d2NVa8vLb7KXUDZuDZPPPH4Ul54gE0qk2U4KH5QY35/8dqc69G/lx3dleQuThSIy4/Sm4u2xooNHRXV0PIOD2rlLht0xY+ua1J2YRc5wRkZGKraRZnUNYtrYch3Ab/dHLfoDSinOSQaQi2avwx04vfx3S27x21vAcsyFd0z4zjPUgbs/wC8K9OoAxRXu0qapx5UeFVqOpLmYUUUVoZhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAV8//F/wvdNZzILSTy4JWaCYLldpOVGfXHGPWvoCsrxVpzar4evrOMZlePMf++PmX9QKwr0vaLzRvQq+zl5M+FXVkchgQR1BpNxQ8HrXoXjbw69+0mqaemZgAJ4FHPA+8P6j2rz6VGUYYEEdiMV58ZKSO6cHFik8U7OUqHdxipT/AKnI6mqJEyStI0hLfSkDEDp0pE3OxwKAHMxz7mvSfhTo8i3huniLTumLePuxPTH+e1cj4X0GbVboSzIVso2+djxu/wBkV9b/AAx01bDwrbyFAr3LGYDHRTgKB/wEL+dOEPay5EEp+xjztHQ6PZLp2l21omP3SBSR3bufxOTVyiivTSsrI81u7uwooopiCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooACMivMfHFsuja7DOmEgvidvp5o5K/iOR+PpXp1cP8AF+yjvfC8ayDOy5Vge4O1hx+dc+JgpU3fodGFm4VFbqZtjerKgBxmo9QtkmQkwqW9QMH868807WbjTXEGpFmhHC3I6j/f/wAfz9a7HT9dUxq25ZYzyGU5BH1rxWmj2F3RD5F0WEapcbf89617C2+ypnywGI5Y8n86k/t+2CZC/NWVqfiCNYZJHdYowOWY4pt9g5pPci1O4LTFQeO5rf8AhQkN+9/qUeWWJ/ssbEcHgMzD8wPw968nv9SuNWkMcKvFak/Mx4aT/Afzr2L4PbV8O3MSgDbcHgf7q/4V14SCVRXObFyfsnY7yiiivWPICiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPI/HWgR6Rrv221fEGoBmMWPuODk49juzWPcaFpupQIt9ZQzHH3mXn867T4pHM2lr7yH/ANArFsUyqg14WLXLVfKe7hm5UVzHFv8ADHQHclFukHosvA/MGp7b4baDEiK0E8u05JeU8+xxiu+WIA1Ksa56VClJ9QfKuhw0nw+8OtEw/s4DJzkSvn+dJZ+FtH0lvMtLGJJF6M2WI/E5ruZVAU1j36ZQ1EpPa5pBJ9DIsNAn8Q6xBZWzrDAp82d+mEHBx7817hbQx21vFBCu2KJQiL6ADAFeb/DUhfEVyp6m3OP++lr0yvWwMUqfMt2eXj5N1OXogooortOIKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5D4nsF8Oxju1wo/RjXX15n8QNSXVNRisLRw8FvlnZeQXPGPwH8zXPipqNN36nRhYOVVW6HILpy3sRG3msebQb2xkZrCV4cnkKMqfwPFd9pVp5IUsOK0Z44tuWUV4qk0exK1zysnXPuBoP8AeERz/PFLHotzcukt9M0zDkBug+g6V6Q8VqImY7awpCplbZ90dKfP2BRT3MWSyEEWQOa7b4S3ohvLuyc485RIn1Xr+h/SsKWFZAKfZCTTbqG8tziWJtw9/UfjV0avs5qTJrU/aQcT2oZorO0TVrXV7NZrWQEgfPHn5kPoa0a92LUldHhNOLswooopiCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooz6Vh+IfENvpSGOPE94fuxA9Pdj2qZzjBc0mVCEpvlijlfiJIJ9etIFOfJi3H2LH/ACq1jEQATUMUc15dy3d026aVtzH+g9q040CgAV4NaftKjke3Tj7OmoAFp6rwTTscU5eF5pxIkV5BnNULqEshxWkw5qN1GKzkaxdjA0i8OjeILa7fPkg7JMf3Twfy6/hXsSsrqGUgqRkEd68p1C1Dg8da2/BviFrZo9L1JsJ92CZv0U/0/Ku7A11H93I5cbRc17SPQ7yiiivVPKCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooPSo5ZEhiaSZ1SNRksxwAKAJCfSszWdasdIiL304DkZWJeXb6Cua13xsg32+iL5snQ3DD5F+g7/wAvrXGRwPPO89xI0sznLO5ySa4a+NjDSGrO6hgpT96eiNTWvEWpa2xjj3WVkf8AlmjfO/8AvH+n86bplisagBcVLaWycZIrUiVEGBXmTqSqO8megoxprlghwQeXtA5qE4b5G59asbgCOeao6mrovnQ9R1FSJbkNxp8eMgnntWbLbhG2qKvJfK0e4nn0qK2Vry6woOxeWNBonbcWG0G3OKJ4CUPFa8ioidgBVGU8+1JiUrnOp9p0+6FxZSvDKDkMpx+fqK7/AML+NIb4ra6rst7rosnRJP8AA1yk+xjz1qldWAkQsgrajiJ0npsTVoQrL3tz2rvRXlvhvxXdaMBa6gr3NmOFOcvH9M9R7V6JpurWOpRq9ncxyZGducMPqOtevSxEKq03PIrYedJ6rQvUUUVuYBRRRQAUUUUAFFFFABRRRQAUUVDd3UFpCZbqVIox/E5xQ3bcEr7E1Vb+/tbCHzLydIl7ZPJ+g6muZ1LxihDR6VE0jdBLIMKPoOp/HFc3KtxfXBuL2RppTxubsPQDtXFWxsYaQ1Z20sHKWs9EauseKLy/Jh01WtoDwZD99h7en86yLezO4s5LMTkk8k1egtcY4qz5YWvMqVJ1XeTO+MYU1aKI40CLgCpAeaCRTc1FrDvclzxUZftSE/LVZnKtRzBy3LY5FHUVHE2QM08nFK47EUiZGMVm3losikEVscGo3QNSsUpWKOla/qmjsELG7tR/yzlPI+jdR+tdtpHibTtS2oJfs9wTjypjtJPseh/CuOlts9qqT2CSjDAV1UsZUp6PVGNXC06uuzPV6K840nW9R0grHIxu7McbHPzKP9k/0P6V2+kaxZ6rFutJfnAy0TcOv1H9a9OjiYVdtzzK2HnS1exoUUUV0GAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFRXM8VtA807rHEgyzMcAVQ17WrbRrXzJzulb7kQPzMf8PevN7/Ub/XbjfdORCD8sS8KPw/rXLXxUaWm7OqhhZVtdkb934qvr+4dNLC29uDgSMu529+eBWZqOmX+ppm7v5pSOQGbKj/gPSp9PhEUYGKuHcPuk15cq85/Ez0VTjD4EcjcafqNnwIFnQd4zg/lVdNQER2yo8Lejriu2ExAw65pkhikGHRSPQjNZ6GqnLqcxFqAP3WBq3FqBHetU2dmf+WEX4KKU2tqf+WaflUj5k+hSN2JV5OCOhq1ZTmaMh+cHH1qRbO37RrUyRJGMKoAprQltGPdaM73BaBwsbdQe1aUUSWdvsjHA5J9an3c04gGi4m29zCnvWd/YdBVaS8c5+XiuiMMZOdi5+lHlxD+BfypFKS7HKG8Tcd3X2FTxXUrjbDbTSfRSBXSDyl5Ea/lUiTjOFTFPQTmzn49MvrvmREgT35NXbfQrWBc5cyDnfnBB9q1izGomDk4p+hPM2S2PiGfSplivXe5s+m88un49x+tdpa3EV1Ak1vIskTjIZTkGvPbi23ryM1Rha90uXzLCeSLnJQHKn6jpXXQxkoaT1Rz1cJGprDRnqtFctoPi2K7dbbUlW2uTwGz8jn+h+tdTXqU6kaivFnm1KcqbtJBRRRVkBRRRQAUE4GT0prusaM7sFRRksTgAVwPiTW31ORre1dks1OMjgye59vasK9eNGN2bUKEq0rI1Nd8XJbyG30tVuJuhlP3F+nqf0rlpY7nUJvPv5nlk7bjwPYDtTrS3Axha1I4eK8iriJ1nrsetCjCivd3KkNqq9quRxAU8oFoBArJIblclUDFQXBKN7VIGycVDej92T6Vd9CEtSF3xUZkrmrrxPah2hsFk1CdTtIt8FFPfc5IUY7jOfas+ZtT1JcX119kgPW3smIJ9ml4Y/wDAQv41LXc3hSlP4Ub+peIYLWRrW1ja91Af8sIiAE95G6IPryewNcVb+L5dR1BohqNzbXMYDPD/AGTOkMQIJHmPIgOMA8kpnHSt60ht7G38q3jjhhXJwowPcn/GuXs76GDX9X1JC81tdRwiKRIZSmUDA5cIRt5HzDI6042adkdHsFC3M/6+86rwz41tb60Sa7kgNqztEmo2+fszsp2nOeU5BwSSp4wxyBXZsMgHtXnPgWzu7fSbr7eunvFdXU93G1pcNOjLLIz4JKL03Y759ulasNpdaZg6LdeTCP8AlzmG+D/gI6x/8BO3/ZNOSjzNGXsJOKlE7EcUKO9czbeJ4vtCwatC2nTE4DSNuhc/7MnT8GCn2rqwvy8dKXKznlpoxikHg0jR56UEYapE61Nh3Kzw56iqz2zRSrNbO0Uy8q6HBFa5UEVHJHgUWa1Q1Loy3oniz96LbWQI36LcAYU/73p9en0rr1IZQVIIPIIrzW8tlkU5HNLomu3GizrHOzS2BOGU8mMeq/4V34fGte7U+85K+DUvep/celUVHBNHcQpLC6vE43KynIIqSvUPMCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKpavfx6Zp893NysYyBn7x7D86u1wXxNvTvtLBTxjznHr2H9axr1PZwcjahT9rUUTmJbi41jUHurptzseB2UegrdsbMKo45rL0SIE5xXSwgKua8Ne87s9mb5VyoBAFFMZcVma/wCIFsJUs7OL7VqUi7lhDbVRem+Rudq59iT2Bwcc9LaXN+C2s301yW58mImGFfbapyw/3y1W0luKlTnU2OovL+ysv+Py7trfjP72RU4/E1QPiPQT/wAxrTP/AAKj/wAayLbTLC1/49bG1h5z+7iVefwFW6zvE6VhJdy3/wAJDoH/AEGdM/8AAqP/ABqSPWdGlBMWq2DgcErcIf61QpkkEUjZkiRz0yyg0Xj2H9Vl/N+H/BOgt57eUgQTxSEjI2ODx61O3ArjZNH0yXiXTrJxnPzQKefyph0HSlH7vTrWL3ijCH9MU7xJeFl3Ot34eplbIrx6C41JvE8ukvZeQkUUdy8kWvXWBG7uowuwAt8hJGQOnNanhaVNbgvWuIdVtWtrprcwz6nLIflCnJAcrn5ugJ+tU423/T/MzVGUtF+v+R6exCqSxAA5JPasy41zR7ZttzqthE3pJcop/U1zn9haUTl9OtZWH8UsYdvzOTV6CCGBdsEUca+iKF/lUXiaLCy6sv8A/CTaH1XVLRx6o4YH6EdaF8TaMD814Ix6yRug/MgVUpc0c0exX1R/zfgaUHiXQZHCDWLASHgI1wqt+ROa3I/LkjDIysp5DKcg1yDAMpVgGU9QRVAaRZRyGSzjaxmJyZLNjASf9rbgN9GBFWpxM5YOXRneSRcZFUp4gQeK5+31rU9MAGoA6lZDrNEgW4jHqyDiT3K4PoproLa6gvbaO5tJUmglXcjochh60TS3Rz8soO0jHv7QFSccV0XgnX5DKul377jj9xIx5OP4T/SqNymVNc/eK8EyyxMVkRgysOxHSnRqulLmQ6lNVocrPZKKo6HfjUtJtrsYBkT5gOzDgj881er3k01dHhtNOzCiio7mZLe3lmkOEjUs30FNuwkrnJeONWIxptu2CQGmI9Oy/wBa521gyBmoPMe9vZbiT70jlj+Na9qg4r56tVdabkz36dNUaaiiaCIKuamZsCjoKikPalsRuNZiTSVV1G+ttOtWuL2ZYogQMnJJJ6AAcknsBya5m6uL/W8ibzdP049IFbbNMP8AbYfcH+yvPqeq0rdWaQg5O0TVvvESR3L2ulw/b7xDtfa22KE/7b4OD/sgFvYdazbuwn1FN2uXbXeefs6Dy7ce2zPzf8DLfhVm0t4baBIbaJIoUGFRFCqo9gKi1LVbSzPkszTXRGVtoFMkpHrtHQe5wPU1SbekTpjQhDWeplXG23lWONQiDgKowAKq3WrRW8ogRXuLthlYIhliPU9lHuSBVHWF1G7uFMpFhAf+WaEPKR7t91foM+xqeyjtNMtmZfLghHzySO3X1ZmPJPuTUWS3O27a00Qs+lS6pE41uTdC4IFpA7LGoPqwwzH34HTAyM1xtk2m6f8A8JM+qaxqVvBZ3ZhRjqU7NHF5cRwoLHncxGcZ54Irrrhr/WbeRbN2sLUqQkzofMlOOCFyCqfiGPbbwa5zQ7O9vYtTt5hogitLh4FC6W7bnUK3mEecSTyeBznnNaxdl7zOaau1yr5vqangCzWXTby90XWELy3TSiD7WL1Y0IGElIY5fgtuDZG7GWAFdQdY+yjbrFu1n/03B3wH/gY+7/wML+NYHg2+1mXS7iYOl9FBcyQeQ6tDLtXGCBISyHn7kpz0O4AgV09jqVtfh0iYrNH/AKyCRdsifVTzj0PQ9iadT4ncmjblSTs/6/rQWMxzvxskicfUMD/MVJb6fPpyg6FdGyUc/ZnXzLc+2zI2f8AK/jWO+kRw3hk0yV7CVjkiIAxsf9qM8fUjB960hqt1YDGs2hEI/wCXy1BeP6uv3k/8eUd2qaf91lVkn8aNS28Rokiwa1ANPuGO1ZC26CQ9gsmBgn0YA+ma3kbDYNc4Wt760DRtFcW0y8FSHR1P6EVnwpe6OQdJcTWg62M7/KB/0zfkr/unK9ht60m032OaWHaV46o7tWyKefmWsTRdatdUVxCzR3EePNt5Rtkj+q+noRkHsTWwjZp7aM5miGZKx76INkEda3ZRlc1l3a9azmjSmy98ONSeO5uNImbKgGaHPbn5h+oP5131eNC7Ol65Y3ynAjkG/wD3Tw36E17KOeR0r18DU56fK+h52Pp8tTmXUKKKK7ThCiiigAooooAKKKKACiiigAooooAKKKKACiiigAryTxvO0/ii75yse2Me2AP65r1uvGtfbf4i1An/AJ+HH5EiuDMHaml5nfl6/eN+Rp6EuEyau61qKaXpVxeSKziJMiNerseFUe5JAHuag0kYhFZfih/tOqaZY5zGha8lHrswqA/8CbcPeOvMieg4uUrIpaZbSQRyTXjiS+uG824kHQtjoP8AZUYAHoPrV2s6+vlhlCk4HcmqkN/d6sNulEQ2nRr11zu/65Kev+8ePQNU6ydz07Kmkkat5eW1lF5l5cRQRk4DSOFBPpz3qiNaWX/jysdQuh6rD5Y/AyFQfqM1NY6TaWkvnBGmuiMG4nbfIfbceg9hge1X6NEFpPyMsXWrSHMWmQIv/Txd7T/46jD9aXfrJ58jT09vOdsfjsH8q06Wi/kHK+5nI2s5z9n05/8AZ891/XYf5USXWqRD9/pUbj/p2ug5/wDH1StiJaS4Hy1fTYmzvucPMXj1ybVP7J1MXEtvHbMpkt9oVGdgf9Z1y57+lM8K2OpaW140CXdybuXzn/tG4hTD4wSPJj7gDjkcDGOaw5fDmlWXirXrn+wYEtUs4GhMFmAS377zPL2j75G3O3n7vtVz4ZJZ28uo3ENnLpSXHl4s3tJbeONVBAJZ1VWkbPzbc9BycZNu1nby/rczV7q+m/X/AIB2IbWn6xadB/21eX/2VaPJ1k8m909fb7G5x+PmjNSy6xpkP+t1GzTnHzTqOfzqP+39G/6C2n/+BKf41l73RGnu9X+InlayOftunv7fZHXP4+af5UnnazH96zsJgO6XLIT9FKEfrT113SHYKuq2DMegFwhz+tXYLiG4XdBLHKvqjBh+lDut0CSfwsz/AO12iP8Apmm39uP7wjEwP/fssfzAq3Y39pfqzWdzFPsOGCMCVPoR2Psauxpmqmp6VZ3rLJcQjzkGEmQlJE+jjBH50WTQXkttSxmoNDl/s3XGss4tNQ3SxL2SYcuo/wB4fNj1Vz3rDmvrrR7iOG9druzkYIlztAdGJwFkA4IPQMAPQjub+sS+Tpy368NYut3kddqHLgfVN6/jTirO3citHng+6O1kGVrH1GPI6VtcEZByD0rOvUypqWcMHqbvw2uM2F3ak/NFLvA9mH+INdhXnvgGTyteniJ4lgP5qR/ia9Cr28JLmpI8nFx5arCud8dXJh0XylODPIEP0HJ/kK6KuL+IMu64sYB2DOfxwB/I0YuXLRkwwkeatFHP2EeAK14ABVC0GAKug46V4cT156smkcDgVn6nfQadZS3d2xWKMZOBksegUDuSSAB3JqaV9iEmuQ1ad9Q1uIS4FnaKHjTP35TkbiP9kdPdiewqrp7hTpubsgghmvbpdR1Vf9K5MMG7ctqp/hXsWx1b6gccVJqGoW9giG4Y75DtjiQFnkPoqjk/078VBfX8iOlrYxrNeyAHDH5Ylz99z6dcDqTwO5D9N01LN2nlka4vZBiS4k+8f9kD+FfRR+pySt9ZHoRjyrkgMjh1LUvmupG0+1P/ACwhYGZh/tSDhfonP+1WlaWdpptq620McCHLuw4LHuzN1J9zVB9XMsz22kw/bbhCVd922GI+jv6/7Kgn1A60r6MLnbLrU325xyIcbbdD7R55+rFj6YrXproR193V/wBf1oc3rmqfa5lGkxfaxn/XbtsI/wCB/wAX/AQfwosdNMksc+oy/apkO5FxtijPqq+vucn0x0qXxBqNvDfiDcXmxkQxLvfH0HQe5wKhgj1C+2+Y39n2/dEIaZvq33V/DJ9CKyXlob6W11f9f1qaGqatb2EbKVluLkIXFvboZJCPXaOg9z9OtcbpktvrrX9pbqIfNn8+4iks7yPy5QFbmclNjYCHgDHUA13FtaW1hbMLeNYkOWdiclj6sx5J9zXFxWdpfW+u2015efZdRvftCy6dA8uU8uNSpby2U5KHI5BB9yK0hboZVVLS9vT/AIJ0fgXWdCl08w6YPJMtw4MjyvKtzKOGZZn5kPHfnAHGMGuiv9Ntr9UM6HzY8+XMhKyR5/usOR/XvWB4F0SGDQdSt7i9h1W1ub2aUKVQqqs2drKEXDeq4wD0wK1DZX1hzpU4nhH/AC63bk8f7EnLD6HcPTFOpbn0ZFJv2a5kULmTUtMuV8xTqNsP40AWdR7rwrfUYPsa6bSNTtNQjYWsyvJHgSRkFXjPoynlfxFYE+qQvMkVyklndHgRTgDd/usPlb8CffFaf2Cz1OGNrmL99GPkmRikkf8AuuMEfnSi9bSRck2rxdx13oyrM9zpkpsbpjltgzFIf9uPoT7jDe9VU1VreRYNYhFrIxCrMDugkPs38JP91se2etTt/ammD5y2q2n94BVuEHuOFk/DafZjUsNzZ6paOYWjuIGyjqy9D3VlPIPqCKJ+eqJh5aP+v60Ir2xjunjkDSQXUX+quITtkj+h7g91OQe4NaWi69Kt3Hp2shEu3yIZ0GI7nHPA/hfHJX2JBPOOea2utI+fTg9zZDrZs2XQf9MmPb/YJx6EYwVuJ7TVrAbJGMUh+V0+V43B4IzyrKw78gipTsvIVSiqvlI9FZty8VSuRkGpLeTKDJzx1pJhlamWpxR0ZzWtw77Zj3FepeFLs3vhvTp2OWaFQx9SOD+orznU0zA4rsvhnJv8KxJ/zylkT/x7P9a7MulabXkYZgr00/M6qiiivYPHCiiigAooooAKKKKACiiigAooooAKKKKACiiigAPSvGdTTfrd+w5/0iT/ANCNetaxfx6bps91L0jXIH949h+Jrya1VpMyyfM7sWY+pNebmElaMT08ui/ekbWmcRgVgyt53iXV5uf3IhtMeyp5n/tb9K6WyAEYrlLFvMl1Of8A563sw/74by//AGSvOXws9Ggr1UYniZY3t5BOgeM4DK3QjPINXLbWYIz9mto5Lu6UDMFuASv+8SQq/iR7Zqp4hjE0EqHoykVF4QmiisIY4o0iCfI6qMfMOp/Hr+NSmranpSi3sbAi1i65muLewjP8EC+bIP8AgbfKPpsP1pw0WN+bm91Gdv7xumi/SPaP0pX13Tw5SKY3Mg4KWsbTFT6HYDj8cU1dWmc/u9Iv3Xsd0K/oZAf0q/e9DD3Ouv4jv7A0pj+8sYZv+uw83/0LNPTw7o3/AECNPx/17J/hSLqV1n/kC6h/33B/8dqVdSu/+gJqP/fdv/8AHaa5u/4ifJ2/AkTw7ov/AECNO/8AAZP8Kjn8P6IqfLo+nDHpbJ/hThqd2P8AmCaj/wB92/8A8dqvdareFcLo16p9ZJIQP0kNW3K2/wCJKUL7fgcLqCbfEw0tfDOhCMoZ1lE2D5QcLkr5P3uQduce9XPC0llc+ILrTZtE0dJreISNLaOswQk42PmNSrEcgc8ZrOuNe0268SJPHc2X9oeWbIQnUoecuDgAEtuyAMVb8N2N1a63LMk6ahf28Atyl3qKl4I2IYAhIc87c5bJOOvWh3tr+f8AwRK11bXXt/wD0GG3ghx5MMceBgbVA49KlrMD6y/SDTof+2zyfj9xfypdus/89dP/AO/b/wDxVY27s35uyNNohIpV1DKeoIyKqS6Dpdw26406zkb1aBSfzxUKtrKd9Ok9sOn680NfavEMyWNgwH9y9YE/QGPH61aVtmRJ33X4Ew0K2hGbSe9tG7eVcsVH0RiU/Sq8y6xa58q4t9QjH8M6+TJ/32o2n6bB9aX+3XAzcabfRKOroqzD8o2Zv0pqaxZXe5Le5RpQMmJvlkX6qcEfiKcpSsKMY300f3HP6pq63U8dq8U1tdM6kwyjnAOSQRlWH0JxnnFdVBGs1oY5BuR1KsD3Brl55PtWtxxjlYF3t9T0/T+ddTZsDGKyfkdFnazNbwlM8/hnTHmbdMLdEkOMZdRtb9QasXfQ1n+D222F7bfxW95MD/wNvNH6SCrt0Sc1ctzyIqzsL4TbZ4otfRg6/wDjpr0yvKdNl+zavZzHgJMufoTg/oa9Wr1MA/ca8zzsevfT8grgvHLZ1yIdlhX+Zrva8+8ZsH18gfwxqP5n+tPH/wAL5iwH8X5Fa26CrVV7UfKKsV46PTluUtSk2Qt9K861TUWtdQdIV8y4mwkMefvN7+wGSfYGvQNY5t2rzm7cRazbu2MbimT2zQtzooaNWN3S4rfSNOlmupwXP725uZOC7ep9B2A7DAFNWK61n5rnzLTTj92AErLMPVz1Uf7I59T1Wquir/bE0d/OAbKI7rOM9GP/AD2P1/hHYc9Txo3epO1y1npkQuLxf9YxOI4P98+voo5PsOapXv5nS7W8vzLzXFlpFknmGO2t1wkaKvU9lVRyT6ADNULltR1OMs5k0yy7KCDcSD3PIjHsMt7qatabpcdtKLu6kN3fkEG4kH3QeqovRF9h17knmqfiLWILQfZ13z3bDKwQjc+PU9lHuSBVXsrLVkJXd5aIyILS3tpHW1iVFLZY9Sx9WJ5J9zzTm1FEmNvaRveXa8GOLoh/226L9Dz6A1BaafeagN1/KbeBv+XeBiCf96Tr+C4+prftba3sbcJEkUEEYzhQFVR3NZ6X11Z0Nu1o6L+v6/QybnSJr+Bv7WuMkg7IYQPLjPY4YHew/wBobeB8orlbA6y0XiIQ+IZUns7k2lq92kCRKTHEys5WLrucj06cGuuvtUmubeR9KgLwIpY3ciMyED+4i/NIfTGAexPSuSgn8PX66it5dXxQFnvZJrKW3hVgqk7wYwhO3bw+SRjrW0b9V+BzTcfsv8bXOj8K28+orqn225u49asbn7NJdLJFID8isFDJFGHXDjh0yCT0rX/tO4075daiVYx/y+QA+V9XHJj/AByv+1VPw1P/AGfoynTLHz9HDfL5Ng1nMvGSxhKqHB67kAz2U1vWd5b30PnWkqyx5IJXsR1BHUEeh5oq76rQmivd0ev9ff6kN/bW+o2TJKkVxbyDOGAZWH8jWPp1reWLldMu8oOPs10S6Y/2X+8v47gPSr0mkLA7y6TN9ikc7mQLuhc+rJ/VSpPc1mNqNxp9znVLRoVB5nhJki+pwNy/iMD1NQrr4TZ2a95W8zfi1yKNki1WJ9PmZtqmUgxue22QfLz2Bw3tTdU0qG4m+0ws9rfAYFxFwxHow6Ovsc+2DzVq1mt9QsQymK4tpV6gh0dT+hFZsunXGn/Po0gMI5NlMx8v/gDcmP6cr7DrVtrpoZpPrqiGHUpYJ1s9WRIrhjiKVM+VP/u5+63+yfwJwTWTfxlNdtprZgglkC3Cdnx0b/eGAM9x16DGjNdWesWs9rPEQ4GJraYYdPTI/DhgcccGues/tEeu29ncs0yR/PFOerL0w3+0PXuPfNZ21NW7Ru9V0PVdNk3xirkn3azdJ+5Wk/3Kk86WjMnUB+7NdN8LWB0K6X+7dN/6Ctc5ejKNWz8LJdq6ratjcsiyAexGP/Za6cC7VUY41Xos7yiiivcPECiiigAooooAKKKKACiiigAooooAKKKKACiig0AcF8S785tdPQ8n9849uQv/ALNWJpsO6ECm+MbkXnii6K8rERCP+Ajn9c1e0xcRrXg4mXPVbPdoR5KMULqF0mlaRd3soLJbxNKVHVsDOB7npXN6ZbPZ6VbwTMGmVMysP4pDyx/FiTWp4uJl/s3TlP8Ax8TiaQf9M4sOT/335Q+jVC44NZS0Vjrwiu3I57VFzmuMvFt7fWkjvFaS0kXdIhY+WpJwpZejZw3Xjg122qdT9a4nUI5Lq2hmiaMSXszSpvUsPJQbUHUcHJb/AIEaKS1bO2tLRRS3O7s5ons/sybY124UKMACmpZ3JfAZNuc7s1xVjdapp6hJbRZ4R90wy5YfgwH862IPEMq48yyvUHuit/6CxpcrHzL0O2t1aOFVkfew6mrCuAOTXHx+I8j5bS9Y+ghx/PAqVdYv5uINMkVvW4mRF/8AHSx/ShJkOx1EtwoBwazLmfecVlOur3P37m2tVP8ADDGZGH0ZsD/x2kGgxznN1NdXRPXzZSFP/AFwv6UO3VjV+iM27sLr/hJrm8jdLeJ9OFvHcPhgsu9iPlyCcZB9/WsrwBoGo6J4j1ee5uLe5tbiGAG5SLa1xKC5Zj+8Ygjdzkc7hjAXB0rI6emvDS/+ERnjuNokMnlWgRYy5XzCRJnGQeAN3tR4WvfDvi8ySWWiQhI1DF5VtXI54BVHZlPX7wHStveUWumnb/M57xc0+t33+fQ7iF8rUlY6+H7BP9THLb/9e0zwj8kIp5028iBNtq117JOiSKP0DH/vqsbLubXl2/r8DVrO1Gylnk3xSAZA4J6VTeXW4M5Gn3X/AH3B/wDF1Xl1XVEHz6fEfXyrnP5ZUUcpSkXrO0ktpN80oJ54FZXi25shp0jXcC3GwEomMsWx/D3B9xVG91XVCCVsEz2DT4/kprDtjfza/ZTai0Kp5oURJk4zx14/lTjHW7FOXuuyv8jd8NwmO0WQuZGlAcuWLE56cnk11lnkACub0yL7BeXOmkYWEiSD/ri2cAf7pDL9APWumsxlc1MviLjJSgmiXRpPs3iW4tycJfW4mT/fjO1/xKvH/wB8mt6ePdxXM6u32SO31MD/AI8JROxH/PPlZP8AxxmP1ArtEh3txzWlrpM8ut7k2ZUFm88wRByTXpkOfJj3fe2jP1rE0eyWL5ivzVvDpXq4Sl7ON31PIxdX2kkl0A8DJrzzVv8ATNUmmXozcfQcCu7vifszqvVhiuUNoUl6cVONTklErBtRbkVba3KrzRKu2tJosLwKo3I4NebKHKjtjPmZhau37lq828U26S25EozGW+cA4yO/6V6JqzZjIrifEEfmWkoxxg1lH4jsjpEnguZr6c2OmuYYo8C4uVH3P9hO27Hfoo98VuRJZ6Pp/BjtrWEZZnbAHqST1JPc8k1yvh/UYbLTrW2s4GnumQFLeM8nPVmJ6DOSWPXnqeK6C20x5po7vV5FuLlDujjUfuoD/sg9W/2jz6bRxVbeh2PV3Wr/AARHJdX2qDFsXsLE/wDLZ1xNKP8AZU/cHuwz7Dg1DHZQQjyrWPYhO5mJLM59WY8sfc81p6jdWtlCJLuVY1Y7VB5Lt/dUDlj7DmsxIr/Uz0fTbL14+0SD9Qg/Nv8AdNJ3kuyCNoPu/wCvuHzX0VrILaCN7q9IyIIsZUdi56IPc9e2elLDpEl5Is2tOk5BDLap/qIz24PLn3bjuAK07CxtrGDybSJY0zk45LHuSTyT7nmqk+roZnttNia+ulJVhGcRxn0d+i/QZb2px7RFLvP7v63Ld1whzwK8yvrKK7sPENqlz5v2++W6ikto5pEAQQ/K7xr8uTEQcEkA5rt7jSpLzLa1MLkHkWyDbAv1HV/+BcegFczo9tqL+JNSsG8Qaj5FpHF5eIrYH51briHtgEfrmqhaN2nsTUvJJNb/AOXqjqPAcFzFp15LPfJcwzzb4IUvZLwW6hQCvmyAOxJBOCOM4q7f6TFPObm3eS0vcY8+E4LegcdHH1Bx2xXN+E9Nm1a41XU31S9lt/NFvY3e2GOVxHkO5Mcaq6FshQwYYXPet03Wo6dn+0YftluP+Xm1Q7wP9uLk/iufoKuonzXT1M6TXJqtBhv7uxYpq1vuhHS7tlLJ/wACTlk/8eHqRVstFeW6y28iSxsMq6MGDD2I61YtbmC8gWa1mjmiboyNkfSs250WP7Q9zp8sljdOdzPDjbIf9tD8rfX73oRWLs99DdXWq1RF/ZapK01jK9jck5Z4gNsh/wBtDw316+hFOOsTWZ2azEsK9BdRkmFvrnlD/vcf7RpDqFzY8aza4jH/AC92oLx/Vl+8n/jwHdqv+bDc2yywSRzQSDKshDKw9iOtNtpe9qhJJv3dH/XQyNbtY7xVkDtFcR5MU8f3k/xB7g8GsPRpp7jXCLpAssI2Er91v9oegPp26c9asXtpNp25tKwYP4rMnCf9sz/Afb7v061U8OzeffzT7WXec4YYI9jRHZ9hVnZW2bPT9JPyVqNytY+jHMYrdjj3JUpXOCejM6ZNwNM8J3P9n+MIlJxHdoYT9eo/UY/Grs0eAa53VWa2uIbqP78EiuPwOaqnL2c1IJR9pBx7ns9FMglWaCOVPuuoYfQin19GfPBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABSMQoJPQUtVdUYppl246rC5/8AHTSbtqNK7PGo3NxePM/LSOZD9Sc/1rqtPX5FrlLLh1rrtNHyLXzi1dz6GporGJdP9q8UX8nVLKKO1X2dh5j/AJq0X5UyY4zUWiP59ncXh5N3czTA+qFyE/8AHAlJethDV1t7HVhY2gjl/ErtJCLaFis104gQjqu7qw+ihm/CsbVbi1i8SJab1hS3hSKJW4U98AngnGOOtbVkv2zxDJIeYrJNo9PMfk/iFx/32axbdEvrm6mkVXjmkY7WGQVzgfoBUqyjqaJudXTobdtCJl5AzWjb6apXJArnbbSbaF/3SzQL6QTvEv5KQP0rftdPBUeXfagh/wCu27/0IGotHubylNdC4mmxqclRVhLONTwtVRo8ZHzXmonPX/SnGfyIx+FL/YdmfvPeuPR76dh+ReqtHuZ80+xdMccSlnKqo6knAFUW13SlYpHexTSDgpb/AL5h/wABTJpyaDpKMG/s20Zx0d4lZvzPNXiFjUKoCqOgAxij3UL33/X/AAxzLSxN4il1SJdR+ezW1CfYJF2kOzbssB/e6Y7VU0Mi11h9T1y/lnu/sy2iv/ZctqoQNuJYnIZicdCAOw5ptxqeu2/iWezuL3TDZQWovnKWEgkMe9gUB87G7C/ex1PSpfAviWfXOb+SGGeWFbiKyFnNE8cZPXzJMCUcqCUUAHucitbNRb6f15GCackuv9eZ01pqmn3jbbS+tZ29IpVY/oauVBdWVreLi7toJ19JYw386pjQNLUYhtEgHpbkxD/x0isvdN/eNF1BFVZo1UEnFV20S1/566h/4MJ//i6p3Oi2x4L3rD0e9mYfkXotHuNOXb+vuK+oOCTyAo6muR1fUbZZN1tMs80ZB2w/OQQeM46fjXRXOi6ZGdxsrdmHRnQM35nmqF4iiEqqgKBwAMChcqZraUlbb+vkb+ugNZ2urwcm3Xe2P4oWA3j8MBv+A471rabIHQFSCCMgjvWb4Yl87RIEPJjzGfoOn6Yo0CM2F5LpTcJEPMtfeEngf8BPy/Tb60NX+RyUpcjcGdQsSzRtG6hlcYIPcGul8Hadc2uh2kF9zNCpiDE5LIpIRj7lQpPuTTPDumcLPMP90H+ddUi4xXoYajpdnlY/EKUuWPQkgQKvAqxTIxgU+vTSsjyG7kMq7s5qpNbqRnFXiOKY4+WonFMqMrGPLHjjFZt5H8pwK3ZotxOKz7mBgp4rgq0jspVDhNaBQHiuVnia6cQoCXdgoHqSa77WrfchGKyfDGmmbxRZLjhJPMb6Lz/SuJUnzJHpKqlBvsc5dWNn4W1rUYH8q2iEgdnY4yWAI5P1wB+Aqwt3f6gNunwG1tyP+Pq5Q7j/ALkXB/FsfQitj4maVbw+OYtReIPLPbqVd8ttKkqdoPC8Y6VmT6taWm2J5DJcsMrbxKXlYeoUc49zx6mitHlqyildnZQnz0ISbsrEljpUFpKZ2L3F4ww1zOdzkeg7KPZQB7UX2qwWkwt1D3F4RkW8A3Pj1PZR7sQKrtHqWo/6xjptseqIQ07j3blU/DcfQir1hY21hCYrSJY1J3MerOfVieWPucms3beWpor7RVkUBY3uo/Nqs3k25/5c7ZyAf9+Tgt9BgdjurUijgs7QRxJHBbxLwqgKqAfoBWdLrAmkaHSYft0wJDOG2wofRpMHn2UEj0FImkG5cS6xP9tcHcsO3bAh9k/iPuxPtim7/a0ErfZ18/6/QqXerS3iH+xLb7UuP+PhzshP+6ern6fL/tCuL/tnyrrU7jUrPWbdrZFN7JHHaIoG3cowrszZBwMlgM84GTXoup3UFlD5lzKkUecAscZPYD1PsK4e90m/1U66LGMxR6p5eHuW8krtULwuGJBxyGC8HHvV02u2hNVSto7v/gG74W1G7a0mg0y3d7awZYHsblIYpYwUVl8t4iYmG1hgce7CuhstTtryRoVZorlRlreZdkij1weo9xke9c74UiHh83iasUs5ryZZAkduILQHaF/d4dwGYjJywLHtXTXtlbX8QS6hWQKcqTwyH1Vhyp9xzTq2uTR5uX9CpeaTDLcNc2zvZ3jY3TQ4G/HQOp4cfUZHYioDqN1YDGsQfugf+Pu2UtHj1deWT9QO5FPaHUtPBNtJ/aEA/wCWUzBZVH+y/Rvo2D6tU1lqttdy+Tl4LrGTbzrsk+oB+8PcZHvWevqjTS+mj/r+u5bhminhSWCRJYnGVdGDBh6gjrWLf6XEkrz2EjWVwx3MYh8kh9XTofrwferFzo8CyyXFg8ljcucs8GNrn1ZD8rH3xn0IrOuL2/tARf2ouIx/y3tASfqYzyP+AlqS/usvf40ZV7fXUAaO8tizH5VmtwXRj2yv3l/UD1qLQo/Lj3nqTXV/D9LbxB4njihkWRIlaSVOjIAMDcp5HJHWsNYTbyywkYKMVI+hq+VqF2rXMK01KooJ3sr/AH/8MdpoL7ohXVWgytcZ4cf5BzXZ2Z+UVNPc465FdpjNc7rMe6Jx6iupu14zXP6muValNWYUWd54NuftfhnT5M5KxCM/Vfl/pWzXF/C6436Td2xOTBOSPYMM/wAwa7SvfoS5qcWeLiI8lWS8wooorUxCiiigAooooAKKKKACiiigAooooAKo66caJqBP/PvJ/wCgmr1ZviRxHoGoM3TyGH5jFTN2iyoK8kjyK0GJFrfurw6d4fv71fvW1vJKOM5KqSP5VgRcMn0q94hk/wCJDFAPvXNxDFj1XeGcf98K1fPQ+JH0FVXVkPsLYWOlWloDkQQpED/uqB/SszWrlLa0mmlbbHGhdj6ADJrVkl+WuZ8Sf6QLWz/5+rhEPuoy7D8VRh+NEnzM71+7i32G+HbCc2cNuw2Xt4+ZP9mSQ9P+A5A+i1z8uhz6LfXFrYTbGgkaNopRujYg4yO6k+3HfBr0zwRZm88SQuRmOAGVvr0H6kH8Kwfik9vpXjiUTt5KXcaTIzjCMT8pG7pnK9Pet/ZydH2i7nHQqx+sezk+n4nP2upywts1CwuEx/HCPOU/Tb835qK2rfWdLj5muhbf9fKtD/6GBSQwrOisvXqDWvbAqgVuormuux6ElLoyCDVdOn/1F/aS56bJlP8AI1K97aRrue5gVR3MgAp09pb3GfPt4Zc/30DfzqOPTLFHDJZWysOhESg/yp+6R7xW/t/S2/1F4l0fS1Uzn8kBpkmrbx+40/UZfT9x5f8A6GVrbROOlRzrgU9Owlzdzl2f/iZm9fQ7/wC0NEIGcvEcxgk42iQ9ye2aj0a20TRZmktdO1SCXZ5Q8yG4nEaZzsT7youR91cDge1ZMOlRf8LAu7Q3eqm2jsILhYzqdyVEjSzBjjzPRV46DHStHwLb+dqGp6na3N++lM32W0juL2a4EgQnfMPMZurcDHZc9600SZjdtrTv/WyOgGuaaow9yE/66IyZ/MCmf8JBo/fVbAexuEBH4Zra/hqE9azfL2Nlzd/6+8yj4g0bOP7X07J7faU/xqvda9pAQlNTspG7KkysT+ANbZOKq3PzAil7vYpKXf8AD/gnH3Gr28rEotzKO3l28jA/jtx+tZl5c3k+Vt7Mwj+/cMPzCqST9CVrqb0bQRWVZJFea/p+nySKr3c6RKv8RBIBOPQCnHV2SLk3GLcnZHe6R4cfTdE0pJDulntVmkbbjLkknj6ECtK00GG6vLSaZWEls5ZGU4zkYKn1B449QD2ru9TtVljh2qP3ZwAOw/zioYbQRngc16bwtp3R8z9bclruS20QjUCrUa5NIkZwM1MFwK7IRscUpXFFK3Q0lL2rQgZ7UjDinMOaSpGRBeaSWEOMYqTvT6XKh3sYl9pqyjpzTPDejrZXM9y6/Ow2L9O9bTcnpUifdGKhUo83MaOrLl5TzX416f8AabbSrjzp4gkjxsIm2lgQDgnqPu9iK5LQra2tIClrCkQJy20csfUnqT7mvRPi5byz+EHeB0SWGZHDOm4DJ2njI9a8p03SYrlR/aM096O6StiP6FFwpH+8DXl45Wq6vc9/LHzYfRaps059ahMjQ6fG+oXAOCtvgqh/23Pyr9Cc+gNNOm3F+d2sThos5FpASsX0c9ZPxwp/u1oO9tY2m52htraIYySERB/IVn/2hd35K6Tb7Iv+fy5UhP8AgCcM/wD46PQmuVf3Tsf97Xy/r/hi/NNa6daBpXhtraMBRkhVX0A/wrPN7f32RYW5tbf/AJ+bpCGb/cj4P4tj6EVNa6RDFOlzdO95eL0nnwSv+4o4T8AD6k1PfXUNtA8txKkUSjLO7BQPqTSultqOze+iMyHTILaf7Q7SXN5jBuJzufHcDso9lAFcZH4Q059Y8RpDpsWno9tGltdW1mA0RKOHMWBnPIyF5Nbms+IjbWxnit7iO15Ju5LSWRVAGS2xFLEe7bR6E1Ss9R0iaWye+1TUPNvZhBAspntGlY4+5GApK/MPmwRzya1hzrXuZz9nL3dNP+G9S18O9MuIJdaaW1hg0iZYYoIk05rFJGUP5j+Q7EjO5QScbtvTuehXTbjT/m0WZViH/LnOSYvoh5Mf4ZX/AGazrzV00vVRptrqrXM29IzbXkUjKjsMqn2hVIViOQH3E5GOorTt9Zh85Yb5JLG4Y7VS4wA59FcfK30Bz6gVVVyb5iKKgo8vb+v6RLBrEDSpb3qPY3bnCxT4Ac/7Dfdb6A59QKsX1lbX0QivII5kB3AOM7T2I9D7ipbiGG5haK4ijlicYZHUMD9QazP7Lns8HSbtokH/AC73GZYiPQEncv4HA9DWOm60N9Vo9URyWmoWIJsbn7VCP+WF4xLD2WUc/wDfQY+4rOn1mDeIbtZLO4bgJOAAx/2WHyt9Ac+1aMusi2XZq9u1i3/PUtvgb6Sdv+BBTVLUjHNGUdVkjYcgjIIpS/vIukr/AAs9C+EGnKEv9TZBvci3Rsc4HJ/DJH5VxvjOzNh4rv4sYVpPMX6Nz/WvV/h7pUOj+EdPt4IxGHTzio6Avz07dQK5b4v6aA1lqKDDHMLn9V/rXpVaNsMrdDwYYjnxkm+un3HMaJJtcD1rt7B8qK890tiCp967fTJMovNedB2Z2Vloa1yMpWDqK8GteRyRis2/GVNVUdzGloSfDKXy9Z1O3/56RrJ+Rx/7NXo1eX+B38nxeq9PNhdP5H+leoV62Bd6SPOx6tWv3Ciiiuw4wooooAKKKKACiiigAooooAKKKKACuW+IV0YtGS2Q/NcyBT/ujk/qBXT7xuArzrxle/bNfMIOYrUbB/vHk/0H4Vy4upyUn56HVhKfPVXlqc+8e1lwKh1SYS6no9qT/q/Nuz9VURgf+RT+VaE64wQK5o3STeJL2TcAIIorcD0bl2/MOn5V4sdLs92EeeUUbkj5rFfE/iId1tbUuR/tSNhT+Ubj8avCUv0OaraJEZv7SvCDiW4MSH/ZjAUj/vvzKUerOnEO0Uu56R8NLPy9Pubsj5ppNo/3V/8Ark/lWP8AGO0R/wCzZ2UMGDwsCMgjggfzrr/BQC+GrIAfwsfx3HNc18aYZn8OWclrIscyXS43rlW+VuD3x7j9elevOCWFsux4OHqP66n5s8z03ShAM2NxcWS/3YWBT/vhgVH4AVrousxAFX0+8H+0Htz+JG/P5CszS9Yjtl26rC9njrKw3Q/XzBwB/vbTXTQSRzRLJA6SRsMqyHIP0NeVeS3PoGot+7p/XYz/ALZqaZEmlBj/ANMrlWH/AI8F/lTl1C9Y/Jo12P8ArpLCP5Oa0akj60JrsJxff8iilzqzj93pcK5/57Xe389qtTJm1p15ttOh9/PeX/2Ra2k7Uyf7ta6W2M7O+5yssesCcHz7Dr93yX/PO/8ATFXkbWVxiHTpv+2zxf8AsrV5/rHhS0g1bxXJp3h+AN/ZsQsjBbrEfNInDeU+3h+UyRz93Patf4WWJsbrVBFZyQWjR222Q2L2Ku4Vg2IW53dCXHDZHpQ4K1yVUk2otW36/wDA8jsTc6si/vNMt2/643e7/wBCRearm+v8/wDIIl/7/wAf+Nbrfdqq3Wok12NIp9/yMlrnVH/1emQr/wBdrrb/AOgq1QTHWZEPy6fbfQvP/RK3KinaOKJpJXVI1GSzHAH1NRfsi+XuzkL7TrqTm81GYg9UgURL/Vh/31Wz8J9It/8AhNYWhhUeSjzOx+Zm42gljyeWHWsrV9Wgm/5BySXxPRoBmP8A7+HC/kSfauu+BtvcHVtWurto94hRFjjGQgLEn5jyScD06dK6MNFuqkzDFzjHDylHXT89Nz2FhkEUwJUgphJr22fKocMCkLUw5pVFFwHCnHpSClNMQ0mjHFGOaWkMZjml60+mkelFgGnvUgGABTcZNOpgc58RFLeCtVKxtIVi3hFxk4YHjJA7V4npj6pchRElvZIf4pD5r4/3RhQffcfpXuXjmSOHwfq7zOqRrbtlmOAOPWvCtM1mBtos4571u32dMqf+BnCf+PV5OPT500uh7+Utexkm+v6feblto1ukyT3bSXt0vKy3JDbT6qoAVT7qAau3l3b2UBmu544IgcbpGCjJ6Dnv7Vn41e8HWDToT6fvpv6Kp/77FTWmk2ttP9oYPcXf/PxcNvcfTPCj2UAe1cL/ALzPRX91FWS+v75SNMtTBGePtN4hUfVY+GP47fxpsGjRrMk93JJe3S8iWfB2H/ZUfKv4DPqTV/UNQtbFVN3Oke84RerOfRVHLH2Aqj9o1K+yLO2FlCf+W90MufdYwf8A0Igj0NGttNEPRPXVkPiWES6DqMDSxQ+bbyRiSVtqKWUgEnsOa5HVHv7m00SHRrJbwWc0M0sjtJEhMe0gIfLO4HnkdPer3xA0yWw8O3urwalef2hZQPMjyLFIrMBx8roQvT+AKeeSaffSanpV7oSRam9xDNfLDOZ4UMkisGIAZQqgDHZc+/rpBJJNamdRuV01bRdu49tLm1TVryKyubP7FPqVtqs6ytJHdQtGsfyeUUGVYxLhiRjJ4NdncwRXETw3EaSwuMMjqGVh6EHrWBfwzX/jpbG/eGWwGnm4t1jiMcsLh0Ut5obdk5P3dowcEHrV9rfVbP8A49547+EfwXH7uQfR1GD+Kj3NOrrbUmj7t9P69Bi6ddWHOjXOIh/y6XRLx/RW+8n/AI8B2Wpo9aijZY9TifT5mOB53+rY/wCzIPlOewJB9qjXWraNgmoJLp7n/n5Xah+kgJQn2zn2rU+SWMqwV43HIPIINZNv7SNUl9hjLrBjPcGuTfREa9ij02R7J5XC7YseWST3Q8fiMH3rYuNFhgUnTZZrD/YgYeX/AN+2BUfgAfeoPDyaj/wlmlRTm0njN1Hudd0RA3D+H5sn8RRFXaSZblaLclt/XqfQNpF5FrDDkHy0CZAxnAxWZ4t0z+1tAu7UDMu3fH/vjkf4fjWxRX0UoqUeVnxsZOMlJbnz9p7DcB09q63Tn2gCsHxNaf2d4n1CBRhBLvX6MA39av6VdCQKCea+dlHkk12Po7qcFJdTowxNQXYyhqSPpSTjKmkzFaMy9CbyfFumPnAMhX81I/rXrFeQyyizvrW7Iz5EqyH6A8166rB1DKQVIyCK9TLpe40cGYr3oyFooor0TzwooooAKKKKACiiigAooooAKKKKAKd/cLZ2dzdP0hQsPwFeUWAkurlpHJZnYsxPck13XxCu/I0IQKfmuJAv4Dk/yH51y2hw7Yt2K8nHzvNR7HrYKPLTc+5Ya1UgZ6CuL0iwgvrJr4ghr2R7lWHHyMf3f/jmwfhXU+L5mj0R7eFitxfMLSMjqN+dzD3VA7f8BqmiLGioihUUAADsBXE1aJ6OFu5OXYoR2cVikkzudiKWJJ6AU/RF+z+GLBZQFlaFZZB/tv8AM3/jxNV/FDE6HdQqcPcAWyn0MhCA/m1dN4WtFv8AxDAhA8mAGYr2+XGB+ZFVTg52iurHi6nLq+iO88NWr2Wh2cMoIkCbmB7EnJH61zPximitvCSzXDbIkuUy2CQucjJ9Bz16Cu5Fch8UgG8KsDyPOT+te1Wio0WvI8HCycsRF9WzzjScFVKnIIyDUk2h6fI7SRwfZ5WOWktnaFmPuUIz+OayNM02e1+fR51hQHJtZQWhP+7jlPw4/wBmtRdWlg41LT7q3I6yRKZ4z9Cg3Ae7KK8NJ/ZZ9RNpu00L9g1CEf6Lq0jei3cKyqP++djH8TT4/wC2oz/zDp/f54s/+hVPZalZXxIs7uCdl6rHICV+o6irsfWi7T1RPKmrplPzdbbpa6bF7/aXk/Ty1pkttq8q/vdSt4V9Le1ww/F2YH8q1XOFqFnAUliAAMkntV89tieS+7POJ9bZL2+i1GHxLEthCLm6llktFWKIhyG/dPk/cbhQTxzWx4fvX1W4lt0vtbsbiOKO4EN0ts26N87XBUNkEqeM5HoOKXfpi6/qt8mowXJvLeG3aGOIzLH5fmfe2k5z5nQ46e9VvA+laRpWo309teaW2oXQRGgsrZbRI0XOAIdxYEliSSSTx6VbtZuxkr3Sv36/cdSbPUgAU1Yn2kt0I/TFV3tdTJwdUQD1W1AP6k1qljjFRMeaxc2zoVNf02Zw0uWTi51XUJV7qGSIfmihv1pyaJpqOsj2qzSryslwxmcfRnJIq1PcQ2sTS3MscMS8l5GCgfiazpNaW4UjSraa+PaRRsh+vmNwR/u7qE5PYGoJ6jdbIERYkADqT2ro/gRdpeHXHhVjEDCFkPST/Wcr6j379q4fUbCe8G/VplkQci1iGIh/vZ5f8cD/AGa7f4MXEa6rqlrvQStCkgTIzgMRnHp81b4Oyqo58w5nhZdFp+aPWaQilor3D5YZSgUEc0tIYoooopiDFFFFACGiloxQAUUUUAc38RZhD4N1EnHzKqDPuwFeR6a6RrvkZVRRyzHAFeg/Gdy3hi3tQ7p59yoJQ4OACev1xXmelaJYeYryW4ndeQ1wxmIPsXJx+FeNj2nVSfRH0uUxlHDtpbs0v7ct5ht02OXUW9bYAx/9/CQn4Zz7U022q3h/0m5jsYj/AMs7X53P1kYYH0C5960554bWAyXEscMKjl3YKo/E1nf20txxpdtPfHtIq7IvrvbAI/3d30rkX91HY/7z/r8yex0u0smZ4IR5zjDzOS8j/V2yx/E0+91GzsCq3M6rK/3IlBaR/wDdQZZvwFVfsWo3n/H9ei3iPWCyyCfYyH5j/wABCGtDTtOtNPRzawJEX5d+rP7sx5Y+5NFl1dwu7WirHI+MNTv/AOyZ3/sKSTTtjGfzhE7eWASSYmdQRgd2z/s1ztyLHUTpU2v2uotJdzrBbfabG0m279uG3BXVFORwW3HB4OK7bX7mHWNOvrDTvNvJJ4ngLWqeYqEgry5IQEehYGsHUfD3iS+ttJt7BLG1FlJHKftOZGdo8beFYADg55PUYNbQ0t0OepJa63JL9/7I8Uw3EugQX88kyW66rJZxQyeYyYUCUEsxx8uQiqOhYV1VvrFtJOtvOJLO6Y4EFyuxmPop5V/+Ak1hX9lrEHiSPVdYnS2soivkR3NgZooBjDlZY5tqs3PzyLkZwOMg9RNHbahbbZEhubaUdGAdHH8jRVtZXHQd+blfX+vP7x7IGUqwBUjBBHBrLbQraMltPkm09yc/6KwVCfeMgofrjPvS/wBkS2vOlX0tuvaGbM0X5E7h9FYD2pBfajbZF9p3mqP+WtnIHH1KNhh9BurFJr4Wbtp/EiGc6xbD50tb6P1QmGQD6HKsfxWqmlaxFb+ItOkure8titxGSHhLAfMP4kyv61orrOnzuIluVjnPSGYGKQ/8AcA/pVO+JRw6nDKcg0X5Wm0aRjzxajL9T6FoqGymFxZwTDpJGr/mM1NX0id9T4tqzseR/ExAviskD79ujH8yP6Vym+aCWOSPO5G3Y9a7j4rwlNYsLjHEkJjz/utn/wBmrnbGJZcbhXg4lWrSPfwzvRiX7HXRMyoYZVbuWFb0Z8yMH1qja2sYxhBmtSJMLisbBJow9Th3K4I6iu38B6j9u0GON2zNanyX9cD7p/LH5GuW1FOM0ngK6Fn4mkt2JCXcZUDtuXkfpmunB1OSrbuY4qHtKN+x6bRRRXtnihRRRQAUUUUAFFFFABRRRQAUGikPUUAcB8RpvM1KxtuyRlz+Jx/7LUdhHsgUCq3i5/O8XSr1Eaog/IH+taVsoCDPAArwq75q0j2qa5aMV5HOak323xPtHMOmw7evHnSYJ/FUC/hIaJOGqDQWM+nNfsPnv5Wu8nrtc/ID7hNg/CpZj1qKumh6WGjaCMHVn+0axY2yn5IM3cvpx8qA/ViWH/XOvRPhnakreXjDqREp/U/zFecaYPPhn1Fjk3sm6M+kK8J+B5f/AIHXsXga1Nr4bttww02ZT+PT9MV0YOF6vojzswqfu2+7N8DHSuJ+L0Uk3hLbDM0D/aEIdQD69j2rtq5P4oK58G3ckUTzNCySbExk/MAcZIHf1r066/dyt2PMwjSrwv3R5DpOpXVihXUbRpYx/wAvFopcfjHyw/Dd9a6OzvLe9h820njmjzgsjZwfQ+h9q57QNRt7lykbkTJy8Tgq6/VTz+PSte80m3uZvtUJe1vcAfaYDtc+zdmHswIrwNNnofVyutYu6J77TrK/AF9aW9wB082MPj6ZquuiWin9y95B6CK7lVR/wHdt/Sov7QvLA7dVtmkhH/L3aoWX/gUfLL+G4epFallc293brPazRzxN0eNgwP4in7y66Ee5LpqVG0piuDqeolfTzQOPrtz+tVpdCsMBpbY3jDp9rkafB9g5IH4VudRXO+Pfttt4W1PUNO1G5sZ7G0muV8pImEhVCwDB0bjI7YPvVJyk7JiajFNtXsUrzUb+G6EcUO2MD5VVTj9OlbUcA1C1VdRtIZUPVJVDj8jXPamNV02y8PyR6q1wtxfwR3LXNvGZHWQgbVKBVUDn+Ek56jFVptZ1NNclmW/KwRa3FpQ08Rx7WjaNSXJI37vmLcNjA6HrTVJvVMUq8dmjpzoOnL/qYHt/a2meED8EIph0S1x/rdQ/8GE//wAXWu9V5mCg5OBWblLuaKEexnw6Rp8MyyraxvOvSWXMjj6M2T+tX3kVYmZyFUDJJ4AFYT6ybssmjRC7IODOzbYF/wCB4O76KD7kU6PTftAD6vP9tYciLbthU+yZOf8AgRbHbFDT+0wTX2F/kZ97qE2o5XSQPJPW8cZj/wCAD+M+/wB33PSuz+CVilprGpshZ3eEGSVzlnO7jJ/PjoO1cnrWox2ziCNGnu3GUgTrj1J6KvufwyeK9A+CVhdR2Op6heyqz3EixqiDCIFBJA7n73JPXHQV04RN1VbRHLmElHDyvq/6/ruemUUUV7Z8uBopKWgAooooAKKKKACikzS0AFFFFAHl3xxnuUg0aK1hjlZ5JGO+TYBgL7E9/SuG0+yv5wDc6j5Kf3LWML+BZtx/LbXefGhSDo0h+4GlBP8A3z/hXAWN/cX7rHo8AnXobiQlYh9D1f8ADj3FeJi7us7I+nwDjHCxcn3/ADNi20fT4ZVmEAluF5E07GaQfRmJI/CpbnVLS3n+ztL5l0RkQQqZJSPXYoJx74xVq08MiZVfV725um6mKNjBEP8AgKncR7MzVvWNla2EPk2NtDbRZzsiQIM+uBXPp1dxyxFtII5uG31m+x5FrFp8R/5a3Z3v+EaH+bA+1alv4VsnAfVJJtTf+7ckeUP+2SgIfxBPvWyKmzwKcZW2OapOU/iZQu41SMKihUUYCqMAVnQj/SQfeta75Ws2MfvqmQ47G6p/dCufvPDOnSyvLao9hcNkmWzby8n1K/dY/wC8prcibMYpCeaty7GaVmcpPpet2f8AqZbXUovSQGCUD6jKsfwQVTl1WK1YLqcNxp7HvcphP+/gymfbdmu2ao5EDoVYAgjBB71Lae6N4V5x6nJXiwXVuUmSOaJh91gGU1zF5o9mgY2qyWuOgt5WjUf8BB2/pXS6r4bS23zaLJ9hkPJiAzA590/h+q4PrmudF8zSva3sX2a8AJ2Fsq49Ub+IfkR3AqXdfCzvo1IVH7y1Pe/B5J8LaTl3ci2jBZzknAA5rYrL8LRmLw3piEYIt04+oFalfRU/hR8jWt7SVu7OK+Ktp5uiW1yBzbzjPsrDH88VwulsAyivXfEdl/aOhX1qBlpIjtH+0OR+oFeNaexVlz1ry8fC1RS7nqYCfNScex2NjgitEJxWTpr5ArZhwRXPHUuejM69TMZrmp5msb63u4/vQSh/rg5rrrpODXL6tDlXFZS913RtTakrM9gidZI0kQ5VgGB9QadWJ4MuftfhmwcnLInlN9VO3+lbdfRQlzRUu54E48snHsFFFFUSFFFFABRRRQAUUUUAFJ/FS0g6k0AeXXh+0eKb9+oEzL+Rx/SpvFMrQeF9Q2MUlmj+zRsOoeUiNT/304qppz+dqVxKP45Wb8zU3ittyaRa5G2a9VnH+zGjyA/99KleDF3m5HuSjpGHoiEqsMSRxgKiKFUDsB0rB8Ru8ltHYwMVnvn8gMOqqQS7fggYj3xW7MetYFl/pepXeonBhhDWlufXBHmt/wB9AL/2zPrUPe56FSXLCy6l2G1+03ltZWyhAzLEiqOFHT8gK9ngjWGGOKMYRFCqPQCvOvh5Z/aNZlunXK26cH/abgfpmvSK9LAU7Qc31PCx87zUF0Cqmr2gv9MurRv+W0bICexI4NW6Qnr7V3NXVmcMW4u6PnC6sIpZ2ivIiJoXKhgSrxsODtYcg/Sr9vf3WlIP7Rk+06f0+14w8P8A10A4K/7YxjuMZNQ6/p07apd6tpOPMnmaSa3JwkuTyR/db36Hv6ibRtRjvLfdHnGSjo4wyMOqsOxr55+7tqj6+E1VXaR0CsGAIIIPIIqhdaRaTzNcIr2103We3by3P+9jhvowIrN2zaGS9rG8+lE5aBBue290HdP9gcj+HPQbFreQ3UCTW8iSwuMq6HIIqdY6orSWklqVkOsWRGGt9RiH979zKB9QCrH8EFOn1SGa3lg1PSb5YZVKPG9uLhXUjBBEZfII4wauhxWL4v1q90DRrjUrSytryG2ieWdZbloWCqM/LiNtx69cVcZcztYiceVOV9Pv/wCCO1N/C+qrCusWNpcCAERC/sT+7zjIXzF4zgce1LJcaC2orqEGmi51FF2Jcw6ezSYxjAl24Axn+IVBc+IdQsLvR7XUdKjR9QuTbmW3uhJFEdjuOWVWLEIeNoH+12Mw16RvFUmjvYyxotr9pW5aRdsnzKCFUEnjd1OORwCOatt/0zNJN/8AAJJbzVbkYtrGKzU/x3kgZh/wBCQf++xVSbSluCG1W4lvj18t8LCP+2Y4P/Atx961JZOaryPgFmOAOST2rFzfQ6VSX2tQyFAUAADgAVlTX019K9tpTBVQ7ZrsjKxnuqDozfoO+elRB5dbOIHeHS+8qnD3Hsh6qn+11PbA5N6RXTyNN0mKMXTriNAuEgjHBdgP4R2Hc4HqQKNn5inNWvsv62Ma4MVjIbLTYTcX0nzvufk9t8jnOB6fTAHHHt3wsDp4Ot45miaZJJA5jUqM7iR1J7Ef/WrzqHQoNKtisbNJK53ySvy0jd2J/wAgDgYFdz8K582l/bE/ckWQD/eGP/Za7MFJKrbueTmEnUo9kuh3VFFFeweEFFFBoAKKKKACkpaKAEFLRRQAUUUUAebfGuGC+07S7GZd5a4MxXPBCqRg+oJYcdDisbw/ZiFFOBwKteP5zeeLzFnKW0aoPqeT/P8ASremxbIRXhYufPVfke5ho8lFeZdHSiilrnLAdakqOlDU0SQ3P3aoR/66tCcjbVRQA+aTLjsXojhBSnrTI/u0/FMkCc0lLiigCnfJuQiuN1zT4bpds6E7GDKVOGUjup7Gu2ujhDXN6mM7qluzujanroeyae0T2Ns8AxC0alB6LgY/Sp6wPAt19q8MWRJy0YMR9tpwP0xW/X0dOXNFSPnqkeWbi+gV4xr1m2neIby3IwvmF0/3W5H88V7PXA/E+ww1pqSDofJkPt1X+tcuOp81PmXQ6sBU5anK+pjaXLjFdDbPnFclpz10tg+QK8uDPRqItXK5Fc7qqV00oylYOqp8tKqhUXqb/wAM5M6PdQnrFcH8iAf8a6+uC+Gsu291SA/xLHIP/Hgf6V3te1hJc1GJ5eLjy1pBRRRXQcwUUUUAFFFFABRRRQAVW1OcW2nXU5OPLiZvyFWawfHFx9n8OXABw0pWIfief0BqKkuWDkXTjzTUThfD69DS63J5viawjB4gs5nYe7vGFP5I9S6GuErOmmVvEmr3DsqxwRQ2zEnAG1WkJP4SivCpuyZ7yXNURDr1xNFbrBZkfbrpvJgyMgMQcsR6KAWPstMMENhZwWVtkQwIEXJyTjuT3J6k+tSaNGbovrdyrL5qbLONhgpCed5HZnwD7AKOuav+HrM6l4ht4tuY0bzZM9No5/U4H40crlJQRVSqneb2R3/hHTv7N0WFJF2zSfvJPXJ7fgMCtqgUV70IqEVFdD56cnOTk+oVT1ObyNLvJumyJ2H4Crh6VheMbgQeG7rB+aTEY/E/4ZpVJcsWx04800jznTE3jBFUtb8PyRTHU9KT/TFA82HOFuUHY+jAfdP4Hg8a2kJg1u4BXmvn07HvSk07o4myvIrq2SWEko394EEEcEEHkEHgg9KpXOlqJ3udOnayuXO5yg3Ryn/bTofqMN71q+I9Gms7iTVdJhMm/m7tUHMuP+Wif7YHb+IADqBVC3uYrq3Se3kEkTjKsO/+fSk7x1Wx30qkays9yuL+/tuLyx89R/y1tGDcepRsEfQbqq61faPrOkXml3979lju4mhcS/uJMEY4EgHP4GtPzAKz9d1f+y7CS5NjdXkSKzSiAx5RQMkne65GB2yfaiMrvRamk4NRd3oM1y1s9ZnsLo63LbLYy+fGLd4Shfay5JZGP3WYYyBz64NU7htKXxONWbxEfPWIwi0EsBTYcEjGzf1Ab72c+3FVzrmmiPT57vRLm3kvp1hg8y3jc/NjDsyMyqPm6EgnBwDirl3r0VhqMVm+n3kcEkqwLdBEEPmMMgfe3H0yFxnvV6rT/IytF637dy3Lq/m8WNnd3DepjMSD/gT4yPpmoPsE9827WJY3hzkWkOfL/wCBk8v9OB7GtEtmo7ieO2iEtwxClgqgDLMx6KoHJJ9BWaf8qN3FWvN6fgPvLoWkKlI2mmkYRwwr1kc9FH8yewBPauj8N6SdNtpJLhllv7gh7iVRwSOir6KvQD6nqTVLw1os5n/tPU02XLLthgzn7Oh6gnoXPGSOBwB0JPU7MLVW5VY86vW9o9NjG1XkGrXw3uPJ8QywE4WaI/mCCP0zVfURlWqj4YmNv4o0984zKE/76+X+tXRly1Isxqx56UkezUUDpRX0B4AUUUGgAooFFABRRRQAUUd6KACjpRVLW5za6PezjrHC7D64NJuyuNK7seSGQ3+t3d0TkSzMw+meK6S3XbGBXNaGvIrqYRwK+cvzNs+hmuVJIeq5qQJUsa8VJsrRROdyK5So2T0q5sJpGTHWm4ApGfLGSvSq6xndz0rTcCmbATWbiWpEManip9vFSJHUgiqlAlzRVKc0hWrZjxTHTim42EpXM26X5DXO6gvNdRcr8prmtSHzVjJHTSZ1vwsm3aZewH/lnPuH/AlH+FdvXnPwsl23+pQ/3kR/yJH9a9Gr3cG70YnjY2PLWkFZ+v2A1PRru0wN0iHZnsw5B/PFaFFdEkpKzOaLcWmjxXS2Iba4Kup2sD1BFdNZNjFZ/jWxOl+JWmQYgvB5g9A38X68/jUlhNkCvAlF05OL6Hu8yqQU11Oh6pWRqK5Q1pRyZjqhdjcpoqaoinoyDwI5i8VsnaS2YfiCDXpVeX+Gm8nxfYk9H3p+an/CvUK9PAO9K3mcWYK1W/kFFFFdpwhRRRQAUUUUAFFFFABXDfES68y5srFT0BmcfoP612lzPFbQPNPIscSDLMx4FeT3upjUdYuLyXdh2wgxnao6CuLHVOWHL1Z24GnzT5uiNbTYfKgHqa4zT4T4g1nVLZhusVvpGvj2fYfLSH8RGGb/AGcD+OuuhvFKDb0FQWEVnpdm8NlGsUbyPMwHJZ3YsxJ7kk15cZKKZ6LUrjNXm4IHaup+HmnfZ9Ne9kH725Py57IOn5nJ/KuLZH1LUILSA/PMwXPoO5/AZNeuW0KW1tFBEMRxqEUewGK7MBT5pOb6HNjanLBU11JRRRRXqnlAelcT8RrgBLK0U8sxlYfTgfzNdt3ry/xhP9q8TXABysQWIfhyf1Jrkxs+Wk/M68FDmq37DNKXpWq2ccVV0+MLED3q5XjHqSepAJMHDVzWt+HpVnlv9EKLNId09q5xHOf7wP8AA/v0Pf1HSXCHBIGcVUiuwrbScH0NNOw43TvHc4KTULeGXyr1msbjOPKuv3bE/wCyTw31UkU3UoBqOlXdqkoC3ELxeYPm27lIz79a9JIiuEKyKrKeoIyDWVceFtFnbdJpOnufVrZD/Si0d0dKxcrWkr/gebavo97d2Wl21nfQQCyeOUtLbNLvaPG3o64HBz169u7LzTbweIE1K51exFtGV8mC5tj+5GMMVbzQNzc/MVJGcDjOfRP+EQ0PPOj6dj/r2T/CrlpoGkWZzb6bZRN6pAq/yFUpW6/giZV4vXl/F9Dj7SeS+YJo1u18x/5bA7YF9zJ0P0Xcfaun0XQIrGZby/lF3qOCBIV2pED1Ea/wj1OST3OMAak1wkSk5AqvFMbg5U8VN0tERUqTqfFsasZDDilbpTIV2oKkPSgwMm+T5Wrm3ka3uo5k+/GwcfUHNdXer8prlr5cOanZm0NVY9xgkWaGOVDlXUMPoRT6w/BFybnwvYMxyyIYz/wElf5AVuV9HCXNFS7nz048snHsFFFFUSAopD1paACg0UCgAooooAK57x9cfZ/C15jrJtjH4kZ/TNdDXEfFS42aVZwA8yTbseoUf/XFY4iXLSkzfDR5qsV5nI6J2rqLfkCuX0LnFdPBxivAie3VL8S1OFzUMR4qdTiuuNjikLsxUFxwtWWcYqhdPwaKlkggm2Z9zcbB1p1pceZ3rM1Z8RPz0BqHw3P5trE2eorlu7nXyLludXEc4q0qgiqkR4FWkfiuqByTEdcVDIvFWWYEVBJTkkKLKF0PlNczqKZLEV012flNc/fAAMa5JnbRJvh1L5XinYf+WsDr+oP9K9UrxvwrN5PizTnBxmQof+BAj+teyV62Xu9K3mebmMbVb90FFFFdxwHM/EHTDqGgPJEMzWp85cdwPvD8ufwrgNGut+3n2r2RgGUggEHgg14xf2TaN4onssERb90Xuh5H+H4V5ePp2aqI9TAVOaLpv1OsjPyYqOZflohfO2rDLmP3ritdHRezOfiY2/iDTJh0FygJ9icH+desV5PrUbJEZEzvQhhj1HNepWc4ubSCdfuyorj8Rmu/LpaSicmYK/LImooor0jzgooooAKKKKACqWr6lBpdk1xcE4HCqOrnsBU13cxWlvJPcOEijGWY9q4S5lk1q+F3cArEvEMR/hX1Pue9c+IrqlHTc6KFH2ju9kV72W9124El6xjtlOUgU8D6+p96sR28UCYRAAParsMXcjArM1q5WFMLXjzcpe9JnqRt8MSRfLlJGBmszVbFwpeFyCO1Lo87TEt71qXa7oGrM0+FlT4axibXp3mA8yGE7R9SBn/PrXpory/wTL5Hi5EHHnI6H8t3/steoV7GBadI8vHJ+1+QUUUV2HGDEAEnoK8fDm71CeduskjP+Zr1XVpfI0u8lHVIXI/I15ZpQGAT1rzcwl8MT0svWkpG5bDCgVPUduOKn2E15yR1t6kZ5FY+qQA5ZeGHett1xWdqI+WhocHqY9nfN5hjJ+YdRWvHcZAzxXH38v2fUbeZeMuEb6GuhkuVjERbkSME/OpsavU0GnH97iq1xdAKduTTrmMRQF+2Kxrq5DaRJMnGUOKBJLcRLk37gJnYT+ddFYWwiiUYrmPCq/6PCe5UV2ERyMU7aim9CQUGpFTNNcYp2MrlK66GuX1FfmNdTcjiuZ1P7zVLN6Z3Xwvm36LcxE/6uckewKj+oNdlXnnwqlIn1GHsVRx+GR/WvQ693CS5qUTxcXHlrSCiiiug5gNFFFAAaBRRQAUUUUAFeYfFOffrNpB2jh3/AIsx/wDiRXp9eQ/EOTzPFlwM52Ii/wDjoP8AWuPHO1I7cAr1vQj0MYArolOAK53RTwK6FDla8VHq1NyzHLjrU4n4qhS5rRTaMXBMuvPxVO4lyDTSagnb5TSlNscYpGNrj/6LMf8AZNVfCjldMtT6qDTtcbFjcH/YP8qg0A+Xptr/ANcx/Ko6HRbodtbzfKKsrIKxLabKjmrqy8da0jM5pQNDzMd6ieXiqvmGkLE03MSgNuGyDWHfn5Wral+7WLqOAprKRvTM3R5PK8Q6a/pcx5/76Fe3V4Tbts1C2f8AuyqfyYV7tXqZa/dkjgzNe9FhRRRXpHmBXAfFLT9qWWrRL80LeVJj+6eQfzyPxrv6xvGMSzeF9SRxkeSWH1HI/UVjiIKdNpm+Gm4VYtHFafdLPCjoc8c1rxnI+tcz4ciZLcZrpIuleHBnr1VYq3tuHBB6GtHwnrS2iR6XfnZtO2CU9COyn0PpUTjdVO6sluI2VhkVrTnKlLmiZSjGrHkkeh0VxGha7NpkyWerSF7Q/LHO3VPZj6e/b+XbAhgCDkHpXsUa0asbxPLq0pUnZi0UUVqZBQaKw/FmoGy0ibyziaX9zHjsx7/gMmpnJQTkyoRc5KKOe1q8bWdTKRufsFu2FA6O3dvf0H/16UTRwABiAKxlv7fSoY4JvkYjIJ6H2zWFq95eXF9AuxoYnTzFLcFlOQDj04P5V4U5ym3JntRpqKUVsdVfaxDGhAcfhXJ6hfyXs21MnPApY9LnmIMkoC/WtjTtNigwVjaRv7x4FZt33NUlDYs6HamC3Utxx3q9PKHjYL06Zph4/wBe6heyDpSXEsfkMRuAHT5SBSJ3ZX8HW7S+L4XA4iV3P/fO3+bCvUK434d24aO8vWHLuIl9gOT/ADH5V2VezgoctJeZ5eNnzVX5BRRRXWchk+LJPL8O359Y9v5kD+tebaccECu+8cNjw5d+5Qf+PivPLE/PXkY9/vEvI9fAL9235nS233RV9AMVQtB8gq+gNc0C5jJl4rMvlzGa2JF+Xmsy9GI2omh02ef+Ivl8s/8ATVP/AEIVoajIfsts4PCzxn/x4f41Q8VD92h/6ap/6EKlvHzpAPoVP6iotsdDOt1DnTc+1cqTnw8wHdP6V0162dKxn5sVzERH/CPpk5zGP5UkJbEvhRj9it2/2B/KuwszurjvCnGnQ/7orsdPHAp/aFLY00XioZhg1ZQcVBcCtZLQ5ovUoXA+WuZ1QcmuouPumua1YcmsGdVM2/haf+JveD/ph/7MK9MrzL4Xf8hm7/69/wD2YV6bXtYL+Ejycd/GYUUUV1nGFFFFAAaKDRQAUUUUAFeK+L38zxTqR9Jdv5AD+le1V4br7b/EGpMe9xJ/6Ea8/MH7iR6OWr32/Isaa+1BXQWs25RXL2rYQc1rW021eDXkXPUnG5s7xSGQCqAufWo5bn0NO5HIX2lHrVS4mqo1wahaQsaVy1CxU8RPjSbpu3ln+VJpfy2FsP8Apmv8qzfHF6Lbw7coDmWUeWg9Sf8A61J4X1Bb3SIATiaJQkinqCB1+hqnF8txprmsdPBIVxzV2Of3rGSbbwamWdfWouNxubaSg96f5g9axVuR2NP+1e9Vcz5DTlkwKxNRkzmpZLvIxms65fdSbLhGzKbcSIR13A/rXvdeBoC1wijqXA/WvfK9TLdpfI83M94/MKKKK9M8sKwfHUpi8LXpB5OxPzdR/Wt6ue8fxmTwnfBeqmNvwEik/pWdb+HL0ZpR/iR9UclpShbZK1VGAMVlaQd8A+laqHIrwIHs1Nx+PlpofYeacpyCKaw3gjuK0fkZrzG3CQzxkOoINSeH9UbSpktLpi1g5xHIT/qj6H/Z/l/LI1DUPskwjMbsNu5mAyFGcZP5inTt9ps28sjBFEK0qcuZFSpKceWWx6XRWR4Vvvt2jQsxzLEPKkz1yO/4jB/GtevdhJTipLqeNOLhJxfQD0rhvFV0LjW47Qn93bLvb3dv/rY/Ou5rJ1bw/YapMJrmN1mxgvGxUsPQ461liKcqkOWJrh6kac+aRwa2Y8QazFYom63X5p2xwE7j6npVDxlPHJ4zvYgQBEI0XHTGwHH4EmvUre2sdEsJWhjSCCNS7t3IA5JPU15Vd2ttf6VLd3XyzzSNMHVvmUsc9a4K9NUaai92d9Cq6tTmWy0NOxuIxAuecDsOauoJJslv3aHoB1rhtOk1OG2WdYjPCxO1l4YgHg4+nNatp4jG0iZXUg4OR3riszqavsdSkMcfIUZ9T1rL1m6URGNTknjis2bXo5PlSUZx0B5q94NtP7X8QILhWEMC+dhx98gjA+mT+lVCDqSUV1FJqnFzl0PQ/DNh/Z2i28DDEhG9/wDePP6dPwrUoor34xUUoroeFKTk3J9QoooNUSc147BHh2c9i6fzrz7TuZBXonjwE+GpsdnQ/wDj1ee6bnd0rxsf/EXoezgX+6fqdPZchRWmicA1k2GcitpB8grOkriq6MZIPlrMvlzG30rXdfkNY9+cKfpTqoVJ6nn/AIqX/RS391lb8iKryz5sIx/CJELfTcM1ravCtxDLGw4YEGuat7g2wNtdjkfLz0b3FYx1R2PQ7i/MK6cZt7D5eeeK5eWTyNFjjPBWMZB7YFQxzMcq9xI0XGI2YkcdP8/nmq99P9qb7PH8zOdrY7L3oURXN3wwCthbg9dgz+Vdrp68CuT0pdu0Y6Cux04fKKUdWKrojTReBVe6Tira9BUFzyK6pLQ4ovUyrjoa5rVu9dHdHArmtTOSa42d1M3fhav/ABOLw9vIx/48K9Lrzv4WLm71F/REH6n/AAr0SvbwX8FHkY5/vmFFFFdRyBRRQaACiiigAooooAK8K1r/AJDmof8AXxJ/6Ea91rwvWh/xPtRB7XMg/wDHjXnZh8KPSy34pEUeduBSm4uoR+7RHHoxI/Wnwrk1oW1uHGDXknrNmSdakT/W2M2f9hgw/XFN/t6InBtboH3Qf41sS6Vu5AqL+yD0xTv5C07mS+uqDhLO6Y/7oH9aibVr6UYgtEiz/FI+cfgP8a1zpBB4HFSGwES5wKV/IfzOL1uKRraeW7kMsxXA7BR7CjTrU7Y5rZ2ilCgbl7/X1qz4rOyxnPoKteHow9sh7YFa3fLchJcw9L6/QYeCGYDupKH+tPGrMv8ArbK5U/7O1h/OtYWG7BA60p005rK/kX8zLXWY8cW90T6eX/8AXp6alcSkCKxkA9ZWC/41o/2eQeBT1siOop38g+ZVhE7/ADSso/2UHH60+XjrV5Ito6VWuV4NSwRTsfm1K2HrKg/8eFe814bo6b9c09eubmMf+PCvcq9bLV7sjyszfvRCiiivSPMCq2p2q32n3Nq/AmjZM+mR1qzRSavoxp2d0eXeGwxieOQbZIyVYehHWtm3GXZaz9XQ6Z4xuY1G2G6AmUe56/qDWfb6vcL4imtJYwLcKpST/aOeD+X868GUeSTj2Pb/AIi5l1OhX5ZsHpSF1SfPY1zviHU5bG9s3BxE7hWPpn/IqTxJLLFp32uEtmAiQhe4HX9Kjm7D5O5s2bwjxNAk6K0F3E9swbocjOPx24rMvYW0DUWs7jPkk7oJD/Gnp9R0P/16SeQ3Fpb3toQ0iFZoyPUc16D5dlrmmQvPDHPbzKHAcZxkfoa6qNNV4OHVGFWp7CSl0ejOT8G3jW16+9sw3TBWGMBGzhcfXOPyNd5WHYeFtLsbxLmGF96HKB5GZVPsDW5Xo4enKnDlkcGInGpPmiFFFFbmBy3j+5YafbWMfBvJQrf7g5P9K8+8V20cAWCy/dzXJEYAPGT3x+ZrrvF6/wBo+IFhMrRx2cIIKHBDtyT+QFcK26XXbK7upt0KTOiZ43FQMsf++gB+NePipc9R+R6+FjyU15mvNdy2Gmi2ktGjCrsVhgg/TFM0P7LHojNNsaZyXYdeSaZ4mvBO0UUR+VSCW9OeD+eKsarHax6VGsMSNKwA4HJPpXMlodHkUdMiW21JbmaGSRJoRINiFgvzsBn6hQfxrtvASifUtUuiuNoSJRjp1J/pWLe+fp+tz2cFuZUgt4Ity4AXEYro/hxGw0i7nkGGnumYfQBV/mDXZh4Wr27HJiJ3o37nWUUUV6p5YUGikPagDF8Zpv8ADtyB6of/AB4VwGmwEPivS9ci87SblPVc/kQa5C0s9j9K83GU+aafkejhKnLTa8yayiwela6KdoqOCDA6Vdjj4FTSp2FUqXZXlX5TWJqKfKa6SRMisu7ts54pVqeg6VRJnDXURJYYrNuLNJFImQMPcZrrrmyJJOKzbuyOK5PZu53KqrHByWNt/a6x+WAnllsDgZzW/Y2UKYEUYQewqxJpA85LrB3EtF+QB/rWtZWXA4q503oKNRDLGDDjFdJZKVAqtaWe0g4rWt4MdqUKbuZ1aqZOg+UVBdDCmr6x8Co54sg8V1ShocsZq5zN1kk8VzepKSTXa3NsOTiufvbPcx4rilTdzup1UbfwsiKW+oSH+J0X8gf8a7qua8C24t9LkGMF5S36Af0rpa9rDLlpJHkYmXNVkwooorcwCg9KKRqAFFFFFABRRRQAV4n4hhK+JdSHrcOfzYmvbK8y8T2OfEd42PvMG/MCuLHRvBHdgJ8s36GBbxnPStG0UhsVZgsT6VbisyG6V5Sps9KVVDolBUcU/YPSrcVqdoqb7KfSr9kzL2qM54hjpWVqC7VNdLJb8dKyNStyV6VMqbRUKiZwmo2A1S7hsTkCeQISPSovDXy2iA+ldTotmW8V6dkfxsf/ABxqxtHs2WPGMYOKtw/dJlqp+8a8jo7KPMa1c+z57VJY22I14q+kBNZqDJlUVzMFr7UrW4A6VrG3wKhki4p+zJVW5gzR7c8VnXanFb9xDnNZtzATniocDaNQzvDqk+JNNH/Twh/I17ZXk/ha1z4msOOA5b8lJr1gV6uXq0H6nmZhK816BRRRXecAUUUUAcX8Q7cpcaVfqOEkML/8C5H8j+dcfqNvI9/dTL8rx232gLnrtdQf/HWY16Z4vtxceHL4EZMaeaMdcqd39K4nTAtxr+l+cVaG4SSBwO6tG3B/HFeViaa9uv73/DHqYao/Yvy/4cyvE8Y1Dw+7RMv2hY/MQZ7jkfqKt6bdxajoVvk/6+IDGPap7a2W2jubGYDzYHaEkjk+h/Ec1m+FALOOezJZljO5PXGT/Lp+FcDTWjO26auiHwS5NhJp8jnfZStFj/Z7foRXo3giXGnT2hOTbykAeityP1zXArbi0vbi8iyuJ1SY/wCy4+Un8VP5103ha6WHxGER90V1EUJ9XXkfpurqwsuSqn3/AK/M5sVHmpvy/r8ju6KKK9o8cKKKKAOQ8SeGb2+1KW6027ihFwqrMsgPGBjIx14xxx9aw77Tray15bMqpgtbNEXePvZJLMfckkmvS6wPEXhm31ueOdp5redV2F4sfMuc4Ofqfzrkr4dSTcN2ddHENNKb0R5rBZC5juboJts2u47UYGBgBpG/VY/1ra07TYLrxPp9vahmhhYTy/MWAC8jr/tYFd1BoNhDoi6UIi1oo6E/MTnO7I755zT9G0az0hJFtEbdIcu7tuZsdOfSojhGpR7IuWLTjK27Oa8T6fqMesXFxY2j3Md2ijKEfI4GOfbGOa6fw/YHTNHtbVyDIi5cjoWJy36k1oUV0woxhNzW7OaVWUoqD6BRRRWpkFFFFAEV0m+2kX1U1jx2wDDArcIyCKrLFg1nOHMaQnyorpDjtUqpipttKFoUEJyICntVeaHOeKv4prLmlKFwUrGJNa9eKoTWO7+GulaIGojbj0rH2KN1WZz02mj+y4vl5+0E/moH9KdbWW3+GujkgH2JFx0bdUSQYHSqnSvYUarRQhtgO1W44MVaSIDtUgShUkTKo2QLHx0pskWe1XAopCtW6aM1IypbfI6VmzWO5uldI0eajMArN0UbRqtCaRCILGFQMdf1Jq/TI12oo9BT66Yqysc8nd3CiiimIKTqaWigAooooAKKKKACua1qzEmpPJj7wH8q6WqV5FulVvas6seaNjSnLldzBisgD0q0loM9K0Vh9qeI8VgqKNXWZTW2A7U7yB6VdC0bR6Vp7JGftGZ72+ao3VmGB4rdKVE8QNZyoplwqtHNaNY7dfgkK/cVz+mP61m2elhGOF/iP867KygCXpfH8JqulqAzcfxGlKj7iRpGs+Zsp29qFAGKtLbjPSrixY7VKI+aSo2JlVKDW/HSoHtge1a5TIqMxUOiKNUwZrX2qpNZZU8V0jQA9qja2yOlZugbRr2MXw3ZbdZSQjGxGP8AT+tdpWXplv5dw7Y/hxWpXXQhyRsc1efPK4UUUVsYhRRRQAjqroyuAVYYIPcVwGmaDdWmsQQC0fZBc71nIG0xg5B3euOMV6BRWVSkqjTfQ1p1XTTS6nAeLoZbXxKrx4SK9jBL4z8yjBH1xisX7JNaEXqZINw0DMw6BlVlz+JavUNQsbbUIBDdxCRAdw5IKn1BHIP0qNdLs1sGshADbNyVJJJPXJPXPv1rmng+aUmup0wxfLFJrY5Dw7ZLd31/a3Y8yC6tvmIGOVbt7/NV7S/Dl5bajatM0Rgtn3CRWO58AgDbjjrzzXQ6fplrp+820bBn+8zuzsfbLEnHtV2tKeGUYpS3RnUxLlJ8uzCiiiuo5QooooAKKKKACiiigAooooAKKKKACiiigApuKdSYoATFGKXFGKAExQRS4oxQA3bSFafijFACFfkxTAtS0mKAG7aXFLijFFgExRilxRigBMUm2nYoxSAWiiimAUUUUAFFFFABRRRQAUUUUAFRyjOKkpGGRQBCFpcVJilxSsMjx7UY9qkxRtpiI8e1IVFS7aMe1JoCKJMSE+1R+XyeO9WQMGk20WHciCgClwKl20Y9qLCIsUbKlxRiiwEJSmmOrGKMUrDuRQJtLH1qakUYpaaBhRRRTEFFFFABRRRQAUUUUAFFFFABRRRQB//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This figure depicts the thoracic dermatomes, which are bands of skin that are supplied by the thoracic nerves of the spine.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_21_22868=[""].join("\n");
var outline_f22_21_22868=null;
var title_f22_21_22869="Prenatal ultrasound image of umbilical cord angiomyxoma";
var content_f22_21_22869=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F81730&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F81730&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Prenatal ultrasound image of umbilical cord angiomyxoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 327px; height: 570px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Umbilical cord angiomyxoma. Upper panel, an echogenic mass in close relation with a pseudocyst (C) is identified. Lower panel, color flow imaging depicts the umbilical vessels and shows blood flow within the echogenic mass.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Luis Izquierdo, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_21_22869=[""].join("\n");
var outline_f22_21_22869=null;
var title_f22_21_22870="Mask size pediatric";
var content_f22_21_22870=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F76143&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F76143&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 546px\">",
"   <div class=\"ttl\">",
"    Choosing the proper size mask",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 526px; height: 475px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The correct size mask is the smallest size that completely covers the child's nose and mouth (photos on left), without covering the eyes or overlapping the chin (photos on right).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_21_22870=[""].join("\n");
var outline_f22_21_22870=null;
var title_f22_21_22871="Magnetic resonance imaging changes related to acute seizure activity";
var content_f22_21_22871=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Magnetic resonance imaging changes related to acute seizure activity",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/21/22871/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/21/22871/contributors\">",
"     Andrew J Cole, MD, FRCP(C)",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/21/22871/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/21/22871/contributors\">",
"     Timothy A Pedley, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/21/22871/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/21/22871/contributors\">",
"     April F Eichler, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/21/22871/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 20, 2010.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The recognition of periictal changes on neuroimaging studies predates magnetic resonance imaging (MRI), with reports of computed tomography (CT) abnormalities in occasional patients presenting with seizures. These findings of effacement of gyral markings and patchy contrast enhancement appeared to co-localize with the source of the ictal activity [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/1\">",
"     1",
"    </a>",
"    ]. As MRI has become standard in the evaluation of patients with seizures and epilepsy, a growing range of periictal imaging findings have been described. Knowledge of these findings is important because [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      These findings may be confused with other focal pathology such as brain tumor or stroke, leading to inappropriate treatments or investigations.",
"     </li>",
"     <li>",
"      These findings may be helpful in surgical planning.",
"     </li>",
"     <li>",
"      These findings may help elucidate pathophysiology of epileptic seizures.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic discusses ictal and early postictal findings on MRI; we will refer to these findings together as periictal. The use of MRI and other neuroimaging techniques in the diagnosis of seizures and epilepsy and in presurgical evaluation of epilepsy patients is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/9/25753?source=see_link\">",
"     \"Evaluation of the first seizure in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/39/41593?source=see_link\">",
"     \"Surgical therapy of epilepsy in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     LOCAL PERIICTAL MRI FINDINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Periictal imaging changes may occur in the region of the epileptic discharge (local) or in distant structures (remote). These findings are summarized in the Table (",
"    <a class=\"graphic graphic_table graphicRef59643 \" href=\"UTD.htm?24/3/24635\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Local anatomic abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Local anatomic abnormalities are those confined to the hippocampus or region of epileptic discharge, and include [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/3-21\">",
"     3-21",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Local swelling &mdash; effacement of sulci and gyral markings (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef77630 \" href=\"UTD.htm?41/33/42513\">",
"       image 1",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Increased T2 signal intensity (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef77630 \" href=\"UTD.htm?41/33/42513\">",
"       image 1",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Restricted diffusion &mdash; bright signal on diffusion weighted imaging (DWI), dark signal on apparent diffusion coefficient (ADC) maps",
"     </li>",
"     <li>",
"      Focal parenchymal",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      leptomeningeal contrast enhancement",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    CT is less sensitive for these changes than is MRI, but it can also show decreased attenuation, effacement of sulci, loss of",
"    <span class=\"nowrap\">",
"     gray/white",
"    </span>",
"    differentiation, and contrast enhancement [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/3,22\">",
"     3,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These MRI findings usually resolve on follow-up imaging; however, residual T2 signal abnormalities can persist for several months, perhaps indefinitely [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/16-18\">",
"     16-18",
"    </a>",
"    ]. Focal atrophy in the region of T2 and DWI signal changes is also often reported on follow-up imaging, but these studies are usually compared to the periictal study, not a preictal baseline [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/3-5,7,23\">",
"     3-5,7,23",
"    </a>",
"    ]. This evolution of findings has also been documented in animal studies of induced epileptic seizures and suggests that these MRI findings are the result, not the cause, of the seizure [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/24\">",
"     24",
"    </a>",
"    ]. Case reports of these findings resolving with treatment and then reappearing with recurrent seizure activity also support this association [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/5,15\">",
"     5,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An exceptional case report documents a patient with multifocal epilepsy related to mitochondrial disease [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/2\">",
"     2",
"    </a>",
"    ]. Migratory T2 and DWI lesions appeared on serial MRI scans (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef63800 \" href=\"UTD.htm?14/51/15158\">",
"     image 2",
"    </a>",
"    ). These lesions corresponded to regions of focal hypermetabolism on positron emission tomography (PET) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef62082 \" href=\"UTD.htm?40/55/41843\">",
"     image 3",
"    </a>",
"    ), as well as to areas of maximal electroencephalogram (EEG) abnormality. This case provides further evidence that these MRI lesions are the consequence of the epileptic activity and not its cause.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Abnormalities of blood flow and perfusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Perfusion-weighted MR imaging may show initial hyperperfusion in the area of ictal activity with subsequent relative hypoperfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/5,16,25\">",
"     5,16,25",
"    </a>",
"    ]. This temporal evolution is similar to that seen in single photon emission computed tomography (SPECT) studies that typically show focal ictal hyperperfusion with surrounding hypoperfusion, followed by postictal hypoperfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/26-29\">",
"     26-29",
"    </a>",
"    ]. Postictal hypoperfusion on MRI can be confused with acute stroke. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Impact on clinical management'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    MR angiography (MRA) in patients with status epilepticus may demonstrate a reversible prominence of arterial branches in the region of the seizure focus, with corresponding increased flow-related enhancement (",
"    <a class=\"graphic graphic_figure graphicRef78191 \" href=\"UTD.htm?1/15/1266\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/3,5,18\">",
"     3,5,18",
"    </a>",
"    ]. This finding corresponds with the observation of arterialization of venous blood reported by surgeons examining the cortex during provoked or spontaneous epileptic seizures (",
"    <a class=\"graphic graphic_figure graphicRef78191 \" href=\"UTD.htm?1/15/1266\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/5,30\">",
"     5,30",
"    </a>",
"    ]. SPECT studies may not demonstrate corresponding ictal hyperperfusion, thus, some portion of the local increased blood flow observed on MRA may represent arteriovenous shunting.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     REMOTE PERIICTAL MRI FINDINGS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Diaschisis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diaschisis is a phenomenon of functional loss in an area of the brain that is anatomically remote from the primary lesion, but neuronally connected to it. This is most often described in the setting of stroke, but can also occur with a variety of cerebral pathologies including migraine, tumor, and encephalitis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. Crossed cerebellar diaschisis, in particular, is associated with lesions in the contralateral hemisphere. In acute injury, MRI evidence of diaschisis includes restricted diffusion and increased T2 signal. These findings typically normalize over time, although, with chronic injury, volume loss in these areas may occur.",
"   </p>",
"   <p>",
"    Similar MRI findings have also been described in association with acute seizure activity. Restricted diffusion and increased T2 signal in the ipsilateral diencephalon and contralateral cerebellum have been prominent findings in a number of case reports of patients in both generalized and focal status epilepticus (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef58269 \" href=\"UTD.htm?13/2/13347\">",
"     image 4",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/3,5,12,13,16,18,21,33-35\">",
"     3,5,12,13,16,18,21,33-35",
"    </a>",
"    ]. These lesions usually resolved over days to weeks with control of seizures, but may presage the appearance of local atrophy of the affected structures [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/13,21,32,34,36\">",
"     13,21,32,34,36",
"    </a>",
"    ]. The pathophysiology of these lesions is unknown, but presumably results from the recruitment and driving of connected thalamic and cerebellar circuits by the epileptic activity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/32/37385?source=see_link\">",
"     \"Pathophysiology of seizures and epilepsy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Lesions of the splenium of the corpus callosum",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transient lesions of the splenium of the corpus callosum have been described in patients with epilepsy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/37-45\">",
"     37-45",
"    </a>",
"    ]. These lesions are typically ovoid and well-circumscribed regions of increased T2 signal with restricted diffusion and resolve on follow-up imaging several weeks later (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef64710 \" href=\"UTD.htm?3/49/3861\">",
"     image 5",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/37,41\">",
"     37,41",
"    </a>",
"    ]. In most cases, this finding appears to be clinically silent, although we have noted this finding in several patients who also had psychiatric disturbances [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Neither the mechanism nor the precise nature of the white matter change is understood [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/45\">",
"     45",
"    </a>",
"    ]. Most cases are described in patients with clusters of seizures who have been rapidly withdrawn off antiepileptic drugs as part of presurgical video-EEG monitoring [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/37-39,41-43\">",
"     37-39,41-43",
"    </a>",
"    ]. Although abrupt drug withdrawal might underlie this phenomenon, this theory is based on the assumption that the splenium lesion represents vasogenic edema [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/39\">",
"     39",
"    </a>",
"    ]. Our finding that the lesion demonstrates a decreased apparent diffusion coefficient (ADC) is inconsistent with that hypothesis and suggests instead that the lesion is related to ictal activity per se [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/37\">",
"     37",
"    </a>",
"    ]. Micro-vacuolization of the myelin is one pathological substrate that could account for the increased T2 signal, the decreased ADC, and the reversibility of lesions of the splenium. In one report, splenium lesions were associated with AED toxicity in the absence of seizure activity, but the two cases in this report appear to be exceptional in this regard as such lesions are rarely seen in large numbers of patients who undergo MR imaging while on anticonvulsants [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Reversible posterior leukoencephalopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reversible, symmetrical, white-matter edema in the posterior cerebral hemispheres in large part defines the reversible posterior leukoencephalopathy syndrome (RPLS), of which seizures are a hallmark clinical feature. RPLS usually occurs in association with hypertensive encephalopathy, eclampsia, and the use of cytotoxic and immunosuppressant drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. However, some patients with seizures and radiologic features of RPLS have none of these conditions, suggesting that seizures may be the cause or contribute to the occurrence of this MRI finding. It is usually difficult to exclude moderate elevations in systemic blood pressure with respect to the patient's baseline as a cause [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/48\">",
"     48",
"    </a>",
"    ]. Moreover, the high, rather than low, ADC values that are typically seen on DWI in RPLS make it at odds with other ictal MRI abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/47\">",
"     47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/16/43273?source=see_link\">",
"     \"Reversible posterior leukoencephalopathy syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathophysiological basis of local periictal imaging findings appears to be related to increased neuronal activity and its associated metabolic and vascular responses. The pathophysiological basis of lesions that occur remote from the site of ictal activity is not understood.",
"   </p>",
"   <p>",
"    Whereas increased T2 signal suggests edema or gliosis, restricted diffusion is usually associated with metabolic dysfunction or energy deficiency. This phenomenon is best described in acute ischemic stroke. In this setting, restricted diffusion suggests the presence of cytotoxic edema and permanent injury. However, in the periictal setting, the fact that these lesions are often reversible indicates that cell death is not an inevitable sequelae [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/49\">",
"     49",
"    </a>",
"    ]. Another difference is that in ongoing status epilepticus, DWI and T2 signal changes appear to occur roughly synchronously, whereas in acute ischemia, restricted diffusion often precedes any abnormality of T2 signal. This suggests a difference in the pathophysiology of restricted diffusion in seizures and stroke; in ischemia there is early energy failure; in ongoing status, activity-induced injury with cytotoxic edema may precede overt energy deficiency. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/56/17290?source=see_link\">",
"     \"Neuroimaging of acute ischemic stroke\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is hypothesized that prolonged ictal activity increases glucose utilization that is not adequately matched by enhanced blood flow [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/3,16,19\">",
"     3,16,19",
"    </a>",
"    ]. A depletion of cellular energy reserves causes",
"    <span class=\"nowrap\">",
"     Na+/K+",
"    </span>",
"    ATP pump failure. This, along with the excitotoxic effects of ictal glutamate release, may trigger NMDA receptor-mediated calcium and water influx into the cell. A reduction in extracellular fluid causes restricted diffusion on MRI [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Only limited pathologic correlation for these MRI findings is available. Animal studies have shown swelling of dendrites and astrocytes [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/9\">",
"     9",
"    </a>",
"    ]. In cases in which a biopsy of the affected lesion was undertaken, findings have included gliosis and cellular edema with little to no other evidence of inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/5,7,10\">",
"     5,7,10",
"    </a>",
"    ]. Evidence of neuronal death is seen in some cases.",
"   </p>",
"   <p>",
"    It is not know why local acute periictal changes on magnetic resonance imaging (MRI) occur in some but not all patients. While most reported cases with these findings are status epilepticus or seizure clusters, these findings have also been described after single seizures [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/6-9,11,50\">",
"     6-9,11,50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In some cases, MRI changes are first apparent days or weeks after the start of focal status, suggesting that there may be a threshold of seizure duration",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    severity below which changes will not occur [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/5,16\">",
"     5,16",
"    </a>",
"    ]. Other patient-specific variables may play a role, such as the seizure type and location, the duration and severity of ictal discharge, pharmacologic interventions, and the patient's age, comorbid conditions, and cardiovascular or metabolic reserve. In one small series, restricted diffusion on MRI was more likely with a neocortical rather than a medial temporal focus [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     IMPACT ON CLINICAL MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Local and remote periictal imaging findings must be interpreted with caution. It is important to recognize that these changes can occur as the consequence of seizure activity per se and therefore may not be helpful in establishing the cause of the seizures.",
"   </p>",
"   <p>",
"    In some cases, acute findings may mimic tumor or stroke, and if misinterpreted, would lead to inappropriate diagnostic or therapeutic interventions [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/3,7,51\">",
"     3,7,51",
"    </a>",
"    ]. Because periictal imaging changes evolve over time, serial imaging studies can establish the nature of these findings as periictal and not related to another process.",
"   </p>",
"   <p>",
"    In the setting of potential acute ischemic stroke, when treatment decisions are time-limited, the use of MRI or CT perfusion studies can be helpful. The combination of hyperperfusion with increased T2 signal and restricted diffusion is uncharacteristic of ischemia [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/16,32,52\">",
"     16,32,52",
"    </a>",
"    ]. If there is hypoperfusion, a symmetric mean transit time on either the MRI or CT perfusion study suggests a postictal state rather than ischemia [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/52,53\">",
"     52,53",
"    </a>",
"    ]. Areas of signal abnormality that do not respect vascular territories are another clue to an ictal rather than vascular origin [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/3\">",
"     3",
"    </a>",
"    ]. An angiographic study may be required to detect or exclude a vascular occlusion potentially amenable to thrombolysis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/56/17290?source=see_link\">",
"     \"Neuroimaging of acute ischemic stroke\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The variability in the occurrence of these findings are such that acute MRI changes have little utility in the routine diagnostic evaluation of patients with seizures [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/16\">",
"     16",
"    </a>",
"    ]. Because some acute MRI changes are remote from the site of maximal ictal activity, it is important to evaluate imaging abnormalities in conjunction with clinical and electrographic data; however, when these findings are convergent, it may support a plan for early surgical intervention and help in the process of surgical planning [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In exceptional patients, MRI may be useful to assess the efficacy of antiseizure treatment. We and others have observed that in focal status epilepticus, anesthesia sufficient to suppress seizure activity also results in reversal of imaging abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22871/abstract/5,25\">",
"     5,25",
"    </a>",
"    ]; this finding might be exploited in settings in which EEG activity is difficult to monitor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Magnetic resonance imaging (MRI) studies performed during or immediately after epileptic seizure can show structural abnormalities that are understood to represent the effect of the seizures rather than the underlying cause. These findings are summarized in the Table (",
"    <a class=\"graphic graphic_table graphicRef59643 \" href=\"UTD.htm?24/3/24635\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The most common acute periictal MRI changes occur at the site of seizure focus and include local swelling, T2 signal hyperintensity, restricted diffusion, and contrast enhancement. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Local anatomic abnormalities'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Perfusion MRI and MR angiography can also show evidence of seizure-related blood flow changes, including increased prominence of blood vessels and ictal hyperperfusion in the region of epileptic discharge. Hypoperfusion characterizes the immediate postictal state. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Abnormalities of blood flow and perfusion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      MRI changes that occur in brain areas remote from the seizure focus include signal changes in the ipsilateral diencephalon and contralateral cerebellum. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Remote periictal MRI findings'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The pathophysiology of these changes is not well understood, but likely reflect the consequences of increased neuronal activity and its associated metabolic and vascular responses. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Pathophysiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most important clinical caveat regarding acute periictal MRI findings is to recognize that such findings may be the consequence, rather than the cause, of the seizures so as to avoid inappropriate diagnostic and therapeutic interventions. Follow-up imaging is generally sufficient for this distinction. However, in the setting of acute ischemic stroke adding perfusion studies (CT or MRI)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      angiography can be valuable in treatment decisions. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Impact on clinical management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/1\">",
"      Goulatia RK, Verma A, Mishra NK, Ahuja GK. Disappearing CT lesions in epilepsy. Epilepsia 1987; 28:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/2\">",
"      Cole AJ. Status epilepticus and periictal imaging. Epilepsia 2004; 45 Suppl 4:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/3\">",
"      Lansberg MG, O'Brien MW, Norbash AM, et al. MRI abnormalities associated with partial status epilepticus. Neurology 1999; 52:1021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/4\">",
"      Briellmann RS, Wellard RM, Jackson GD. Seizure-associated abnormalities in epilepsy: evidence from MR imaging. Epilepsia 2005; 46:760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/5\">",
"      Doherty CP, Cole AJ, Grant PE, et al. Multimodal longitudinal imaging of focal status epilepticus. Can J Neurol Sci 2004; 31:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/6\">",
"      VanLandingham KE, Heinz ER, Cavazos JE, Lewis DV. Magnetic resonance imaging evidence of hippocampal injury after prolonged focal febrile convulsions. Ann Neurol 1998; 43:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/7\">",
"      Raghavendra S, Ashalatha R, Krishnamoorthy T, et al. Reversible periictal MRI abnormalities: clinical correlates and long-term outcome in 12 patients. Epilepsy Res 2007; 73:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/8\">",
"      Diehl B, Najm I, Ruggieri P, et al. Postictal diffusion-weighted imaging for the localization of focal epileptic areas in temporal lobe epilepsy. Epilepsia 2001; 42:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/9\">",
"      Hufnagel A, Weber J, Marks S, et al. Brain diffusion after single seizures. Epilepsia 2003; 44:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/10\">",
"      Costello DJ, Simon MV, Eskandar EN, et al. Efficacy of surgical treatment of de novo, adult-onset, cryptogenic, refractory focal status epilepticus. Arch Neurol 2006; 63:895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/11\">",
"      Diehl B, Najm I, Ruggieri P, et al. Periictal diffusion-weighted imaging in a case of lesional epilepsy. Epilepsia 1999; 40:1667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/12\">",
"      Fazekas F, Kapeller P, Schmidt R, et al. Magnetic resonance imaging and spectroscopy findings after focal status epilepticus. Epilepsia 1995; 36:946.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/13\">",
"      Nagasaka T, Shindo K, Hiraide M, et al. Ipsilateral thalamic MRI abnormality in an epilepsy patient. Neurology 2002; 58:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/14\">",
"      Meierkord H, Wieshmann U, Niehaus L, Lehmann R. Structural consequences of status epilepticus demonstrated with serial magnetic resonance imaging. Acta Neurol Scand 1997; 96:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/15\">",
"      Yaffe K, Ferriero D, Barkovich AJ, Rowley H. Reversible MRI abnormalities following seizures. Neurology 1995; 45:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/16\">",
"      Szabo K, Poepel A, Pohlmann-Eden B, et al. Diffusion-weighted and perfusion MRI demonstrates parenchymal changes in complex partial status epilepticus. Brain 2005; 128:1369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/17\">",
"      Kim JA, Chung JI, Yoon PH, et al. Transient MR signal changes in patients with generalized tonicoclonic seizure or status epilepticus: periictal diffusion-weighted imaging. AJNR Am J Neuroradiol 2001; 22:1149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/18\">",
"      Toledo M, Munuera J, Sueiras M, et al. MRI findings in aphasic status epilepticus. Epilepsia 2008; 49:1465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/19\">",
"      Wieshmann UC, Symms MR, Shorvon SD. Diffusion changes in status epilepticus. Lancet 1997; 350:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/20\">",
"      Heinrich A, Runge U, Kirsch M, Khaw AV. A case of hippocampal laminar necrosis following complex partial status epilepticus. Acta Neurol Scand 2007; 115:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/21\">",
"      Boyd JG, Taylor S, Rossiter JP, et al. New-onset refractory status epilepticus with restricted DWI and neuronophagia in the pulvinar. Neurology 2010; 74:1003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/22\">",
"      Silverstein AM, Alexander JA. Acute postictal cerebral imaging. AJNR Am J Neuroradiol 1998; 19:1485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/23\">",
"      Gong G, Shi F, Concha L, et al. Insights into the sequence of structural consequences of convulsive status epilepticus: a longitudinal MRI study. Epilepsia 2008; 49:1941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/24\">",
"      Prichard JW, Neil JJ. Diffusion-weighted MRI: periictal studies. Adv Neurol 2000; 83:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/25\">",
"      Leonhardt G, de Greiff A, Weber J, et al. Brain perfusion following single seizures. Epilepsia 2005; 46:1943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/26\">",
"      Rowe CC, Berkovic SF, Sia ST, et al. Localization of epileptic foci with postictal single photon emission computed tomography. Ann Neurol 1989; 26:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/27\">",
"      O'Brien TJ, So EL, Cascino GD, et al. Subtraction SPECT coregistered to MRI in focal malformations of cortical development: localization of the epileptogenic zone in epilepsy surgery candidates. Epilepsia 2004; 45:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/28\">",
"      O'Brien TJ, So EL, Mullan BP, et al. Subtraction ictal SPECT co-registered to MRI improves clinical usefulness of SPECT in localizing the surgical seizure focus. Neurology 1998; 50:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/29\">",
"      O'Brien TJ, So EL, Mullan BP, et al. Subtraction SPECT co-registered to MRI improves postictal SPECT localization of seizure foci. Neurology 1999; 52:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/30\">",
"      Penfield, W. The evidence for a cerebral vascular mechanism in epilepsy. Ann Intern Med 1933; 7:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/31\">",
"      Chakravarty A. MR evaluation of crossed and uncrossed cerebral-cerebellar diaschisis. Acta Neurol Scand 2003; 108:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/32\">",
"      Mewasingh LD, Christiaens F, Aeby A, et al. Crossed cerebellar diaschisis secondary to refractory frontal seizures in childhood. Seizure 2002; 11:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/33\">",
"      Bohnen NI, O'Brien TJ, Mullan BP, So EL. Cerebellar changes in partial seizures: clinical correlations of quantitative SPECT and MRI analysis. Epilepsia 1998; 39:640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/34\">",
"      St&uuml;bgen JP. Crossed cerebellar diaschisis related to recurrent focal seizures. Epilepsia 1995; 36:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/35\">",
"      Katramados AM, Burdette D, Patel SC, et al. Periictal diffusion abnormalities of the thalamus in partial status epilepticus. Epilepsia 2009; 50:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/36\">",
"      Natsume J, Bernasconi N, Andermann F, Bernasconi A. MRI volumetry of the thalamus in temporal, extratemporal, and idiopathic generalized epilepsy. Neurology 2003; 60:1296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/37\">",
"      Oster J, Doherty C, Grant PE, et al. Diffusion-weighted imaging abnormalities in the splenium after seizures. Epilepsia 2003; 44:852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/38\">",
"      Mirsattari SM, Lee DH, Jones MW, Blume WT. Transient lesion in the splenium of the corpus callosum in an epileptic patient. Neurology 2003; 60:1838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/39\">",
"      Polster T, Hoppe M, Ebner A. Transient lesion in the splenium of the corpus callosum: three further cases in epileptic patients and a pathophysiological hypothesis. J Neurol Neurosurg Psychiatry 2001; 70:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/40\">",
"      Kim SS, Chang KH, Kim ST, et al. Focal lesion in the splenium of the corpus callosum in epileptic patients: antiepileptic drug toxicity? AJNR Am J Neuroradiol 1999; 20:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/41\">",
"      Cohen-Gadol AA, Britton JW, Jack CR Jr, et al. Transient postictal magnetic resonance imaging abnormality of the corpus callosum in a patient with epilepsy. Case report and review of the literature. J Neurosurg 2002; 97:714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/42\">",
"      Prilipko O, Delavelle J, Lazeyras F, Seeck M. Reversible cytotoxic edema in the splenium of the corpus callosum related to antiepileptic treatment: report of two cases and literature review. Epilepsia 2005; 46:1633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/43\">",
"      Carrara G, Ferlazzo E, Tampieri D, et al. Transient edematous lesions of the splenium in epileptic patients. Can J Neurol Sci 2005; 32:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/44\">",
"      G&uuml;rtler S, Ebner A, Tuxhorn I, et al. Transient lesion in the splenium of the corpus callosum and antiepileptic drug withdrawal. Neurology 2005; 65:1032.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/45\">",
"      Gr&ouml;ppel G, Gallmetzer P, Prayer D, et al. Focal lesions in the splenium of the corpus callosum in patients with epilepsy. Epilepsia 2009; 50:1354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/46\">",
"      Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/47\">",
"      Covarrubias DJ, Luetmer PH, Campeau NG. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol 2002; 23:1038.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/48\">",
"      Bakshi R, Bates VE, Mechtler LL, et al. Occipital lobe seizures as the major clinical manifestation of reversible posterior leukoencephalopathy syndrome: magnetic resonance imaging findings. Epilepsia 1998; 39:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/49\">",
"      Grant PE, He J, Halpern EF, et al. Frequency and clinical context of decreased apparent diffusion coefficient reversal in the human brain. Radiology 2001; 221:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/50\">",
"      Oh JB, Lee SK, Kim KK, et al. Role of immediate postictal diffusion-weighted MRI in localizing epileptogenic foci of mesial temporal lobe epilepsy and non-lesional neocortical epilepsy. Seizure 2004; 13:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/51\">",
"      Riela AR, Sires BP, Penry JK. Transient magnetic resonance imaging abnormalities during partial status epilepticus. J Child Neurol 1991; 6:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/52\">",
"      Mathews MS, Smith WS, Wintermark M, et al. Local cortical hypoperfusion imaged with CT perfusion during postictal Todd's paresis. Neuroradiology 2008; 50:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22871/abstract/53\">",
"      Eastwood JD, Lev MH, Wintermark M, et al. Correlation of early dynamic CT perfusion imaging with whole-brain MR diffusion and perfusion imaging in acute hemispheric stroke. AJNR Am J Neuroradiol 2003; 24:1869.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2234 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-7705E05A5A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_21_22871=[""].join("\n");
var outline_f22_21_22871=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      LOCAL PERIICTAL MRI FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Local anatomic abnormalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Abnormalities of blood flow and perfusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      REMOTE PERIICTAL MRI FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Diaschisis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Lesions of the splenium of the corpus callosum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Reversible posterior leukoencephalopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      IMPACT ON CLINICAL MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/2234\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/2234|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?41/33/42513\" title=\"diagnostic image 1\">",
"      MRI acute seizure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?14/51/15158\" title=\"diagnostic image 2\">",
"      Migratory periictal MRI changes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?40/55/41843\" title=\"diagnostic image 3\">",
"      Multimodal MRI and PET periictal imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?13/2/13347\" title=\"diagnostic image 4\">",
"      Crossed cerebellar diaschesis in epilepsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?3/49/3861\" title=\"diagnostic image 5\">",
"      Transient DWI changes in the splenium after seizures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/2234|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?1/15/1266\" title=\"figure 1\">",
"      Cortical hyperemia associated with focal seizures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/2234|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/3/24635\" title=\"table 1\">",
"      Periictal imaging abnormalities",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/9/25753?source=related_link\">",
"      Evaluation of the first seizure in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/56/17290?source=related_link\">",
"      Neuroimaging of acute ischemic stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/32/37385?source=related_link\">",
"      Pathophysiology of seizures and epilepsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/16/43273?source=related_link\">",
"      Reversible posterior leukoencephalopathy syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/39/41593?source=related_link\">",
"      Surgical therapy of epilepsy in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_21_22872="Laerdal trachlight";
var content_f22_21_22872=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F63169&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F63169&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Laerdal trachlight",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 397px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    From top to bottom: Rigid internal stylet, lightwand, Trachlight handle and assembled device with a cuffed endotracheal tube.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Murphy MF, Hung OR. Lighted stylet intubation. In: Walls RM, Murphy MF (eds). Manual of Emergency Airway Management, 3rd edition. Lippincott Williams &amp; Wilkins, Philadelphia, 2008. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_21_22872=[""].join("\n");
var outline_f22_21_22872=null;
var title_f22_21_22873="Disability assessment and determination in the United States";
var content_f22_21_22873=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Disability assessment and determination in the United States",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/21/22873/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/21/22873/contributors\">",
"     Linda Cocchiarella, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/21/22873/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/21/22873/contributors\">",
"     Suzanne W Fletcher, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/21/22873/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/21/22873/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/21/22873/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 11, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disability evaluation is an important aspect of clinical care. Accurate evaluation significantly affects the well-being of both patients and society, given the impact of disability status on financial remuneration, return to work, and access for existing and future health care needs.",
"   </p>",
"   <p>",
"    Both treating and consulting clinicians are often asked to evaluate their patients for disability. Some determinations involve clinicians who choose to serve as independent medical examiners, but many other clinicians are unfamiliar with the disability process and uncertain of their role. Input from treating clinicians is crucial to disability evaluation because they often have the most in-depth and longitudinal knowledge of the patient's conditions and function, may be aware of the cause of the problem, and can best advise on severity, permanency, and possible accommodations needed for an impairment.",
"   </p>",
"   <p>",
"    Assessment of disability is complex, variable and challenging even among clinicians experienced in disability determination. A number of factors give rise to these challenges [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The determination of disability requires a synthesis of clinical and nonclinical information.",
"     </li>",
"     <li>",
"      The definition of disability is not standardized across agencies that request a disability assessment.",
"     </li>",
"     <li>",
"      The clinician is often required to define limitations in functional abilities and provide medical judgment for legal interpretation when medical evidence is insufficient.",
"     </li>",
"     <li>",
"      The skills necessary to interact with multiple administrative and legal entities are not usually taught during medical training.",
"     </li>",
"     <li>",
"      Disability determination usually has financial implications for the individual and society that clinicians often consider.",
"     </li>",
"     <li>",
"      Treating clinicians may feel uncomfortable making a determination which is not consistent with their patient's preference and could impact the doctor-patient relationship.",
"     </li>",
"     <li>",
"      Limited time availability in the medical encounter can magnify these concerns.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic will discuss definitions of impairment and disability, and review the clinician's role in disability assessment. Issues related to worker's compensation, as well as specific occupational disorders, are discussed separately (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/36/32326?source=see_link\">",
"     \"Social Security Disability Insurance and workers' compensation in the United States\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/34/42535?source=see_link\">",
"     \"Occupational low back pain: Evaluation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/40/32391?source=see_link\">",
"     \"Evaluation of pulmonary disability\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICIAN ROLE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of the clinician is to assess and document medical impairment and functional abilities, in accord with the requirements of the requesting agency. This documentation is interpreted and used by the judicial system, state and federal agencies, and private insurance companies, to determine the degree of disability and resulting compensation.",
"   </p>",
"   <p>",
"    Specific objectives of the clinician in disability evaluations are to:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Define and document findings related to the individual's medical problems or impairments",
"     </li>",
"     <li>",
"      Define the severity of the medical problem",
"     </li>",
"     <li>",
"      Synthesize medical information from different sources into a coherent picture of the individual's medical conditions and function.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Most agencies recognize that treating clinicians can provide the best evidence for the existence of medical impairments and their consequences. While medical training may not specifically prepare clinicians to assess functional limitations, clinicians in practice have the unique opportunity to observe the effects of physical and mental impairments on their patients' overall function, including the ability to work and live independently. Social Security Administration (SSA) regulations note that treating medical professionals, with their longitudinal patient experience, can provide a perspective not obtainable from medical findings alone or from independent examinations [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The first step in disability evaluation is the determination of medical impairment and its impact on the ability to perform activities of daily living. An assessment of a patient's ability to perform work-related tasks for a particular occupation may or may not be required as part of the disability evaluation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Impairment is a disorder that causes alteration of body structure or function. Disability, commonly confused with impairment, refers to the limitation, due to impairment, in the ability to perform activities of daily living or complex activities such as work. Impairment is not defined relative to an environment. In contrast, disability accounts for the ability of an individual with an impairment to function in a specific environment. As an example, impairment of carpal tunnel syndrome is present whether an individual is at home or at work. However, an individual with carpal tunnel syndrome may be disabled for work as a typist but have no disability as a dispatch agent or while functioning at home.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Impairment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Formal definitions of medical impairment vary, but common to all is the concept of a disorder that causes alteration of body structure or function, and specifically loss of use or derangement of a body structure or function. Specific definitions vary in whether a specific health disorder must be associated with this loss, whether supportive clinical or laboratory findings are needed, and the requirements for the incorporation of psychological abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/4-8\">",
"     4-8",
"    </a>",
"    ]. Commonly used definitions of impairment and disability are shown in a table (",
"    <a class=\"graphic graphic_table graphicRef63436 \" href=\"UTD.htm?31/24/32141\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The American Medical Association (AMA) \"Guides to the Evaluation of Permanent Impairment,\" first published in 1958, promote a standardized approach to the assessment of medical impairment, especially for use in workers' compensation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/4,5,9,10\">",
"     4,5,9,10",
"    </a>",
"    ]. Differing editions of these guides, or portions of these guides, are mandated by more than 30 state legal statutes, codes or regulations as the standard to determine medical impairment (",
"    <a class=\"graphic graphic_table graphicRef50347 \" href=\"UTD.htm?24/62/25579\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinician may need to provide supporting medical evidence to establish an impairment, whether disability is present and, if so, whether it is temporary or permanent, and whether it is partial or total. As an example, following a carpal tunnel release with residual symptoms, is motor loss temporary or permanent, and is loss partial or total? Is the patient temporarily or permanently disabled from work as a secretary, and does the disability encompass all of her secretarial work (total) or only parts of her work?",
"   </p>",
"   <p>",
"    Most agencies consider an impairment permanent if there is no significant change in the condition for a 12 month interval. Changes in the condition and stability versus progression should be documented. Changes refer to fluctuations in the natural history of the condition (eg, variable glucose levels in a diabetic patient). Progression would be noted if the individual's diabetes progressed to involve renal dysfunction or if a disc herniation led to objective motor loss.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Disability",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Social Security Administration (SSA) defines disability as \"the inability to engage in any substantial, gainful activity by reason of a medically determinable physical or mental impairment(s), which can be expected to result in death or which has lasted or can be expected to last for a continuous period of not less than 12 months\" [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Models of disability distinguish impairment, function, and disability [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/11\">",
"     11",
"    </a>",
"    ]. These models acknowledge that disability is not inherent in the individual but results from the interaction between the impaired individual and the environment in which they function. The presence or absence of accommodations at work or home significantly determine whether the individual has a disability in a given setting.",
"   </p>",
"   <p>",
"    Clinicians contribute to the determination of disability through their assessment of impairment and its impact on activities of daily living and work. Disability assessment is commonly medically centered, but not exclusively medically based [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/11,12\">",
"     11,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Definitions of disability from leading agencies vary (",
"    <a class=\"graphic graphic_table graphicRef63436 \" href=\"UTD.htm?31/24/32141\">",
"     table 1",
"    </a>",
"    ). In common, these definitions convey that disability incorporates the interaction of an impairment with its functional impact on a person's ability to participate in a life situation or activity.",
"   </p>",
"   <p>",
"    The World Health Organization (WHO) identifies work disability as the result of the interaction of an individual's impairments and functional limitations in the context of multiple other factors, including [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/8\">",
"     8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Access to assistive technologies",
"     </li>",
"     <li>",
"      Attitudinal and other personal characteristics (eg, age, education, skills, and work history)",
"     </li>",
"     <li>",
"      Physical and mental requirements of potential jobs",
"     </li>",
"     <li>",
"      Transportation accessibility",
"     </li>",
"     <li>",
"      Attitudes of family members and coworkers",
"     </li>",
"     <li>",
"      Willingness of an employer to make accommodations.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Many agencies, including the SSA, do not have the resources to implement the extensive evaluation required to assess disability as specified by the WHO. In lieu of this, screening criteria or equivalents are typically developed and some agencies and states use impairment as a proxy for disability [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/11,13\">",
"     11,13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Disability",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based upon data from the US Census Bureau in 2005, of the 291.1 million people in the noninstitutionalized population, 54.4 million (18.7 percent) reported some level of disability, and 35.0 million (12.0 percent) had a severe disability. Physical disabilities were noted more commonly than sensory or mental health disabilities and disabilities were noted with basic activities of daily living, including walking, bending and reaching [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    African Americans and Hispanics typically experience disability at a higher rate than do whites [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/12\">",
"     12",
"    </a>",
"    ]. Rates of disability also increase with age; 41.9 percent of individuals over the age of 65 report disability, compared with 18.6 percent of younger people [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. The aging population is increasing, with projected doubling of individuals who are aged 65 years and older between 2000 and 2030.",
"   </p>",
"   <p>",
"    The top three conditions causing self reported disability were arthritis, back or spine problems, and heart conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]. Compared to earlier surveys, rates of musculoskeletal conditions as a cause of disability increased and heart disease as a disability cause decreased.",
"   </p>",
"   <p>",
"    Among adults reporting a disability, the most commonly identified limitations were difficulty walking three city blocks (10.3 percent) and climbing a flight of stairs (10.0 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/16\">",
"     16",
"    </a>",
"    ]. About 14 percent of noninstitutionalized people experience \"complex activity limitations\" and report an inability to participate fully in social roles, maintain a household, work, pursue hobbies, visit friends, and go to the movies or sporting events [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/15\">",
"     15",
"    </a>",
"    ]. US trends in aging and disability are available on the American Society on Aging website [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Given these projections and the increased prevalence of disability among the aged, policy makers need to identify and meet the health and social needs of the expanding population of people with disabilities [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/11,15\">",
"     11,15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Work-related injury and disability",
"    </span>",
"    &nbsp;&mdash;&nbsp;Workplace health and disability reflect overall population health. Rates of occupational injuries, illness, and fatalities have been declining in the United States. In 2010 the Bureau of Labor Statistics reported a rate of 3.5 cases per 100 equivalent full-time workers of non fatal occupational injuries and illness in the private sector, representing an ongoing decline by up to 0.2 cases per 100 workers per year since 2003 [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/18\">",
"     18",
"    </a>",
"    ]. Based upon preliminary data, the rate of fatal injury for US workers in 2010 was 3.5 fatal work injuries per 100,000 full-time equivalent (FTE) workers, down from 4.0 in 2007 [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risk of work-related injury is highest in manufacturing, construction, natural resources and mining, education, and health services [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/18,20\">",
"     18,20",
"    </a>",
"    ]. Highest risk industries for occupational fatalities continue to include construction, agriculture, forestry, fishing, hunting, transportation and warehousing [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/19,20\">",
"     19,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite declines in injuries, concerns have been raised that many workplace practices have not sufficiently improved [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/21\">",
"     21",
"    </a>",
"    ]. Statistical declines may be attributable to changes in the manufacturing sector, outsourcing of many hazardous jobs, and increased attention given to workplace design [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Economic impact",
"    </span>",
"    &nbsp;&mdash;&nbsp;The economic burden of disability to society is dramatic; the projected long term program costs of the Social Security and Medicare programs are not sustainable under current program parameters [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/23\">",
"     23",
"    </a>",
"    ]. Cash flow deficits for Social Security expenditures exceeded non-interest income in 2010 and 2011, the first such occurrences since 1983, and will expand as the baby boom generation retires. The SSA projects reserves to be exhausted in 2033. Medicare's financial status is even worse, with expenses exceeding revenues as of 2008 [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DISABILITY ASSESSMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the United States, systems that commonly require information from the clinician to determine disability include The Social Security Disability System, Workers' Compensation, Railroad Retirement, and Civil Service programs. Two of the most important sources of assistance for Americans with disabilities are Supplemental Security Income (SSI) and Social Security Disability Insurance (SSDI), both administered by the SSA. SSI and SSDI act as a safety net for persons with disabilities, providing both cash assistance (monthly checks) and eligibility for health insurance (Medicaid",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    Medicare).",
"   </p>",
"   <p>",
"    Federal, state, and private programs require medical input, typically at the initial evaluation stage and often at later stages of adjudication, for disability determination. Most often, clinicians are requested to document the medical impairment and provide a medical judgment regarding functional limitations from the impairment. This functional assessment may include the ability to perform specific work activities, as requested by the Social Security Administration, the state and Federal workers' compensation systems, and specific employee groups covered by the Long Shore and Harbor Workers' Compensation Act (LHWCA). Other insurance carriers may arrange private disability assessments, normally performed by clinicians hired by the insurance company, who are designated as \"independent medical evaluators.\"",
"   </p>",
"   <p>",
"    Clinicians and agencies often presume a strong correlation between the presence of a severe impairment and inability to work, with severe impairment used as a proxy for disability. This assumption is often satisfactory with severe impairments such as advanced cancer. For more moderate impairments, determining the patient&rsquo;s functional abilities and limitations will enable the disability evaluator to weigh those abilities in the context of the patient&rsquo;s education and work potential to determine if they are truly disabled from any work. The disability evaluator needs to consider whether a potential accommodation would be feasible, or whether the individual can realistically be retrained before determining if they are disabled from the usual requirements of most jobs. As an example, if the clinician provides information on the functional abilities of an individual who has had a myocardial infarction with atrial fibrillation, with an analysis of METS (metabolic equivalents), the evaluator can more objectively determine if they are totally disabled as a fireman but able to work as a clerk.",
"   </p>",
"   <p>",
"    Using severe impairment as a surrogate for work disability does provide a practical method of evaluation for the complex question regarding who is disabled from work for a segment of severely impaired individuals. The clinician is of significant assistance in providing answers to the more complex and common questions of the patient&rsquo;s current and predicted functional abilities on a routine basis under usual work conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/24\">",
"     24",
"    </a>",
"    ]. The SSA and other agencies have the challenge of using this information along with the patient&rsquo;s age, education, and considerations of the increasingly complex and competitive economy to determine ability to return to customary work.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     The Social Security Administration",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinician's role within the SSA system is to provide medical evidence about the nature and severity of an individual's impairment(s) and his or her functional abilities and limitations. The determination of disability is made by SSA.",
"   </p>",
"   <p>",
"    The SSA asks the clinician to initially determine if the applicant has a severe impairment. An impairment is considered \"severe\" if it significantly interferes with an individual's ability to perform basic activities of daily living that are also needed in the workplace. These activities include walking, standing, sitting, lifting, pushing, pulling, reaching, carrying, handling, seeing, hearing, speaking, understanding, carrying out and remembering simple instructions, using judgment, responding appropriately (to supervision, co-workers and usual work situations),",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    dealing with changes in a routine work setting.",
"   </p>",
"   <p>",
"    If the impairment is severe and meets the listings discussed below (see",
"    <a class=\"local\" href=\"#H12\">",
"     'Listing of impairments'",
"    </a>",
"    below) and the patient is not working, he or she will likely be found to be disabled from work. If the listings are not met, the patient is not necessarily foreclosed from benefits, but further analysis of medical and vocational capabilities is then required.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Listing of impairments",
"    </span>",
"    &nbsp;&mdash;&nbsp;The SSA has two \"Guides\" for disability evaluation for clinicians: a Blue Book for treating clinicians and a Green Book for consulting clinicians, both available electronically [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. The Blue Book explains the SSA disability process and provides a Listing of Impairments that clinicians can use to identify obviously disabled applicants who don't require the full evaluation process because their medical conditions meet criteria of sufficient severity [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/2\">",
"     2",
"    </a>",
"    ]. The SSA listing of impairments can be found at:",
"    <a class=\"external\" href=\"file://www.ssa.gov/disability/professionals/bluebook/AdultListings.htm\">",
"     www.ssa.gov/disability/professionals/bluebook/AdultListings.htm",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    The Listings are divided into 14 broad categories by organ system or disease type (eg, malignant neoplasm), and then subdivided by specific conditions. Each listing specifies clinical criteria or measures of functional limitation (eg, treadmill tests, pulmonary function test, range of motion of joints, or IQ tests) and duration of involvement. The Listings are not measures of disability but measures of the severity of impairment; when the impairments are severe, they serve as a proxy for total work disability [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/2,3,25\">",
"     2,3,25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If an applicant meets criteria for the medical diagnosis and findings on this list, and if the listed impairment has lasted or is expected to last at least 12 months or result in death, the applicant will meet the medical criteria for disability. For example, an applicant with a left ventricular ejection fraction of 30 percent or less, who is unable to perform at a workload equivalent of 5 metabolic equivalents or less on an exercise test without exhibiting specified signs or symptoms (eg, electrocardiogram abnormalities or chest pain, Listing 4.02) is considered disabled according to the SSA. Some severe impairments are based on a diagnosis alone, such as amyotrophic lateral sclerosis (Listing 11.00) or inoperable malignancies (eg, Listing 13.09, metastatic melanoma) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/3,11,25\">",
"     3,11,25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is important that the clinician document all the elements in the listing. Incomplete documentation will lead to a rejected claim and need for resubmission and appeal, resulting in costly delays for the applicant and system.",
"   </p>",
"   <p>",
"    If the medical condition fails to meet requirements for severity based upon the criteria for a single condition, the applicant may still meet disability criteria if the functional limitations of the impairment(s) are equal in severity to the requirements of a listing. This is referred to as \"medical equivalence,\" and usually takes into account multiple impairments. The clinician will need to provide detailed information on functional limitations, the severity of the impairment, and provide an opinion regarding its equivalency to a particular listing. The SSA compares the applicant's medical impairments and functional limitations with those of a listing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Residual functional capacity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Applicants who do not have a listed impairment or equivalent conditions may qualify for SSA if the clinician identifies them as having reduced residual functional capacity (RFC), preventing them from performing their past work or any other work available. The SSA takes into account the patient's age, education, and work experience in this determination. RFC is defined as the maximal activity an individual is able to perform despite functional limitations resulting from all impairments.",
"   </p>",
"   <p>",
"    The following information will significantly assist the SSA in determining the RFC:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      How many hours during an eight hour work day can the individual sit, stand, or walk?",
"     </li>",
"     <li>",
"      How many pounds can the individual lift frequently (about",
"      <span class=\"nowrap\">",
"       2/3",
"      </span>",
"      of a workday) and occasionally (about",
"      <span class=\"nowrap\">",
"       1/3",
"      </span>",
"      of the workday)?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    According to the SSA, RFC assessment may be based solely on medical evidence if sufficient objective findings (eg, signs, symptoms, and laboratory findings) are provided to assess the applicant's capacity for work-related functions. These functions may include standing, lifting, carrying, and handling (which can be translated into functional capacity for sedentary, light, medium, heavy or very heavy work); mental demands, such as making judgments and tolerating job-related stress; and sensory requirements, such as hearing and seeing [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    To assess RFC, the clinician can use his or her clinical judgment based upon their knowledge of the patient, review the patient's daily activities, the severity of impairment based upon relevant measurement studies (eg, pulmonary function, cardiac output, hearing or vision studies), review reports from other providers such as a physical therapist, or order a functional capacity evaluation. Patients should not be cleared to do work activities that could worsen their condition, such as heavy lifting following a hernia repair. Discussion with specialists who performed a procedure to address current and future limitations is often helpful.",
"   </p>",
"   <p>",
"    For example, an individual who completed physical therapy for a rotator cuff repair and lifts their grandchild, carries groceries or laundry will be able to perform some lifting. It is helpful to ask the patient to describe a typical day and assess the scope of their activities of daily living, along with a review of relevant studies for a consistent picture of their limitations. Asking patients how long they can drive and do errands, how long they watch TV, or what movies they have seen recently may give estimates regarding their ability to sit.",
"   </p>",
"   <p>",
"    The SSA uses medical and vocational \"grids\" which identify different levels of exertional capacity (sedentary, light, medium, heavy or very heavy) required for applicants able to work based upon age, education and prior work experience [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/26\">",
"     26",
"    </a>",
"    ]. In general, sedentary work requires the ability to sit for six hours, to",
"    <span class=\"nowrap\">",
"     stand/walk",
"    </span>",
"    for two, and to lift no more than 10 pounds at a time. Light and medium work require the ability to",
"    <span class=\"nowrap\">",
"     stand/walk",
"    </span>",
"    for six hours and to lift no more than 20 or 50 pounds, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Documentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Providing thorough medical documentation at the initiation of the claim will expedite the assessment and conserve SSA resources in claim evaluation. Clinicians may be asked to write a letter or to complete a form documenting findings for an SSA disability claim. They also may be asked by an attorney to complete a questionnaire evaluating the effect of the impairment on the ability to perform activities of daily living.",
"   </p>",
"   <p>",
"    The letter should include the following (",
"    <a class=\"graphic graphic_figure graphicRef75264 \" href=\"UTD.htm?42/2/43050\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/2,3,25\">",
"     2,3,25",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Your relationship (treating or consulting clinician) with the patient and length of the relationship.",
"     </li>",
"     <li>",
"      Summary of the most recent medical evaluation, at a minimum including diagnostically positive or negative findings. The clinician should attach a copy of the medical record to document continuity of treatment and indicate that \"the medical records are attached to this report.\"",
"     </li>",
"     <li>",
"      A list of impairments or diagnoses, with a comparison to the SSA Listing of Impairments (list). Identify which patient's findings match the SSA criteria for that impairment.",
"     </li>",
"     <li>",
"      If criteria for a listed impairment are not met, include details of the patient's functional limitations as a synthesis of individual impairments, the expected duration of the limitations and assessment of the patient's ability to perform basic work activities.",
"     </li>",
"     <li>",
"      An opinion indicating which listing was met, or how the listings are equaled, accounting for the functional limitations.",
"     </li>",
"     <li>",
"      An assessment of functional capacity using the definitions provided by the Social Security Administration for sedentary, light, medium, heavy, and very heavy levels of work exertion and an assessment of functional capacity. As an example, \"This patient should not sit for prolonged periods (no more than one half hour at a time), should not stand for more than 15 minutes, and should not lift or carry more than 10 pounds. They should not participate in activities that require stooping, bending, crawling, or climbing.\"",
"     </li>",
"     <li>",
"      Attachment of all relevant notes and clinical studies.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If the individual does not meet the stated SSA criteria, either singly or in combination, the clinician states the limitations and abilities; the SSA makes the determination regarding disability. A letter will not be supportive of a claim if it indicates the patient has few limitations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     DISABILITY ASSESSMENT TOOLS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Work disability is most reliably assessed through knowledge of the medical condition and its usual limitations, knowledge of the job and workplace environment, combined with an assessment of the individual's specific functional abilities. The assessment is typically based upon the medical evaluation and may include information obtained from tests such as a functional capacity evaluation and validated questionnaires. However, testing measurements do not exist which give highly reproducible, valid, sensitive, and low-cost assessments to reliably classify applicants as unable to work, especially when assistive technology and other accommodations are considered [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Many validated questionnaires were developed for research purposes, to enhance objectivity in the assessment of functional and pain-related impairment. These tools need to be used within the context of the clinician's judgment and can be useful adjuncts to the clinician's medical judgment. Commonly used validated questionnaires to assess function with associated links and a review are listed in a table (",
"    <a class=\"graphic graphic_table graphicRef50394 \" href=\"UTD.htm?39/11/40124\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/27\">",
"     27",
"    </a>",
"    ]. Clinicians can also refer to diagnosis specific questionnaires.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Computer-based questionnaires (PROMIS)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Scientists from seven institutions and the National Institutes of Health (NIH) are part of a cooperative network, the Patient-Reported Outcomes Measurement Information System (PROMIS), to review and further develop computer-based standardized and validated questionnaires. This project has been underway since 2004.",
"   </p>",
"   <p>",
"    PROMIS is focused on ways to better quantify patient-reported symptoms, such as pain and fatigue, and aspects of health-related quality of life and function across a wide variety of chronic diseases and conditions. Clinicians can access the currently developed modules at",
"    <a class=\"external\" href=\"file://www.assessmentcenter.net/ac1/\">",
"     www.assessmentcenter.net/ac1/",
"    </a>",
"    ; although the site indicates their use for researchers.",
"   </p>",
"   <p>",
"    One instrument to assess physical function is available as a short scale of 10 and a bank of 127 items; clinicians can choose which items best meet their patient population needs. The pain behavior question bank has 39 items, with 7 in a defined scale; the pain impact has 41 items with 6 in a defined scale.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Traditional questionnaires",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Musculoskeletal assessment instruments",
"    </span>",
"    &nbsp;&mdash;&nbsp;More than ten validated low-back functional assessment questionnaires are in common use for clinicians to assess function and pain among patients with chronic back pain [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/28-37\">",
"     28-37",
"    </a>",
"    ]. Among the most commonly used include the Oswestry Disability Questionnaire (",
"    <a class=\"graphic graphic_figure graphicRef63444 \" href=\"UTD.htm?34/12/35014\">",
"     figure 2",
"    </a>",
"    ), which assesses pain and more complex activities, and the Short Form 36 (SF-36), which evaluates general health perceptions along with physical, social, and emotional functioning [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. For the clinician who sees a particular condition commonly, it would be best to research the sensitivity and specificity of the scale for a particular disorder. For example, the Roland Morris Disability questionnaire is especially robust for patients with post lumbar disc surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/40\">",
"     40",
"    </a>",
"    ]. The most commonly used functional outcomes for chronic low back pain include the Oswestry Disability Index, Roland Morris Disability Index, and range of motion [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One study compared the modified Oswestry Disability Questionnaire, the Quebec Back Pain Disability Scale (",
"    <a class=\"graphic graphic_form graphicRef60460 \" href=\"UTD.htm?13/38/13923\">",
"     form 1",
"    </a>",
"    ), the Roland-Morris Disability Questionnaire, the Waddell Disability Index, and the physical health scales of the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) for reliability and responsiveness [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/41\">",
"     41",
"    </a>",
"    ]. Measurements obtained with the modified Oswestry Disability Questionnaire, the Quebec Back Pain Disability Scale, and the SF-36 Physical Functioning scale were the most reliable and had sufficient width scale to reliably detect improvement or worsening in most patients.",
"   </p>",
"   <p>",
"    There are multiple validated upper extremity functional assessment questionnaires available for clinicians and other health providers, based upon patient reported or clinical outcome measures [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/42-45\">",
"     42-45",
"    </a>",
"    ]. The Disability of the Shoulder, Arm, and Hand Questionnaire (DASH), SF-36 health Survey Questionnaire, and the Health Assessment Questionnaire are commonly used patient reported outcome measures [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Lower extremity assessment tools for the clinician in assessment of lower limb function include the American Academy of Orthopedic Surgeons lower limb questionnaire [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/46\">",
"     46",
"    </a>",
"    ] and the Lower-Limb Tasks Questionnaire [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Pain disability assessment instruments",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pain disability assessment instruments may be used as a supplement to a functional, body part questionnaire when chronic pain is the major limitation to function. Pain behavior, interference, and intensity can be measured by different instruments through PROMIS at",
"    <a class=\"external\" href=\"file://www.assessmentcenter.net/\">",
"     www.assessmentcenter.net",
"    </a>",
"    . The Pain Disability Index is available online [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/48\">",
"     48",
"    </a>",
"    ]. Other commonly used pain questionnaires are also referenced [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/37,49-52\">",
"     37,49-52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Functional capacity evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The functional capacity evaluation (FCE) is a systematic, comprehensive, and relatively objective measurement of maximum work ability [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/53\">",
"     53",
"    </a>",
"    ]. Its purpose is to assess a patient's safe functional abilities compared to the physical demands of job-specific work.",
"   </p>",
"   <p>",
"    A functional capacity evaluation is typically administered by a physical or occupational therapist. A less than maximal effort on the individual's part will severely limit the results.",
"   </p>",
"   <p>",
"    There is considerable variability in the tests used, predictability of return to work, and interpretation of test results. Physical or occupational therapy providers may be helpful in recommendations for an FCE. Clinicians who wish to assess functional ability without referral for physical testing may use the Roland-Morris Disability Questionnaire (RMDQ), which is relatively quick and has demonstrated validity for measuring functional status [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     WORKERS' COMPENSATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goal of workers' compensation programs is to provide prompt and adequate benefits to injured workers while limiting employers' liabilities. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/36/32326?source=see_link\">",
"     \"Social Security Disability Insurance and workers' compensation in the United States\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Under workers' compensation, employees are spared lengthy and uncertain litigation, while employers can expect more predictable costs than under the law of negligence. Additionally, employers have an incentive to improve workplace safety. Workers' compensation law is variable among states. Common to all state systems are that employers pay all related medical costs, either directly or through insurance, injured workers receive income replacement and medical care for injury, and dependents, in case of worker death, receive income and burial benefits. The income benefit for total disability is set at a specified fraction of the worker's usual earnings for as long as he or she is unable to return to work, or for a set period of time as provided by the state's workers compensation law. In most states, benefits are payable only for certain defined periods of time.",
"   </p>",
"   <p>",
"    Cases of occupationally-caused disease are treated differently than those involving traumatic injury, and are more often disputed as work-related, given their multifactorial nature and the long latency of many occupational diseases. All injuries or occupational diseases deemed compensable must \"arise out of\" or occur \"in the course of\" or \"have been triggered by\" employment, even if manifest and detected years later.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Evaluation of an injured worker",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluation for workers' compensation has some fundamental similarities to SSA disability evaluation. The initial step for workers' compensation evaluations is impairment assessment. Clinicians commonly are asked to also evaluate work-related disability.",
"   </p>",
"   <p>",
"    In the case of an undisputed work-related injury, the clinician is commonly asked to document the impairment, functional limitations, duration of limitation, and the disability. As an example, an assessment of a right-hand dominant worker who developed right-sided carpal tunnel syndrome in the course of work might appear as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Impairment: right carpal tunnel syndrome",
"     </li>",
"     <li>",
"      Functional limitation: inability to bend the right wrist repeatedly, or perform repetitive finger use associated with high force, long duration, and extremes of wrist motion and vibration. Keep the wrists straight as much as possible. Minimize repetitive, strong grasping or pinching objects with the thumb. Take frequent hand and wrist breaks.",
"     </li>",
"     <li>",
"      Duration: temporary pending surgical evaluation",
"     </li>",
"     <li>",
"      Disability: disabled from any work requiring repetitive finger use associated with high force, long duration, and extremes of wrist motion and vibration in the dominant hand.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the case of a right-handed machine operator with repetitive hand use, this would likely constitute total work disability but might result in no disability for a telephone operator who works with a headset and does not need to use his or her hands for repetitive activity.",
"   </p>",
"   <p>",
"    If the worker were thought to have a permanent impairment, the clinician would be asked to assess the permanent functional loss. This is commonly a percentage of the body part or whole person function, referred to as an impairment rating. The AMA Guides to the Evaluation of Permanent Impairment (\"Guides\") developed impairment percentages to reflect the impact of the impairment on the ability to perform activities of daily living [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/10\">",
"     10",
"    </a>",
"    ]. Some states use the AMA \"Guides\" percentage of permanent impairment as a direct proxy for disability and award monetary settlements for permanent loss directly from those percentages, although the \"Guides\" specifically discourage this practice [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/4,10\">",
"     4,10",
"    </a>",
"    ]. Other states use these percentages of impairment as one component of an assessment, also considering factors including vocation, age, and education before determining a disability award. Some states, such as New York, have used their own guidelines to evaluate the extent of loss of use for extremities or sense organs, referred to as a \"schedule loss of use.\"",
"   </p>",
"   <p>",
"    The \"Guides\" can serve as a useful and, in some states, required reference for clinicians to use in their evaluation and documentation of permanent impairment and its contribution to disability. However, the \"Guides\" have significant limitations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      They do not directly estimate work disability",
"     </li>",
"     <li>",
"      Medical criteria are not solely evidence-based",
"     </li>",
"     <li>",
"      Impairment percentage ratings are consensus-based and have varied over time, with decreased impairment ratings being the general trend, given increased overall health care costs [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Role of the clinician",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of the clinician in workers' compensation is to fulfill their state's requirements for evaluating and treating an injured worker. The clinician can usually download required criteria and forms from their state's worker compensation website.",
"   </p>",
"   <p>",
"    The worker's compensation process usually requires the clinician to perform the following steps:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Identify the particular state or federal workers' compensation regulation in effect. The appropriate workers' compensation guideline is based upon the employer and the employee location at the time of the work related injury or illness. Federal employees are covered under the Federal Employment Compensation Act. Most injured nonfederal workers are covered under their state workers' compensation legislation. However, railroad workers engaged in interstate commerce are covered under The Federal Employment Liability Act (FELA) and miners suffering from \"black lung\" (pneumoconiosis) are covered under the Black Lung Benefits Act.",
"     </li>",
"     <li>",
"      Evaluate the individual worker's medical impairments and functional abilities based upon the jurisdiction or state requirements. States may require that the clinician use a particular edition of the AMA \"Guides.\" A list of recent state requirements is provided in a table (",
"      <a class=\"graphic graphic_table graphicRef50347 \" href=\"UTD.htm?24/62/25579\">",
"       table 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      If requested, assess disability, using guidelines recommended by the state workers' compensation board or through use of validated disability assessment tools (see",
"      <a class=\"local\" href=\"#H15\">",
"       'Disability assessment tools'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Request that the employer provide the occupational requirements or the specific job description. If one is unavailable or irrelevant, use the O*NET system [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/55\">",
"       55",
"      </a>",
"      ], a key source for comprehensive occupational information regarding occupations and their included tasks, skills, work activities and work context. Other sources include the Dictionary of Occupational Titles [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22873/abstract/56\">",
"       56",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Assess and document whether the worker has the functional ability to meet the essential requirements of their occupation at the time of injury without harm to themselves or others, or if the essential job responsibilities can be performed with a reasonable workplace accommodation. For example, does an injured worker have sufficient cardiac reserve to safely do moderate work as defined by a recent stress test. If not, the clinician can suggest a reasonable accommodation be made to incorporate a lower level of physical ability. The employer is responsible for evaluating and meeting a request for workplace accommodation.",
"     </li>",
"     <li>",
"      Clinicians may also be asked to comment on whether a patient has the medical ability to do other types of work in lieu of their usual customary work. This requires the clinicians to express an opinion on residual functional capacity, but not on specific alternative jobs. As an example, a clinician might state that a patient could not do her usual work as an LPN, and that her functional capacity is limited to sedentary work as described by State guidelines. The clinician should not specifically state that the patient could work as a receptionist; the determination of whether there are other jobs for the patient is an administrative question best addressed by a vocational expert.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The role of the clinician in disability evaluations is to define and document findings related to the individual's medical problems and associated functional limitations, and to collate information from different sources into a coherent picture of the individual's medical conditions and function. Most agencies, like the Social Security Administration, recognize that treating clinicians can provide the best evidence for the existence of medical impairments and their consequences. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinician role'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The first step in disability evaluation is the determination of medical impairment and its impact on the ability to perform activities of daily living. Impairment has been defined as loss of use or derangement of a body structure or function, and is not synonymous with disability. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Impairment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Disability, the inability to engage in gainful activity due to physical or mental impairment, is a result of the interaction between the impaired individual and the environment in which they function. Clinicians contribute to the determination of disability through their assessment of impairment, associated functional impairments, and any impact on the ability to perform activities of daily living and work. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Disability'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For the purposes of the Social Security Administration, disability may be determined in several ways. Individuals who have \"severe\" impairment, as defined by disease-specific criteria in the Blue Book Listing of Impairments, are considered to be disabled and do not require a full evaluation process. \"Medical equivalence\" is recognized when multiple impairments result in functional limitations equal in severity to the requirements of a listing. Based on objective medical findings, other individuals may have sufficiently reduced \"residual functional capacity\" to qualify for disability. Proper documentation is essential to facilitate the disability process. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'The Social Security Administration'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      While there are no tests with sufficient reliability, validity, or sensitivity to classify applicants as unable to work, tools can serve as useful adjuncts to the clinician's medical judgment. Several assessment tools are available to evaluate patients with low back pain and non-specific pain. The functional capacity evaluation, usually performed by a physical or occupational therapist, can provide information on job-specific maximum work ability. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Disability assessment tools'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Worker's compensation is federally mandated but criteria and administration are state-specific for most nonfederal jobs. A number of states use the AMA \"Guides\" in the evaluation and documentation of permanent impairment. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Workers' compensation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4523555\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The author wishes to acknowledge Nadya Peresleni, who assisted in the preparation of this topic.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     O'Connell, Quick, Zevin. Documenting Disability: Simple Strategies for Medical Providers The National Health Care for the Homeless Council's website 2007. Available at: www.nhchc.org/DocumentingDisability.pdf (Accessed on May 24, 2008).",
"    </li>",
"    <li>",
"     Social Security Administration. Disability Evaluation Under Social Security (Blue Book - September 2008). Available at: file://www.socialsecurity.gov/disability/professionals/bluebook/ (Accessed on September 28, 2012).",
"    </li>",
"    <li>",
"     Social Security Online. Consultative Examinations: A Guide for Health Professionals (The Green Book). SSA Publication No. 64-025. November 1999, ICN 954095. Available at: www.ssa.gov/disability/professionals/greenbook/ce-evidence.htm (Accessed on January 02, 2000).",
"    </li>",
"    <li>",
"     Cocchiarella L, Anderson GB. Guides to the Evaluation of Permanent Impairment, 5th ed, American Medical Association, 2001  p.565.",
"    </li>",
"    <li>",
"     Rondinelli R. Guides to the Evaluation of Permanent Impairment, 6th ed, American Medical Association, 2007.",
"    </li>",
"    <li>",
"     State-by-State Use of AMA Guides, updated July 2009. Available at: www.lexisnexis.com/documents/pdf/20090916052048_large.PDF (Accessed on October 05, 2009).",
"    </li>",
"    <li>",
"     What is the ADA: Definition of Disability. Available at: www.adata.org/whatsada-definition.aspx (Accessed on May 05, 2009).",
"    </li>",
"    <li>",
"     World Health Organization. International Classification of Impairments, Disability and Health. Geneva, Switzerland 2001.",
"    </li>",
"    <li>",
"     Cocchiarella L, Lord SJ. Master the AMA Guides 5th: A Medical and Legal Transition to the Guides to the Evaluation of Permanent Impairment, 5th ed, American Medical Association Press, 2001.",
"    </li>",
"    <li>",
"     McFarren TD. AMA Guides: Sixth Edition Arrive on the Scene. Available at: file://law.lexisnexis.com/practiceareas/Workers-Compensation-Law-Blog/Workers-Compensation/AMA-Guides-Sixth-Edition-Arrive-on-the-Scene (Accessed on December 18, 2008).",
"    </li>",
"    <li>",
"     Jette A, et al. Committee on Disability in America, INSTITUTE OF MEDICINE, Board on Health Sciences Policy, The Future of Disability in America, 2007.",
"    </li>",
"    <li>",
"     National Council on Disability (NCD). The Current State of Health Care for People with Disabilities. Available at: www.ncd.gov/newsroom/publications/2009/HealthCare/HealthCare.html (Accessed on September 30, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22873/abstract/13\">",
"      Forst L, Friedman L, Chukwu A. Reliability of the AMA Guides to the Evaluation of Permanent Impairment. J Occup Environ Med 2010; 52:1201.",
"     </a>",
"    </li>",
"    <li>",
"     Brault M. Americans with Disabilities: 2005. U.S. Census Bureau; Washington, DC 2008.",
"    </li>",
"    <li>",
"     Altman B, Bernstein A. Disability and Health in the United States, 2001-2005. National Center for Health Statistics; Hyattsville, MD 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22873/abstract/16\">",
"      Centers for Disease Control and Prevention (CDC). Public health and aging: projected prevalence of self-reported arthritis or chronic joint symptoms among persons aged &gt;65 years--United States, 2005-2030. MMWR Morb Mortal Wkly Rep 2003; 52:489.",
"     </a>",
"    </li>",
"    <li>",
"     American Society on Aging: Teaching/Training Modules on Trends in Health and Aging. Available at: www.asaging.org (Accessed on November 15, 2012).",
"    </li>",
"    <li>",
"     Bureau of Labor Statistics. Economic News Release: Workplace Injury and Illness Summary. Available at: file://www.bls.gov/news.release/osh.nr0.htm (Accessed on June 08, 2012).",
"    </li>",
"    <li>",
"     Bureau of Labor Statistics. News Release: National Census of Fatal Occupational Injuries in 2010 (Preliminary Results). US Department of Labor. Available online at: file://www.bls.gov/news.release/pdf/cfoi.pdf (Accessed on June 08, 2012).",
"    </li>",
"    <li>",
"     NIOSH Publication No. 2004-146, Worker Health Chartbook 2004. Available at: file://www.cdc.gov/niosh/docs/2004-146/ (Accessed on November 14, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22873/abstract/21\">",
"      Landsbergis PA. The changing organization of work and the safety and health of working people: a commentary. J Occup Environ Med 2003; 45:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22873/abstract/22\">",
"      Subramanian A, Desai A, Prakash L, et al. Changing trends in US injury profiles: revisiting non-fatal occupational injury statistics. J Occup Rehabil 2006; 16:123.",
"     </a>",
"    </li>",
"    <li>",
"     Social Security Administration. Status of the Social Security and Medicare Programs: A summary of the 2012 annual reports. Available at: file://www.ssa.gov/oact/TRSUM/index.html (Accessed on June 04, 2012).",
"    </li>",
"    <li>",
"     Institute of Medicine. \"Linking Components of Functional Capacity Domains with Work Requirements.\" In: Measuring Funcitonal Capacity and Work Requirements: Summary of a Workshop. National Academies Press 1999. Available at: file://books.nap.edu/openbook.php?record_id=6406&amp;page=32 (Accessed on January 03, 2013).",
"    </li>",
"    <li>",
"     O'Connell J, Quick P, Zevin B, Post P. Documenting Disability: Simple Strategies for Medical Providers. National Health Care for the Homeless Council Website. Available at: documenting-disability-simple-strategies-for-medical-providers (Accessed on January 03, 2013).",
"    </li>",
"    <li>",
"     Social Security Administration. Disability Under Social Security: Part III - Listing of Impairments. US Social Security Administration Website. Avialble at: www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm (Accessed on January 03, 2013).",
"    </li>",
"    <li>",
"     Social Security Administration. SSR 82-63: TITLES II AND XVI: MEDICAL-VOCATIONAL PROFILES SHOWING AN INABILITY TO MAKE AN ADJUSTMENT TO OTHER WORK. US Social Security Administration website. Available at: www.ssa.gov/OP_Home/rulings/di/02/SSR82-63-di-02.html (Accessed on January 03, 2013).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22873/abstract/28\">",
"      Fairbank JC, Couper J, Davies JB, O'Brien JP. The Oswestry low back pain disability questionnaire. Physiotherapy 1980; 66:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22873/abstract/29\">",
"      Kopec JA, Esdaile JM, Abrahamowicz M, et al. The Quebec Back Pain Disability Scale: conceptualization and development. J Clin Epidemiol 1996; 49:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22873/abstract/30\">",
"      Manniche C, Asmussen K, Lauritsen B, et al. Low Back Pain Rating scale: validation of a tool for assessment of low back pain. Pain 1994; 57:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22873/abstract/31\">",
"      Bolton JE, Breen AC. The Bournemouth Questionnaire: a short-form comprehensive outcome measure. I. Psychometric properties in back pain patients. J Manipulative Physiol Ther 1999; 22:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22873/abstract/32\">",
"      Ruta DA, Garratt AM, Wardlaw D, Russell IT. Developing a valid and reliable measure of health outcome for patients with low back pain. Spine (Phila Pa 1976) 1994; 19:1887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22873/abstract/33\">",
"      Stratford PW, Binkley JM, Riddle DL. Development and initial validation of the back pain functional scale. Spine (Phila Pa 1976) 2000; 25:2095.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22873/abstract/34\">",
"      Waddell G, Main CJ. Assessment of severity in low-back disorders. Spine (Phila Pa 1976) 1984; 9:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22873/abstract/35\">",
"      Roland M, Morris R. A study of the natural history of back pain. Part I: development of a reliable and sensitive measure of disability in low-back pain. Spine (Phila Pa 1976) 1983; 8:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22873/abstract/36\">",
"      Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22873/abstract/37\">",
"      Chapman JR, Norvell DC, Hermsmeyer JT, et al. Evaluating common outcomes for measuring treatment success for chronic low back pain. Spine (Phila Pa 1976) 2011; 36:S54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22873/abstract/38\">",
"      Garratt AM, Ruta DA, Abdalla MI, et al. The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? BMJ 1993; 306:1440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22873/abstract/39\">",
"      Roland M, Fairbank J. The Roland-Morris Disability Questionnaire and the Oswestry Disability Questionnaire. Spine (Phila Pa 1976) 2000; 25:3115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22873/abstract/40\">",
"      Ostelo RW, de Vet HC, Knol DL, van den Brandt PA. 24-item Roland-Morris Disability Questionnaire was preferred out of six functional status questionnaires for post-lumbar disc surgery. J Clin Epidemiol 2004; 57:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22873/abstract/41\">",
"      Davidson M, Keating JL. A comparison of five low back disability questionnaires: reliability and responsiveness. Phys Ther 2002; 82:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22873/abstract/42\">",
"      Pransky G, Feuerstein M, Himmelstein J, et al. Measuring functional outcomes in work-related upper extremity disorders. Development and validation of the Upper Extremity Function Scale. J Occup Environ Med 1997; 39:1195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22873/abstract/43\">",
"      Chung KC, Pillsbury MS, Walters MR, Hayward RA. Reliability and validity testing of the Michigan Hand Outcomes Questionnaire. J Hand Surg Am 1998; 23:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22873/abstract/44\">",
"      Hudak PL, Amadio PC, Bombardier C. Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG). Am J Ind Med 1996; 29:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22873/abstract/45\">",
"      Velstra IM, Ballert CS, Cieza A. A systematic literature review of outcome measures for upper extremity function using the international classification of functioning, disability, and health as reference. PM R 2011; 3:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22873/abstract/46\">",
"      Johanson NA, Liang MH, Daltroy L, et al. American Academy of Orthopaedic Surgeons lower limb outcomes assessment instruments. Reliability, validity, and sensitivity to change. J Bone Joint Surg Am 2004; 86-A:902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22873/abstract/47\">",
"      McNair PJ, Prapavessis H, Collier J, et al. The lower-limb tasks questionnaire: an assessment of validity, reliability, responsiveness, and minimal important differences. Arch Phys Med Rehabil 2007; 88:993.",
"     </a>",
"    </li>",
"    <li>",
"     Pain Disability Index. Available at: file://www.med.umich.edu/1info/fhp/practiceguides/pain/detpdi.pdf (Accessed on January 13, 2013).",
"    </li>",
"    <li>",
"     Barofsky I, Cohen SJ, Sugarbaker PH. Selecting a quality of life assessment instrument: Standardized tests, clinical assessments, or custom-designed instruments. In: Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies, Wenger NK, Mattson ME, et al (Eds), Le Jacq Publishing Inc, 1984. p.239.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22873/abstract/50\">",
"      Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975; 1:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22873/abstract/51\">",
"      Chibnall JT, Tait RC. The Pain Disability Index: factor structure and normative data. Arch Phys Med Rehabil 1994; 75:1082.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22873/abstract/52\">",
"      Richards JS, Nepomuceno C, Riles M, Suer Z. Assessing pain behavior: the UAB Pain Behavior Scale. Pain 1982; 14:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22873/abstract/53\">",
"      Gouttebarge V, Wind H, Kuijer PP, Frings-Dresen MH. Reliability and validity of Functional Capacity Evaluation methods: a systematic review with reference to Blankenship system, Ergos work simulator, Ergo-Kit and Isernhagen work system. Int Arch Occup Environ Health 2004; 77:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22873/abstract/54\">",
"      Spanjer J, Groothoff JW, Brouwer S. Instruments used to assess functional limitations in workers applying for disability benefit: a systematic review. Disabil Rehabil 2011; 33:2143.",
"     </a>",
"    </li>",
"    <li>",
"     O*NET OnLine. Available at: file://online.onetcenter.org/ (Accessed on January 14, 2013).",
"    </li>",
"    <li>",
"     Dictionary of occupational titles, 4th ed, US Department of Labor Employment and Training Administration, Washington, DC 1991.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2791 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.167.4.114-2B3BC00349-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_21_22873=[""].join("\n");
var outline_f22_21_22873=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICIAN ROLE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Impairment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Disability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Disability",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Work-related injury and disability",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Economic impact",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DISABILITY ASSESSMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      The Social Security Administration",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Listing of impairments",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Residual functional capacity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Documentation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      DISABILITY ASSESSMENT TOOLS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Computer-based questionnaires (PROMIS)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Traditional questionnaires",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Musculoskeletal assessment instruments",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Pain disability assessment instruments",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Functional capacity evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      WORKERS' COMPENSATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Evaluation of an injured worker",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Role of the clinician",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4523555\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/2791\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/2791|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/2/43050\" title=\"figure 1\">",
"      Disability letter",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/12/35014\" title=\"figure 2\">",
"      Oswestry questionnaire",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/2791|Form\">",
"      <a href=\"#\" title=\"FORMS\">",
"       FORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_form\" href=\"UTD.htm?13/38/13923\" title=\"form 1\">",
"      Quebec back pain scale",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/2791|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?31/24/32141\" title=\"table 1\">",
"      Disability definitions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/62/25579\" title=\"table 2\">",
"      Workers comp reqs AMA Guide",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?39/11/40124\" title=\"table 3\">",
"      Funct assess questionnaires",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/40/32391?source=related_link\">",
"      Evaluation of pulmonary disability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/34/42535?source=related_link\">",
"      Occupational low back pain: Evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/36/32326?source=related_link\">",
"      Social Security Disability Insurance and workers' compensation in the United States",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_21_22874="Opioid intoxication in children and adolescents";
var content_f22_21_22874=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Opioid intoxication in children and adolescents",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/21/22874/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/21/22874/contributors\">",
"     Kevin C Osterhoudt, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/21/22874/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/21/22874/contributors\">",
"     Michele Burns Ewald, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/21/22874/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/21/22874/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/21/22874/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 10, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Opioids have analgesic and central nervous system (CNS) depressant effects and the potential to cause euphoria.",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32233?source=see_link\">",
"     Morphine",
"    </a>",
"    is the prototypic opioid. Heroin is a derivative of morphine and is commonly abused. Prescription opioid medications are effective in the treatment of acute and chronic pain and as anesthetic agents. They have the potential to be abused for these effects and the associated feeling of euphoria and may be the source of significant toxicity after exploratory ingestion in young children.",
"   </p>",
"   <p>",
"    The epidemiology, pharmacology, clinical manifestations, and management of opioid toxicity in children and adolescents are reviewed here. Opioid withdrawal in the pediatric patient and opioid abuse, intoxication, withdrawal, and treatment in adults are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/57/39833?source=see_link\">",
"     \"Neonatal opioid withdrawal (Neonatal abstinence syndrome)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20103?source=see_link\">",
"     \"Opioid withdrawal in adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/44/3784?source=see_link\">",
"     \"Opioid abuse and dependence: Overview and patient evaluation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/52/29514?source=see_link\">",
"     \"Treatment of opioid abuse and dependence\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/51/3897?source=see_link\">",
"     \"Opioid intoxication in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several terms are used to describe opioid substances:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Opioid refers to natural and synthetic substances with",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32233?source=see_link\">",
"       morphine",
"      </a>",
"      -like activity.",
"     </li>",
"     <li>",
"      Opiate describes a subclass of opioids consisting of alkaloid compounds extracted from opium, including",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32233?source=see_link\">",
"       morphine",
"      </a>",
"      , heroin,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32230?source=see_link\">",
"       codeine",
"      </a>",
"      , and semisynthetic derivatives of the poppy plant.",
"     </li>",
"     <li>",
"      Endorphins are endogenous peptides that produce pain relief and comprise another subclass of opioids which includes enkephalins, dynorphins, and beta-endorphins.",
"     </li>",
"     <li>",
"      Prescription opioids include",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32233?source=see_link\">",
"       morphine",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32230?source=see_link\">",
"       codeine",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/29/26071?source=see_link\">",
"       buprenorphine",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?3/13/3289?source=see_link\">",
"       hydromorphone",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?10/63/11255?source=see_link\">",
"       meperidine",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/49/22296?source=see_link\">",
"       methadone",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?38/23/39287?source=see_link\">",
"       oxycodone",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/8/32903?source=see_link\">",
"       oxymorphone",
"      </a>",
"      . Morphine and codeine are derived from opium. Buprenorphine, hydromorphone, oxycodone, and oxymorphone are semisynthetic opioids. Meperidine and methadone are fully synthetic (",
"      <a class=\"graphic graphic_table graphicRef66571 \" href=\"UTD.htm?36/23/37244\">",
"       table 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      \"Designer\" opioids are synthetic derivatives of opioids created in makeshift laboratories and include 3-methylfentanyl (implicated in the Moscow theater hostage crisis of 2002), &alpha;-",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/45/35546?source=see_link\">",
"       fentanyl",
"      </a>",
"      (&ldquo;China White&rdquo;) and other agents such as MPTP (1, methyl, 4 phenyl 1,2,3,6 tetrahydropyridine). The agents in this class of opioids change frequently because of variation in laboratories and the attempt to evade law enforcement. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/47/1784?source=see_link&amp;anchor=H14#H14\">",
"       \"Designer drugs of abuse\", section on 'Opioid analogs'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The definitions for opioid dependence or abuse are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/44/3784?source=see_link&amp;anchor=H2#H2\">",
"     \"Opioid abuse and dependence: Overview and patient evaluation\", section on 'Definitions'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20103?source=see_link\">",
"     \"Opioid withdrawal in adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/5/28758?source=see_link\">",
"     \"Opioid withdrawal in the emergency setting\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Opioid abuse is a major international public health problem with up to 22 million people using opium or heroin in 2008 [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/1\">",
"     1",
"    </a>",
"    ]. Recreational use of opioids is increasing in the adolescent and young adult population with increased morbidity and mortality in the United States as indicated by the following statistics:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Centers for Disease Control report that deaths from unintentional drug overdoses have been rising steeply in the United States since the early 1990s and are the second leading cause of death due to injury in 2007 [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/2\">",
"       2",
"      </a>",
"      ]. Death is thought to be secondary to respiratory depression, although prolongation of the QT interval in patients on",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/49/22296?source=see_link\">",
"       methadone",
"      </a>",
"      may also be contributory. While mortality is highest in people ages 45 to 54 years of age, adolescents and young adults are seen in emergency departments more frequently from abuse of opioids and other drugs.",
"     </li>",
"     <li>",
"      Visits to emergency departments for opioid abuse more than doubled between 2004 and 2008 [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Admissions to substance abuse treatment programs increased by 400 percent between 1998 and 2008 with marijuana being the most prevalent drug, but prescription painkillers being the second most common [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Prescription sales of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?38/23/39287?source=see_link\">",
"       oxycodone",
"      </a>",
"      and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/49/22296?source=see_link\">",
"       methadone",
"      </a>",
"      almost quadrupled between 1997 and 2002; a strong correlation exists between states with the highest drug-poisoning mortality and those with the highest prescription opioid consumption [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Nonmedical use of prescription opioids was reported by 9 percent of a nationally representative sample of high school seniors in the United States during 2007 to 2009 [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/6\">",
"       6",
"      </a>",
"      ]. Intranasal use of prescription opioids was described by 37 percent of nonmedical prescription opioid users.",
"     </li>",
"     <li>",
"      The yearly healthcare expenditure for opioid dependence in the United States exceeds 1.2 billion dollars [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In children under age six years, opioid intoxication typically occurs as an exploratory ingestion of prescription opioids that were available within their environment. Some of these medications, such as",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/49/22296?source=see_link\">",
"     methadone",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/29/26071?source=see_link\">",
"     buprenorphine",
"    </a>",
"    pills or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/45/35546?source=see_link\">",
"     fentanyl",
"    </a>",
"    patches, may cause life-threatening respiratory depression or death despite ingestion of only one or two pills or exposure to one patch [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/8-15\">",
"     8-15",
"    </a>",
"    ]. Children are also exposed to opioids maliciously by their caretakers or inadvertently in households where illegal drugs are accessible, often with fatal results [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/19/24890?source=see_link&amp;anchor=H10#H10\">",
"     \"Physical abuse in children: Diagnostic evaluation and management\", section on 'Toxicology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PHARMACOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The activity of opioids resembles that of the body's endogenous opioid peptides (enkephalins, endorphins, and dynorphins) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/18\">",
"     18",
"    </a>",
"    ]. Opioid peptides produce their effects through interaction with receptors throughout the nervous system and the gastrointestinal tract. In contrast, local anesthetics alter pain sensory thresholds.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20287450\">",
"    <span class=\"h2\">",
"     Mechanism of action and pharmacokinetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Three types of receptors have been identified: mu (&micro;), kappa (k), and delta (&delta;); most opioids interact with more than one type [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/18\">",
"     18",
"    </a>",
"    ]. An opioid-receptor-like 1 (ORL-1) receptor or &ldquo;orphan&rdquo; receptor has also been described [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/18\">",
"     18",
"    </a>",
"    ]. The primary sites of opioid action are the limbic system, thalamus, and hypothalamus.",
"   </p>",
"   <p>",
"    Opioids are classified into three groups based upon their actions [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/18\">",
"     18",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32233?source=see_link\">",
"       Morphine",
"      </a>",
"      -like opioid agonists, which include heroin,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32230?source=see_link\">",
"       codeine",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?10/63/11255?source=see_link\">",
"       meperidine",
"      </a>",
"      , hydrocodone, diphenoxylate,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?8/31/8692?source=see_link\">",
"       loperamide",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/45/35546?source=see_link\">",
"       fentanyl",
"      </a>",
"      , and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/49/22296?source=see_link\">",
"       methadone",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      Opioid antagonists which competitively block receptor activation by occupying opioid receptor sites. Examples include",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"       naloxone",
"      </a>",
"      , nalmefene, and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/16/39173?source=see_link\">",
"       naltrexone",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      Mixed",
"      <span class=\"nowrap\">",
"       agonist-antagonists/partial",
"      </span>",
"      agonists which have different effects depending upon the predominance of agonistic or antagonistic activity in the opioid receptor and prior exposure to opioids.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The use of a mixed agent in an opioid naive subject results in analgesia and possibly dependence if the agent is used for a long period of time. On the other hand, the use of a mixed agent in an opioid dependent subject may result in withdrawal. Examples of drugs in this class include",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/16/5382?source=see_link\">",
"     pentazocine",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?26/15/26869?source=see_link\">",
"     nalbuphine",
"    </a>",
"    , and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/29/26071?source=see_link\">",
"     buprenorphine",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Pharmacokinetics",
"      </strong>",
"      &ndash; The pharmacokinetics of opioids in children between age 1 and 15 years are similar to those in adults [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/19\">",
"       19",
"      </a>",
"      ]. Intravenous use of opioids gives an immediate euphoric effect, subcutaneous administration produces euphoria in 15 minutes, and snorting leads to effect in approximately 30 minutes. When taken orally, opioids such as",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/49/22296?source=see_link\">",
"       methadone",
"      </a>",
"      typically produce a peak effect in four to six hours.",
"      <br/>",
"      <br/>",
"      Clinical effects of pharmacological doses of most opioids persist for three to six hours;",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/45/35546?source=see_link\">",
"       fentanyl",
"      </a>",
"      for one hour; and methadone for 24 to 48 hours [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/18\">",
"       18",
"      </a>",
"      ]. The absorption of orally administered",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/33/37397?source=see_link\">",
"       diphenoxylate-atropine",
"      </a>",
"      (Lomotil) usually is delayed because of the",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/13/25816?source=see_link\">",
"       atropine",
"      </a>",
"      (anticholinergic) component.",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?10/63/11255?source=see_link\">",
"       Meperidine",
"      </a>",
"      has erratic absorption when it is used intramuscularly [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/20\">",
"       20",
"      </a>",
"      ]. The toxicokinetics of opioid drugs after overdose have not been fully defined leading to uncertainty as to the length of time necessary for observation of the asymptomatic patient.",
"     </li>",
"     <li>",
"      <strong>",
"       Metabolism",
"      </strong>",
"      &ndash; Most opioids are metabolized by the liver. Patients with liver disease have impaired metabolism and are at increased risk for toxicity caused by accumulation of active metabolites [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/19\">",
"       19",
"      </a>",
"      ]. The active metabolites of opioids bind to specific mu, delta, and kappa receptors in the central nervous system (CNS) to elicit their clinical effects. The &micro;2 receptor mediates many of the life-threatening effects, including respiratory depression. CYP 2D6 is the enzyme responsible for converting",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32230?source=see_link\">",
"       codeine",
"      </a>",
"      to",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32233?source=see_link\">",
"       morphine",
"      </a>",
"      , for example, and individuals with duplicate genes are considered to be ultrarapid metabolizers with an increased risk for toxicity [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/21\">",
"       21",
"      </a>",
"      ]. Opioid metabolites are excreted primarily by the kidneys and can be detected on urine drug screen up to four days after the last use (occasionally longer in chronic users) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/19\">",
"       19",
"      </a>",
"      ]. Renal dysfunction can lead to toxicity caused by accumulation of active metabolites.",
"     </li>",
"     <li>",
"      <strong>",
"       Drug interactions",
"      </strong>",
"      &ndash; Opioids interact with various drugs [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/19,22\">",
"       19,22",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Proserotonergic opioids such as",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/45/35546?source=see_link\">",
"       fentanyl",
"      </a>",
"      and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?10/63/11255?source=see_link\">",
"       meperidine",
"      </a>",
"      in combination with monoamine oxidase inhibitors, serotonin-specific reuptake inhibitors, and cyclic antidepressants can produce serotonin syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Phenothiazines potentiate the action of opioids, possibly by interfering with their metabolism.",
"     </li>",
"     <li>",
"      Cyclic antidepressants increase the bioavailability and plasma level of opioids.",
"     </li>",
"     <li>",
"      Several drugs impact metabolism of opioids through inhibition or induction of cytochrome oxidase enzyme systems. For example,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/58/43943?source=see_link\">",
"       cimetidine",
"      </a>",
"      may enhance effects through prolonging the duration of action. Certain antibiotics may increase (",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/11/38064?source=see_link\">",
"       erythromycin",
"      </a>",
"      ) or decrease (",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/52/17225?source=see_link\">",
"       rifampin",
"      </a>",
"      ) opioid effects.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H886416\">",
"    <span class=\"h2\">",
"     Morphine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Compared with intravenous administration, sublingual, buccal, and sustained-release preparations of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32233?source=see_link\">",
"     morphine",
"    </a>",
"    have delayed absorption, attenuating and delaying the peak plasma concentrations. Sustained-release morphine attains one-half the peak plasma level of a comparable dose of immediate-release morphine; levels peak three to four hours after use and depending upon preparation provide pain relief in opioid na&iuml;ve patients from 4 to 10 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32233?source=see_link\">",
"     Morphine",
"    </a>",
"    's main metabolite, morphine-6-glucuronide, is more potent than morphine and is responsible for most of the clinical effects [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/19\">",
"     19",
"    </a>",
"    ]. It can be detected in large quantities soon after oral or intravenous administration and levels directly correlate with medication effect as described above. (See",
"    <a class=\"local\" href=\"#H20287450\">",
"     'Mechanism of action and pharmacokinetics'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H886423\">",
"    <span class=\"h2\">",
"     Heroin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Heroin (diacetylmorphine) is the prototypic recreationally abused opioid, and it is sold under various creative street names Heroin is produced as a pure white crystal or impure tar-like substance, depending upon the supplier. &nbsp;It is typically adulterated with lactose, procaine, calcium-channel blockers,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/60/43975?source=see_link\">",
"     mannitol",
"    </a>",
"    , dextrose, talc, or other substances [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/24\">",
"     24",
"    </a>",
"    ]; final concentration varies between 1 to 20 mg per dose from dealer to dealer and day to day. For this reason, overdoses are more likely to occur with heroin than with prescription opiates.",
"   </p>",
"   <p>",
"    Heroin typically is injected. It has a quick onset and brief duration of action. It is rapidly cleared by the liver and excreted in the urine as",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32233?source=see_link\">",
"     morphine",
"    </a>",
"    . The pharmacokinetics of inhaling heroin fumes (\"chasing the dragon\") or smoking cigarettes dipped in heroin (\"ack ack\") are similar to that of heroin that is injected intravenously. Chronic fume inhalation can result in spongiform leukoencephalopathy and may represent chronic aluminum toxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/25\">",
"     25",
"    </a>",
"    ]. In one study, the blood concentrations of heroin, either inhaled or intravenous peaked within one to five minutes and decreased to the limit of detection within 30 minutes [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Routes of use",
"    </span>",
"    &nbsp;&mdash;&nbsp;Opioids can be administered intravenously (\"mainlining\"), subcutaneously (\"skin popping\"), intranasally (\"snorting\"), orally, or by inhaling (smoking, \"free-basing,\" \"chasing the dragon\"). Most American adolescents initiate heroin or prescription opioid use by snorting because snorting requires minimal equipment, is not associated with the health risks of injection, and the onset of action is rapid enough to produce euphoria (the \"rush\") [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/6,27\">",
"     6,27",
"    </a>",
"    ]. Cases of \"body packing\" (swallowing large amounts of well-packaged opioids for the purpose of smuggling) have also been described in children and adolescents [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/28/12744?source=see_link\">",
"     \"Internal concealment of drugs of abuse (body packing)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of opioid overdose is based upon the history and physical examination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H886646\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinician should attempt to identify the specific drug, dose, and formulation to which the patient was exposed, the presence of nonopioid co-exposures, and the individual's prior history of opioid use. In young children, the history is typically a small, exploratory ingestion and a list of drugs available within the child&rsquo;s environment should be detailed. The caregiver should also be asked about administration of medicines containing diphenoxylate (eg, Lomotil",
"    <sup>",
"     &reg;",
"    </sup>",
"    ) or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/21/34132?source=see_link\">",
"     dextromethorphan",
"    </a>",
"    (eg, Delsym",
"    <sup>",
"     &reg;",
"    </sup>",
"    ) both of which can cause serious opioid toxicity in young children [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. When infants or young children are ultimately identified with serious opioid overdose and there is no clear initial history of opioid use, health care providers should give consideration to the possibility of a malicious intentional overdose by a caregiver.",
"   </p>",
"   <p>",
"    In adolescents, opioid exposures will fall into one of several categories: recreational use, intended self-harm, or attempt to hide drugs from law enforcement out of fear for arrest (\"body stuffing\"), or rarely, swallowing large quantities of packaged drugs in order to transport them across borders (\"body packing\"). In this patient population, additional history should identify the likelihood of trauma (particularly head trauma) and sexual assault. Often, emergency medical services reports regarding where and how the patient was found and whether he or she was partially or fully undressed can assist in identifying physical or sexual assault.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H886653\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The classic findings of opioid toxicity are (",
"    <a class=\"graphic graphic_table graphicRef56801 \" href=\"UTD.htm?10/12/10443\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef69375 \" href=\"UTD.htm?34/57/35741\">",
"     table 3",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Miosis",
"     </li>",
"     <li>",
"      CNS depression",
"     </li>",
"     <li>",
"      Respiratory depression",
"     </li>",
"     <li>",
"      Other findings, including hyporeflexia, hypothermia, dermal &ldquo;track marks&rdquo;, flushing, pruritus, bradycardia, hypotension, or decreased bowel sounds",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Opioids can also cause multiple physical findings in various organ systems:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Pupillary response",
"      </strong>",
"      &ndash; Miosis (pupillary constriction) usually occurs within five minutes of intravenous administration and lasts for at least six hours [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/26\">",
"       26",
"      </a>",
"      ]. Although miosis is the usual finding, mydriasis or normal pupils may be seen with overdose of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?10/63/11255?source=see_link\">",
"       meperidine",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32233?source=see_link\">",
"       morphine",
"      </a>",
"      (rarely), propoxyphene,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/21/34132?source=see_link\">",
"       dextromethorphan",
"      </a>",
"      , or",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/16/5382?source=see_link\">",
"       pentazocine",
"      </a>",
"      , in the early stages of",
"      <span class=\"nowrap\">",
"       <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/13/25816?source=see_link\">",
"        atropine",
"       </a>",
"       /diphenoxylate",
"      </span>",
"      (Lomotil&reg; poisoning), and after the use of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"       naloxone",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/18,32,33\">",
"       18,32,33",
"      </a>",
"      ]. Mydriasis or normal pupils also may be seen if heroin was coingested with a stimulant or anticholinergic drug, such as cocaine (ie, \"speedball\") or",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/9/34960?source=see_link\">",
"       scopolamine",
"      </a>",
"      , or if hypoxic brain injury occurred because of prolonged respiratory depression [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Respiratory depression and noncardiogenic pulmonary edema",
"      </strong>",
"      &ndash; Most opioid-related deaths are caused by respiratory depression, which is caused by central and peripheral effects. Respiratory depression may be subtle. The isolated respiratory rate is not a reliable measure of ventilation because a small decrease in tidal volume occurs before the respiratory rate declines.",
"      <br/>",
"      <br/>",
"      Noncardiogenic pulmonary edema may complicate opioid overdose. The characteristic findings include pink, frothy bronchial secretions, cyanosis, and rales in a stuporous or comatose patient with respiratory depression and miotic pupils. The distribution of pulmonary edema on chest radiograph usually is nonuniform [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/34\">",
"       34",
"      </a>",
"      ]. The pathophysiology of this form of pulmonary edema is not known. Proposed mechanisms include forceful inspiration (negative pressure) against a closed glottis, direct toxicity of the drug, hypoxia, and acidosis secondary to hypoventilation",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      cerebral edema. Resolution of pulmonary edema is rapid once assisted ventilation is instituted and both hypoventilation and hypoxia are reversed.",
"      <br/>",
"      <br/>",
"      The incidence of noncardiogenic pulmonary edema in patients hospitalized with heroin overdose is 48 to 80 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/35\">",
"       35",
"      </a>",
"      ].",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/49/22296?source=see_link\">",
"       Methadone",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32233?source=see_link\">",
"       morphine",
"      </a>",
"      , and propoxyphene also can cause noncardiogenic pulmonary edema. The interval between exposure and symptom onset usually is less than two hours for heroin-related cases [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/34\">",
"       34",
"      </a>",
"      ] and less than 6 to 12 hours for those associated with methadone. Some case reports have suggested that",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"       naloxone",
"      </a>",
"      itself precipitates noncardiogenic pulmonary edema in patients with opioid overdose. However, alveolar filling was noted on autopsy in 50 to 90 percent of heroin overdose patients that did not receive naloxone [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Cardiovascular",
"      </strong>",
"      &ndash; Opioids cause bradycardia and hypotension via increased parasympathetic activity, decreased sympathetic activity, and release of histamine brought about by their effects on the vasomotor center [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/37\">",
"       37",
"      </a>",
"      ]. The drug-induced bradycardia and increased automaticity can cause arrhythmia, including potentially lethal ventricular tachyarrhythmia [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/38\">",
"       38",
"      </a>",
"      ].",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/49/22296?source=see_link\">",
"       Methadone",
"      </a>",
"      , in particular, can block the inwardly rectifying potassium current with subsequent prolongation of the QT interval [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/39\">",
"       39",
"      </a>",
"      ]. According to case reports, heroin contaminated with clenbuterol, a beta2 agonist, has resulted in tachycardia [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/40\">",
"       40",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Neurologic",
"      </strong>",
"      &ndash; Patients presenting to the emergency department typically are stuporous or comatose. Patients with profound CNS depression are at risk for aspiration of gastric contents because of impaired gag reflex and centrally mediated nausea and vomiting.",
"      <br/>",
"      <br/>",
"      Generalized seizures can occur after intravenous",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/45/35546?source=see_link\">",
"       fentanyl",
"      </a>",
"      and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/6/96?source=see_link\">",
"       sufentanil",
"      </a>",
"      administration, the prolonged use of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?10/63/11255?source=see_link\">",
"       meperidine",
"      </a>",
"      , and large ingestions of propoxyphene,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?26/7/26743?source=see_link\">",
"       tramadol",
"      </a>",
"      , or",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/16/5382?source=see_link\">",
"       pentazocine",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/41\">",
"       41",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      A Parkinsonian-like syndrome has been associated with some opioid-based designer drugs, such as MPTP (1, methyl, 4 phenyl 1,2,3,6 tetrahydropyridine) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/42\">",
"       42",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Gastrointestinal",
"      </strong>",
"      &ndash; Constipation results from decreased motility and increased sphincter tone in the rectum. The classic recommendation that",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32233?source=see_link\">",
"       morphine",
"      </a>",
"      should not be used in the treatment of biliary colic was based upon the long-standing teaching that morphine causes spasm of the sphincter of Oddi. However, no significant differences in intrabiliary pressures were found in clinical studies comparing morphine and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?10/63/11255?source=see_link\">",
"       meperidine",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Muscle rigidity and rhabdomyolysis",
"      </strong>",
"      &ndash; All opioid agonists can produce skeletal muscle rigidity, even at low doses [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/43\">",
"       43",
"      </a>",
"      ]. Acute rhabdomyolysis and renal failure may occur with the use of heroin,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/49/22296?source=see_link\">",
"       methadone",
"      </a>",
"      , and propoxyphene.",
"     </li>",
"     <li>",
"      <strong>",
"       Skin",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      Track marks can be seen frequently in those opioid users who routinely use the intravenous route for injection. Those injecting drug subcutaneously (&ldquo;skin poppers&rdquo;) may be at risk for wound botulism. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/36/37448?source=see_link&amp;anchor=H7#H7\">",
"       \"Botulism\", section on 'Wounds'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Reproductive",
"      </strong>",
"      &ndash; In girls, opioids may cause amenorrhea, anovulatory cycles, and impaired fertility caused by abnormal prolactin secretion secondary to the opioid action on the dopaminergic system. In addition, opioids may cause decreased libido in both males and females [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H886660\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In adolescents, the differential diagnosis for opioid intoxication is similar to adults. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/51/3897?source=see_link&amp;anchor=H8#H8\">",
"     \"Opioid intoxication in adults\", section on 'Differential diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In children under six years of age, common toxicologic causes of coma include ingestions of benzodiazepines and other sedative-hypnotic agents, oral hypoglycemic agents, ethanol, psychotropic medications, and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?13/14/13545?source=see_link\">",
"     clonidine",
"    </a>",
"    or exposure to carbon monoxide (",
"    <a class=\"graphic graphic_table graphicRef80618 \" href=\"UTD.htm?3/52/3918\">",
"     table 4",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      While",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?13/14/13545?source=see_link\">",
"       clonidine",
"      </a>",
"      may produce miosis and obtundation, bradycardia, and hypotension are more prominent than in patients with opioid intoxication. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/50/22313?source=see_link&amp;anchor=H11#H11\">",
"       \"Clonidine and related imidazoline poisoning\", section on 'Clinical Features of overdose'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Ethanol intoxication produces little to no miosis and no change in bowel sounds. Nystagmus and hypoglycemia may be prominent features in young children. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/5/2137?source=see_link&amp;anchor=H2#H2\">",
"       \"Ethanol intoxication in children: Clinical features, evaluation, and management\", section on 'Clinical features'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The sedative-hypnotic agents result in much less respiratory depression than the opioids, especially when taken orally. Pupils are typically not pinpoint and ataxia may be a prominent feature in children. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/52/11080?source=see_link&amp;anchor=H4#H4\">",
"       \"Benzodiazepine poisoning and withdrawal\", section on 'Clinical features of overdose'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Organophosphate-containing substances may cause miosis and coma in children but are also accompanied by prominent parasympathetic and preganglionic sympathetic symptoms (eg, vomiting, diarrhea, sweating, bronchorrhea, salivation, bradycardia or tachycardia, hypo- or hypertension), fasciculations and paralysis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/25/33176?source=see_link&amp;anchor=H4#H4\">",
"       \"Organophosphate and carbamate poisoning\", section on 'Acute toxicity'",
"      </a>",
"      .) &nbsp;",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/44/7878?source=see_link\">",
"       Baclofen",
"      </a>",
"      , a gamma-aminobutyric acid (GABA) B receptor agonist, can cause coma, bradycardia, and hypotension after ingestion in children and adolescents. Miosis is typically not present [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/45,46\">",
"       45,46",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Any medical condition that causes coma may mimic opioid poisoning in children. Key conditions to exclude are those in which delayed diagnosis also delays specific care, such as hypoxemia, hypoglycemia, sepsis, central nervous system infection, and abusive head trauma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/30/28136?source=see_link&amp;anchor=H6#H6\">",
"     \"Evaluation of stupor and coma in children\", section on 'Etiologies'",
"    </a>",
"    .) Intussusception may present with coma and miosis, and CNS depression associated with intussusception may respond to",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"     naloxone",
"    </a>",
"    therapy, presumably due to elaboration of endogenous endorphins",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H886681\">",
"    <span class=\"h1\">",
"     ANCILLARY STUDIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children and adolescents with altered mental status and suspected opioid intoxication warrant the following studies (",
"    <a class=\"graphic graphic_table graphicRef69375 \" href=\"UTD.htm?34/57/35741\">",
"     table 3",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Blood glucose",
"     </li>",
"     <li>",
"      Pulse oximetry and, if respiratory status does not improve after",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"       naloxone",
"      </a>",
"      administration, blood gas measurement",
"     </li>",
"     <li>",
"      Serum",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/15/19705?source=see_link\">",
"       acetaminophen",
"      </a>",
"      concentration if suicidal intent or if ingestion of combination agents (eg, acetaminophen with hydrocodone or",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?38/23/39287?source=see_link\">",
"       oxycodone",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Serum ethanol level (adolescents with recreational or suicidal overdose)",
"     </li>",
"     <li>",
"      Electrocardiogram, especially in patients with",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/49/22296?source=see_link\">",
"       methadone",
"      </a>",
"      overdose to evaluate for prolonged QTc",
"     </li>",
"     <li>",
"      Chest radiograph, in patients with persistent respiratory findings suggestive of pulmonary aspiration or noncardiogenic pulmonary edema",
"     </li>",
"     <li>",
"      Rapid urine pregnancy test in postmenarchal girls",
"     </li>",
"     <li>",
"      Urinalysis, serum electrolytes, blood urea nitrogen, creatinine, and creatine kinase in patients at risk for rhabdomyolysis (eg, prolonged immobilization, muscular rigidity)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Further laboratory evaluation of opioid overdose varies depending upon the circumstances of exposure. A witnessed exploratory ingestion in a toddler or a known recreational overdose with full recovery after antidotal therapy may merit little laboratory investigation whereas an unwitnessed suicidal overdose may lead to more extensive testing, especially if the patient displays persistent symptoms despite antidotal therapy or has evidence of serious coingestants. Other ancillary studies may be indicated in selected patients in whom trauma, infection, or other etiologies besides poisoning are suspected. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/30/28136?source=see_link\">",
"     \"Evaluation of stupor and coma in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/60/22474?source=see_link\">",
"     \"Approach to the child with occult toxic exposure\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Testing for opioids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rapid enzyme-mediated immunoassay technique (EMIT), mass spectrophotometry, gas chromatography, and radioimmunoassay are available to test urine for opioids. However, the results of these tests require interpretation based upon the clinical scenario for a number of reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      False-positive results &ndash; The metabolites of some medications and foods are the same as the metabolites of opioids of abuse (eg,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/15/19705?source=see_link\">",
"       acetaminophen",
"      </a>",
"      with",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32230?source=see_link\">",
"       codeine",
"      </a>",
"      , codeine cough syrup, and poppy seeds). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/44/3784?source=see_link&amp;anchor=H9#H9\">",
"       \"Opioid abuse and dependence: Overview and patient evaluation\", section on 'Detection in drug screens'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      False-negative results &ndash; Some synthetic opioids (eg,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/49/22296?source=see_link\">",
"       methadone",
"      </a>",
"      ) do not contain the phenanthrene nucleus that is needed for detection on typical commercially obtained hospital toxicology screens for opioids. Furthermore, tampering methods or dilute samples may interfere with actual toxicology screening results [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/47,48\">",
"       47,48",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/58/5033?source=see_link&amp;anchor=H17#H17\">",
"       \"Substance use disorders: Principles for recognition and assessment in general medical care\", section on 'Drug testing'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Opioids are detectable in the urine for only two to four days after use. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/44/3784?source=see_link&amp;anchor=H9#H9\">",
"       \"Opioid abuse and dependence: Overview and patient evaluation\", section on 'Detection in drug screens'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In an adolescent with a known recreational exposure to opioids who responds to antidotal therapy, the diagnosis is confirmed. Urine toxicologic testing does not add anything further to acute clinical management and is not recommended. However, healthcare providers involved in adolescent substance abuse treatment programs may utilize toxicology screening results to further enhance outpatient therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In children under six years of age in whom the cause of coma is unknown or in whom malicious administration of opioids is suspected, the most accurate form of testing (eg, gas chromatography mass spectrophotometry, or GCMS), may be indicated to definitively document the exposure for legal reasons.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF ACUTE TOXICITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;A rapid overview provides a summary for the evaluation and treatment of opioid overdose (",
"    <a class=\"graphic graphic_table graphicRef69375 \" href=\"UTD.htm?34/57/35741\">",
"     table 3",
"    </a>",
"    ). Most of the direct morbidity and mortality related to opiate use occur after acute ingestion and are caused by hypoxemia, aspiration pneumonitis, pulmonary edema, acute respiratory acidosis, and anaphylaxis. Immediate management involves airway management and administration of an opioid antagonist (",
"    <a class=\"graphic graphic_table graphicRef69375 \" href=\"UTD.htm?34/57/35741\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Supportive care",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients whose respiratory status is compromised should be supported with bag mask ventilation and 100 percent oxygen while the opioid antagonist,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"     naloxone",
"    </a>",
"    , is administered [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/50\">",
"     50",
"    </a>",
"    ]. They may require supplemental oxygen, endotracheal intubation, and positive end expiratory pressure if there is inadequate response to naloxone or if pulmonary edema is present. If endotracheal intubation has been performed, and mechanical ventilation is being administered, then naloxone administration may be counter-productive.",
"   </p>",
"   <p>",
"    Glucose should be administered intravenously if indicated by immediate bed-side glucose testing (&lt;70",
"    <span class=\"nowrap\">",
"     mg/dL).",
"    </span>",
"    The recommended dose is 0.25 to 0.5",
"    <span class=\"nowrap\">",
"     g/kg",
"    </span>",
"    (0.5 to 1",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    ofD50W in an adolescent or 2.5 to 5",
"    <span class=\"nowrap\">",
"     ml/kg",
"    </span>",
"    of D10W in a child).",
"   </p>",
"   <p>",
"    Seizures and cardiac dysrhythmias occur rarely and should be managed with standard therapies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/28/18888?source=see_link\">",
"     \"Clinical features and complications of status epilepticus in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23953471\">",
"    <span class=\"h2\">",
"     Body packers and stuffers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment, including recommendations for",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/47/33525?source=see_link\">",
"     activated charcoal",
"    </a>",
"    administration and initiation of whole bowel irrigation in body packers or body stuffers, is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/51/3897?source=see_link&amp;anchor=H17#H17\">",
"     \"Opioid intoxication in adults\", section on 'Body packing and body stuffing'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Gastrointestinal decontamination",
"    </span>",
"    &nbsp;&mdash;&nbsp;We recommend administration of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/47/33525?source=see_link\">",
"     activated charcoal",
"    </a>",
"    (AC, 1",
"    <span class=\"nowrap\">",
"     g/kg",
"    </span>",
"    PO or NG with a maximum of 50 g) to alert young children and adolescents who have ingested opioids and who present within one hour of oral overdose. In patients with altered mental status, activated charcoal administration should be delayed until reversal of symptoms with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"     naloxone",
"    </a>",
"    has restored consciousness or the airway has been secured. Alternatively, AC may be withheld in such patients if toxicity is well-controlled with naloxone and the presence of unabsorbed opioid medication is unlikely. Patients who have orally ingested large amounts of opioids (body stuffers or packers), sustained release opioids, or opioid patch medications should receive gastrointestinal decontamination with AC and whole bowel irrigation as described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/51/3897?source=see_link&amp;anchor=H17#H17\">",
"     \"Opioid intoxication in adults\", section on 'Body packing and body stuffing'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This recommendation for",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/47/33525?source=see_link\">",
"     activated charcoal",
"    </a>",
"    administration following oral opioid overdose derives from indirect evidence of benefit in volunteers, animal studies, and evidence of benefit following ingestions of other medications. Opioids, like most other xenobiotics, bind well to activated charcoal.",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/33/32275?source=see_link\">",
"     Sorbitol",
"    </a>",
"    is an osmotically active carbohydrate often used to sweeten activated charcoal and to speed its intestinal transit: evidence for benefit from sorbitol is scant and it should not be used for more than a single dose of activated charcoal. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/1/37913?source=see_link&amp;anchor=H27#H27\">",
"     \"Decontamination of poisoned children\", section on 'Cathartics'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/1/37913?source=see_link&amp;anchor=H10032467#H10032467\">",
"     \"Decontamination of poisoned children\", section on 'Activated charcoal'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The greatest benefit occurs if AC is given within one hour. The efficacy of AC as a function of time from ingestion is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/1/37913?source=see_link&amp;anchor=H10032558#H10032558\">",
"     \"Decontamination of poisoned children\", section on 'Efficacy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/58/16297?source=see_link&amp;anchor=H18993761#H18993761\">",
"     \"Gastrointestinal decontamination of poisoned adults\", section on 'Activated charcoal'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/47/33525?source=see_link\">",
"     Activated charcoal",
"    </a>",
"    administration is not indicated following intravenous or inhalational opioid overdose.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Naloxone",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"     Naloxone",
"    </a>",
"    is a synthetic derivative of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/8/32903?source=see_link\">",
"     oxymorphone",
"    </a>",
"    that competitively binds opioid receptors and is the antagonist of choice for reversal of acute opioid toxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/51\">",
"     51",
"    </a>",
"    ]. It has a greater affinity for the mu receptors than do opioid agonists; for example, the effects of 25 mg of heroin are blocked by 1 mg of naloxone. Naloxone is highly lipophilic, moves rapidly into the CNS, and has an onset of action of one minute when given intravenously [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/51\">",
"     51",
"    </a>",
"    ]. Clinical effects of naloxone typically last 45 to 70 minutes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18254225\">",
"    <span class=\"h3\">",
"     Dosing and administration",
"    </span>",
"    &nbsp;&mdash;&nbsp;We recommend that children and adolescents with clinical findings of coma, depressed respirations and miosis or circumstantial evidence of opioid abuse receive",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"     naloxone",
"    </a>",
"    rather than supportive care alone. Although the greatest amount of evidence supporting naloxone use for opioid intoxication is derived from adult studies, observational studies and case reports in children have also shown that naloxone effectively reverses severe opioid poisoning with minimal adverse effects [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/13,52\">",
"     13,52",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/51/3897?source=see_link&amp;anchor=H14#H14\">",
"     \"Opioid intoxication in adults\", section on 'Basic measures and antidotal therapy'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H18254252\">",
"     'Adverse effects'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Dose",
"      </strong>",
"      &ndash; The dose of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"       naloxone",
"      </a>",
"      for serious opioid intoxication varies depending upon the size of the patient and the clinical scenario (",
"      <a class=\"graphic graphic_table graphicRef69375 \" href=\"UTD.htm?34/57/35741\">",
"       table 3",
"      </a>",
"      ):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Children under 20 kg should receive",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"       naloxone",
"      </a>",
"      0.1",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      IV (maximum 2 mg per dose). The use of naloxone in neonates in the delivery room is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/46/26346?source=see_link&amp;anchor=H26#H26\">",
"       \"Neonatal resuscitation in the delivery room\", section on 'Naloxone'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Children &ge;20 kg should receive",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"       naloxone",
"      </a>",
"      2.0 mg IV.",
"     </li>",
"     <li>",
"      Adolescents suspected of opioid addiction may receive lower incremental doses of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"       naloxone",
"      </a>",
"      (0.04 mg or 0.4 mg per dose) with repeat doses every three to five minutes titrated to patient response to avoid iatrogenic opioid withdrawal.",
"      <br/>",
"      <br/>",
"      Naloxone should be repeated every three minutes until improvement in respiratory depression is noted. Cumulative doses of naloxone great than 10 mg in the first half hour are unlikely to yield additional benefit. Larger than customary doses of naloxone may be required to reverse the effects of drugs with higher receptor affinity than",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32233?source=see_link\">",
"       morphine",
"      </a>",
"      (eg,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32230?source=see_link\">",
"       codeine",
"      </a>",
"      , diphenoxylate,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/49/22296?source=see_link\">",
"       methadone",
"      </a>",
"      , propoxyphene,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/16/5382?source=see_link\">",
"       pentazocine",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?26/15/26869?source=see_link\">",
"       nalbuphine",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/29/26071?source=see_link\">",
"       buprenorphine",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9543?source=see_link\">",
"       butorphanol",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/51\">",
"       51",
"      </a>",
"      ]. If respiratory depression of unknown etiology has failed to improve with a cumulative dose of 10 mg of naloxone, then isolated opioid toxicity is unlikely.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Route of administration",
"      </strong>",
"      &ndash;",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"       Naloxone",
"      </a>",
"      is preferably administered intravenously. However, it can also be administered intranasally, intramuscularly, subcutaneously, endotracheally, or intralingually (ie, injected into the sublingual vein) as well as via an intraosseous needle [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/51,53\">",
"       51,53",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Treatment of recurrent toxicity",
"      </strong>",
"      &ndash;",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"       Naloxone",
"      </a>",
"      has a shorter duration of action (one-half to one hour) than do most opioids and may need to be administered as repeated boluses or continuous infusion until full opioid metabolism has occurred. As an example, children with",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/49/22296?source=see_link\">",
"       methadone",
"      </a>",
"      overdose may require naloxone therapy for several days [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/13\">",
"       13",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Continuous infusions of naloxone have been used safely in children [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/54,55\">",
"       54,55",
"      </a>",
"      ]. Naloxone should be mixed in a solution of 5 percent dextrose OR normal saline and infused at a rate that does not exceed the hourly maintenance rate for weight. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/20/6470?source=see_link\">",
"       \"Maintenance fluid therapy in children\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      One method for administering a constant infusion is as follows [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/56\">",
"       56",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Determine the amount of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"       naloxone",
"      </a>",
"      that was required to restore respiratory function during bolus infusions. Two-thirds of this dose is then administered as an hourly infusion. Care must be taken to avoid induction of withdrawal symptoms in patients who are opioid dependent.",
"     </li>",
"     <li>",
"      A transient drop in",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"       naloxone",
"      </a>",
"      levels may occur 20 to 30 minutes after the continuous infusion is initiated. To prevent this from occurring, one-half of the loading dose (the dose required to reverse respiratory depression) should be administered 15 minutes after the continuous infusion is started [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/56\">",
"       56",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The rate of infusion should be titrated to maintain respiration and avoid withdrawal symptoms. Respiratory and mental status must be closely monitored.",
"     </li>",
"     <li>",
"      The infusion rate may be decreased by 50 percent every hour for the next 6 to 12 hours (the duration of action of most opiates). The",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"       naloxone",
"      </a>",
"      infusion should be continued until complete or near complete reversal of the respiratory depression occurs.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18254252\">",
"    <span class=\"h3\">",
"     Adverse effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Precipitation of opioid withdrawal by",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"     naloxone",
"    </a>",
"    administration is the most common adverse effect. Although withdrawal is not life-threatening except in the neonatal period, the agitation, nausea, vomiting, and anxiety are distressing to the patient. Patients in acute withdrawal may become violent, potentially causing harm to themselves or healthcare providers [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/57\">",
"     57",
"    </a>",
"    ]. Symptoms typically subside 20 to 30 minutes after the administration of naloxone because the antagonist effect diminishes. Incremental low dosing of naloxone in patients with suspected opioid dependence is the main way to avoid withdrawal.",
"   </p>",
"   <p>",
"    Rare complications possibly attributable to",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"     naloxone",
"    </a>",
"    therapy of opioid intoxication and reported in adults include pulmonary edema, hypertension, hypotension, dysrhythmia, and sudden death [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/51,58,59\">",
"     51,58,59",
"    </a>",
"    ]. No sudden death attributable to naloxone has been reported in children outside of the neonatal period.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18253698\">",
"    <span class=\"h3\">",
"     Other opioid antagonists",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"     Naloxone",
"    </a>",
"    is the preferred drug for acute treatment of opioid intoxication. Other longer acting opioid antagonists have been occasionally used as acute therapy in adults, instead of naloxone infusion in patients with prolonged intoxication, and for long-term opioid detoxification:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Nalmefene",
"      </strong>",
"      &ndash; Nalmefene has a longer duration of action than that of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"       naloxone",
"      </a>",
"      . Its use in the acute care setting is controversial. Compared with naloxone, it causes fewer fluctuations in the patient's level of consciousness and decreased risk for recurrent opioid toxicity in patients who leave against medical advice soon after initial resuscitation. On the other hand, nalmefene may precipitate prolonged withdrawal in opioid-dependent patients or recurrent symptoms in patients who have taken synthetic opioids with duration of action equal to or longer than that of nalmefene [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/18\">",
"       18",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Nalmefene may be considered for use in children who have had a single opioid exposure or in those who are being admitted to the hospital and do not experience withdrawal after a trial dose of naloxone [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/60\">",
"       60",
"      </a>",
"      ]. Nalmefene may also be used safely in potentially opioid-dependent adolescents after a trial dose of naloxone has been tolerated safely. Doses of 0.5 to 2.0 mg have been reported to be safe and effective in adults. The duration of action is 4 to 10 hours if the dose is 0.5 to 1.0 mg, and greater than 8 hours if the dose is 2.0 mg. Adverse effects of nalmefene are uncommon and include nausea and vomiting, tachycardia, myoclonus, dizziness, and drowsiness.",
"      <br/>",
"      <br/>",
"      Although the optimal nalmefene dose for pediatric opioid overdose has not been studied, doses of 0.25 to 1.0",
"      <span class=\"nowrap\">",
"       micrograms/kg",
"      </span>",
"      (to a maximum of 40 micrograms) have been safely used to reverse sedation in 15 pediatric patients [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/61\">",
"       61",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/16/39173?source=see_link\">",
"       Naltrexone",
"      </a>",
"      <strong>",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      Naltrexone is an oral opioid antagonist with a longer duration of action than that of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"       naloxone",
"      </a>",
"      . It is used primarily to promote long-term opioid abstinence. Naltrexone is not indicated in the treatment of acute opioid toxicity because it is administered orally and because it can induce a prolonged withdrawal state [",
"      <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/62\">",
"       62",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H887418\">",
"    <span class=\"h2\">",
"     Child protection",
"    </span>",
"    &nbsp;&mdash;&nbsp;In cases where child abuse is suspected, involvement of an experienced child protection team is crucial and in many parts of the world (including the US, UK, and Australia) reporting to a governmental agency is mandatory. The safety of other children in the home must be ensured by local Child Protective Services. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/5/35927?source=see_link&amp;anchor=H3#H3\">",
"     \"Child abuse: Social and medicolegal issues\", section on 'Reporting suspected abuse'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/19/24890?source=see_link\">",
"     \"Physical abuse in children: Diagnostic evaluation and management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Disposition",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following patients warrant hospital admission:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infants and young children who require",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"       naloxone",
"      </a>",
"      administration to reverse opioid effects or in whom intentional poisoning by the caretaker is suspected.",
"     </li>",
"     <li>",
"      Patients in whom delayed or prolonged opioid intoxication is likely (eg, ingestion of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/33/37397?source=see_link\">",
"       diphenoxylate-atropine",
"      </a>",
"      [Lomotil&reg;],",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/49/22296?source=see_link\">",
"       methadone",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/29/26071?source=see_link\">",
"       buprenorphine",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Patients who are suicidal or whose social setting does not provide a safe environment for the child.",
"     </li>",
"     <li>",
"      Adolescents who have recurrence of respiratory depression or noncardiogenic pulmonary edema. As in adults, recurrent symptoms of intoxication or respiratory distress should be evident within two hours of initial treatment and observation beyond that time is not necessary. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/51/3897?source=see_link&amp;anchor=H20#H20\">",
"       \"Opioid intoxication in adults\", section on 'Disposition'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For adolescent patients in whom opioid abuse is identified, the plans for long-term management of the drug problem and referrals to local substance abuse treatment resources should be made before discharge. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20103?source=see_link&amp;anchor=H1692489#H1692489\">",
"     \"Opioid withdrawal in adolescents\", section on 'Treatment programs'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H886898\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many of the complications of opioid use are related to the method of administration. Snorting is associated with chronic rhinitis and septal ulcers with disintegration. Smoking can cause burns and exacerbate preexisting asthma and respiratory illnesses. Intravenous administration is associated with many complications (",
"    <a class=\"graphic graphic_table graphicRef69983 \" href=\"UTD.htm?0/41/669\">",
"     table 5",
"    </a>",
"    ), including bacterial endocarditis, blood-borne infection, septic pulmonary emboli, nephropathy, abscesses, and cellulitis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Opioid use impairs judgment and can put the user at risk for unintentional injury. One-tenth of the adolescent trauma victims in one emergency department had urine toxicology screens that were positive for opioids [",
"    <a class=\"abstract\" href=\"UTD.htm?22/21/22874/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The social and behavioral consequences of opioid use are influenced by the lifestyle of the addict. Adolescents who use opioids typically are involved in other high-risk behaviors (eg, polysubstance abuse, high-risk sexual practices, delinquency, and school failure). These adolescents often run away from home or become homeless. They may resort to prostitution, robbery, or burglary to obtain drugs or money for drugs. In addition, adolescent substance use is a significant risk for violence-related injury. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/42/40617?source=see_link&amp;anchor=H16#H16\">",
"     \"Peer violence and violence prevention\", section on 'Adolescent screening'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The life-threatening effects of opioids are related to respiratory failure and failure of physiological oxygen delivery. Ischemic injury to the brain, heart, and other body organs are dire complications of opioid poisoning.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7471870\">",
"    <span class=\"h1\">",
"     ADDITIONAL RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regional poison control centers in the United States are available at all times for consultation on patients who are critically ill, require admission, or have clinical pictures that are unclear (1-800-222-1222). In addition, some hospitals have clinical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    medical toxicologists available for bedside consultation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    inpatient care. Whenever available, these are invaluable resources to help in the diagnosis and management of ingestions or overdoses. The World Health Organization provides a listing of international poison centers at its website:",
"    <a class=\"external\" href=\"file://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html\">",
"     www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html",
"    </a>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H886958\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H884809\">",
"    <span class=\"h2\">",
"     Evaluation",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Opioid intoxication in adolescents primarily results from recreational use or intentional exposure with suicidal intent. In young children, opioid poisoning typically occurs following exploratory ingestion, although the possibility of malicious exposure by a caretaker should be evaluated. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of opioid intoxication is usually made based upon clinical findings. The classic signs of opioid intoxication include: depressed mental status, decreased respiratory rate, decreased tidal volume, decreased bowel sounds, and miotic pupils. The best predictor of opioid poisoning is respiratory depression. Normal pupil examination or mydriasis does",
"      <strong>",
"       not",
"      </strong>",
"      exclude opioid intoxication. (See",
"      <a class=\"local\" href=\"#H886653\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Any medical condition that causes coma may mimic opioid poisoning in children. Key conditions to exclude are those in which delayed diagnosis also delays specific care, such as hypoxemia, hypoglycemia, sepsis, central nervous system infection, and abusive head trauma. (See",
"      <a class=\"local\" href=\"#H886660\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Laboratory evaluation following opioid intoxication varies depending upon the clinical circumstance and the age of the patient. (See",
"      <a class=\"local\" href=\"#H886681\">",
"       'Ancillary studies'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H887255\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;A summary table provides guidance for emergent management of opioid intoxication in children and adolescents (",
"    <a class=\"graphic graphic_table graphicRef69375 \" href=\"UTD.htm?34/57/35741\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Initial management should focus on support of the child&rsquo;s airway and breathing using bag-mask ventilation with 100 percent inspired oxygen until an opioid antagonist is administered. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Supportive care'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend that children and adolescents with suspected opioid overdose receive",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"       naloxone",
"      </a>",
"      rather than supportive care alone (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). The first dose of naloxone varies depending upon the size of the patient and the clinical scenario (see",
"      <a class=\"local\" href=\"#H18254225\">",
"       'Dosing and administration'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Children &lt;20 kg: 0.1",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      IV (maximum 2 mg per dose).",
"     </li>",
"     <li>",
"      Children &ge;20 kg: 2.0 mg IV.",
"     </li>",
"     <li>",
"      Adolescents with suspected opioid addiction should receive lower doses of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"       naloxone",
"      </a>",
"      (similar to adult treatment strategy) to avoid precipitation of opioid withdrawal (",
"      <a class=\"graphic graphic_table graphicRef55540 \" href=\"UTD.htm?5/7/5245\">",
"       table 6",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/51/3897?source=see_link&amp;anchor=H14#H14\">",
"       \"Opioid intoxication in adults\", section on 'Basic measures and antidotal therapy'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The use of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"       naloxone",
"      </a>",
"      in neonates is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/46/26346?source=see_link&amp;anchor=H26#H26\">",
"       \"Neonatal resuscitation in the delivery room\", section on 'Naloxone'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We recommend administration of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/47/33525?source=see_link\">",
"       activated charcoal",
"      </a>",
"      (1",
"      <span class=\"nowrap\">",
"       g/kg",
"      </span>",
"      PO or NG with a maximum of 50 g) to alert young children and adolescents who have ingested opioids and who present within one hour of overdose (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Activated charcoal administration is not indicated following intravenous or inhalational opioid overdose. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Gastrointestinal decontamination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Beyond one hour of overdose, patients who have orally ingested large amounts of opioids (body stuffers or packers), sustained release opioids, or opioid patch medications should receive whole bowel irrigation as described separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/51/3897?source=see_link&amp;anchor=H17#H17\">",
"       \"Opioid intoxication in adults\", section on 'Body packing and body stuffing'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The following patients warrant hospitalization after opioid intoxication (see",
"      <a class=\"local\" href=\"#H30\">",
"       'Disposition'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Infants and young children who require",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"       naloxone",
"      </a>",
"      administration to reverse opioid effects or in whom intentional poisoning by the caretaker is suspected.",
"     </li>",
"     <li>",
"      Patients in whom delayed or prolonged opioid intoxication is likely (eg, ingestion of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/33/37397?source=see_link\">",
"       diphenoxylate-atropine",
"      </a>",
"      [Lomotil&reg;],",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/49/22296?source=see_link\">",
"       methadone",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/29/26071?source=see_link\">",
"       buprenorphine",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Patients who are suicidal or whose social setting does not provide a safe environment for the child.",
"     </li>",
"     <li>",
"      Adolescents who have recurrence of respiratory depression or noncardiogenic pulmonary edema. As in adults, recurrent symptoms of intoxication or respiratory distress should be evident within two hours of initial treatment and observation beyond that time is not necessary. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/51/3897?source=see_link&amp;anchor=H20#H20\">",
"       \"Opioid intoxication in adults\", section on 'Disposition'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      In cases of suspected child abuse, consult an experienced children protection team (if available) and report suspicion to the appropriate governmental agency. (See",
"      <a class=\"local\" href=\"#H887418\">",
"       'Child protection'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For adolescent patients in whom opioid abuse is identified, the plans for long-term management of the drug problem and referrals to local substance abuse treatment resources should be made before discharge. (See",
"      <a class=\"local\" href=\"#H30\">",
"       'Disposition'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20103?source=see_link&amp;anchor=H1692489#H1692489\">",
"       \"Opioid withdrawal in adolescents\", section on 'Treatment programs'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Opium/heroin. Drug statistics and trends. World Drug Report, 2009, United Nations Office on Drugs and Crimes. www.unodc.org/documents/wdr/WDR_2010/2.2_Opium-heroin.pdf (Accessed on June 01, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/2\">",
"      Okie S. A flood of opioids, a rising tide of deaths. N Engl J Med 2010; 363:1981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/3\">",
"      Centers for Disease Control and Prevention (CDC). Emergency department visits involving nonmedical use of selected prescription drugs - United States, 2004-2008. MMWR Morb Mortal Wkly Rep 2010; 59:705.",
"     </a>",
"    </li>",
"    <li>",
"     Office of Applied Studies, Substance Abuse and Mental Health Services Administration. Substance abuse treatment admissions involving abuse of pain relievers: 1998 and 2008. file://www.oas.samhsa.gov/2k10/230/230PainRelvr2k10.cfm.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/5\">",
"      Paulozzi LJ, Ryan GW. Opioid analgesics and rates of fatal drug poisoning in the United States. Am J Prev Med 2006; 31:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/6\">",
"      McCabe SE, West BT, Teter CJ, Boyd CJ. Medical and nonmedical use of prescription opioids among high school seniors in the United States. Arch Pediatr Adolesc Med 2012; 166:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/7\">",
"      Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. JAMA 1998; 280:1936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/8\">",
"      Hayes BD, Klein-Schwartz W, Doyon S. Toxicity of buprenorphine overdoses in children. Pediatrics 2008; 121:e782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/9\">",
"      Sachdeva DK, Stadnyk JM. Are one or two dangerous? Opioid exposure in toddlers. J Emerg Med 2005; 29:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/10\">",
"      Geib AJ, Babu K, Ewald MB, Boyer EW. Adverse effects in children after unintentional buprenorphine exposure. Pediatrics 2006; 118:1746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/11\">",
"      Martin TC, Rocque MA. Accidental and non-accidental ingestion of methadone and buprenorphine in childhood: a single center experience, 1999-2009. Curr Drug Saf 2011; 6:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/12\">",
"      Pedapati EV, Bateman ST. Toddlers requiring pediatric intensive care unit admission following at-home exposure to buprenorphine/naloxone. Pediatr Crit Care Med 2011; 12:e102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/13\">",
"      Glatstein M, Finkelstein Y, Scolnik D. Accidental methadone ingestion in an infant: case report and review of the literature. Pediatr Emerg Care 2009; 25:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/14\">",
"      Kuehn BM. Fentanyl patch warning. JAMA 2012; 307:2139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/15\">",
"      Kim HK, Smiddy M, Hoffman RS, Nelson LS. Buprenorphine may not be as safe as you think: a pediatric fatality from unintentional exposure. Pediatrics 2012; 130:e1700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/16\">",
"      Nielssen OB, Large MM, Westmore BD, Lackersteen SM. Child homicide in New South Wales from 1991 to 2005. Med J Aust 2009; 190:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/17\">",
"      Perez A, Scribano PV, Perry H. An intentional opiate intoxication of an infant: when medical toxicology and child maltreatment services merge. Pediatr Emerg Care 2004; 20:769.",
"     </a>",
"    </li>",
"    <li>",
"     Yaksh TL, Walla MA. Opioids, Analgesic, and Pain Management. In: Goodman &amp; Gilman's The Pharmacological Basis of Therapeutics, 12th, Brunton LL, Chabner BA, Knollman BC (Eds), McGraw-Hill, New York 2011. p.521.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/19\">",
"      Glare PA, Walsh TD. Clinical pharmacokinetics of morphine. Ther Drug Monit 1991; 13:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/20\">",
"      Clark RF, Wei EM, Anderson PO. Meperidine: therapeutic use and toxicity. J Emerg Med 1995; 13:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/21\">",
"      Gasche Y, Daali Y, Fathi M, et al. Codeine intoxication associated with ultrarapid CYP2D6 metabolism. N Engl J Med 2004; 351:2827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/22\">",
"      Maurer PM, Bartkowski RR. Drug interactions of clinical significance with opioid analgesics. Drug Saf 1993; 8:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/23\">",
"      Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med 2005; 352:1112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/24\">",
"      Schwartz RH. Adolescent heroin use: a review. Pediatrics 1998; 102:1461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/25\">",
"      Long H, Deore K, Hoffman RS, Nelson LS. A fatal case of spongiform leukoencephalopathy linked to \"chasing the dragon\". J Toxicol Clin Toxicol 2003; 41:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/26\">",
"      Jenkins AJ, Keenan RM, Henningfield JE, Cone EJ. Pharmacokinetics and pharmacodynamics of smoked heroin. J Anal Toxicol 1994; 18:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/27\">",
"      Tarabar AF, Nelson LS. The resurgence and abuse of heroin by children in the United States. Curr Opin Pediatr 2003; 15:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/28\">",
"      Beno S, Calello D, Baluffi A, Henretig FM. Pediatric body packing: drug smuggling reaches a new low. Pediatr Emerg Care 2005; 21:744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/29\">",
"      Traub SJ, Kohn GL, Hoffman RS, Nelson LS. Pediatric \"body packing\". Arch Pediatr Adolesc Med 2003; 157:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/30\">",
"      Thomas TJ, Pauze D, Love JN. Are one or two dangerous? Diphenoxylate-atropine exposure in toddlers. J Emerg Med 2008; 34:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/31\">",
"      LoVecchio F, Pizon A, Matesick L, O'Patry S. Accidental dextromethorphan ingestions in children less than 5 years old. J Med Toxicol 2008; 4:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/32\">",
"      Shelly MP, Park GR. Morphine toxicity with dilated pupils. Br Med J (Clin Res Ed) 1984; 289:1071.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/33\">",
"      Nordt SP. \"DXM\": a new drug of abuse? Ann Emerg Med 1998; 31:794.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/34\">",
"      Sporer KA. Acute heroin overdose. Ann Intern Med 1999; 130:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/35\">",
"      Sporer KA, Dorn E. Heroin-related noncardiogenic pulmonary edema : a case series. Chest 2001; 120:1628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/36\">",
"      Helpern M, Rho YM. Deaths from narcotism in New York City. Incidence, circumstances, and postmortem findings. N Y State J Med 1966; 66:2391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/37\">",
"      Ghuran A, Nolan J. Recreational drug misuse: issues for the cardiologist. Heart 2000; 83:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/38\">",
"      Lipski J, Stimmel B, Donoso E. The effect of heroin and multiple drug abuse on the electrocardiogram. Am Heart J 1973; 86:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/39\">",
"      Martell BA, Arnsten JH, Krantz MJ, Gourevitch MN. Impact of methadone treatment on cardiac repolarization and conduction in opioid users. Am J Cardiol 2005; 95:915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/40\">",
"      Wingert WE, Mundy LA, Nelson L, et al. Detection of clenbuterol in heroin users in twelve postmortem cases at the Philadelphia medical examiner's office. J Anal Toxicol 2008; 32:522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/41\">",
"      Koren G, Butt W, Pape K, Chinyanga H. Morphine-induced seizures in newborn infants. Vet Hum Toxicol 1985; 27:519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/42\">",
"      Centers for Disease Control (CDC). Street-drug contaminant causing parkinsonism. MMWR Morb Mortal Wkly Rep 1984; 33:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/43\">",
"      Glick C, Evans OB, Parks BR. Muscle rigidity due to fentanyl infusion in the pediatric patient. South Med J 1996; 89:1119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/44\">",
"      Abs R, Verhelst J, Maeyaert J, et al. Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocrinol Metab 2000; 85:2215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/45\">",
"      Chapple D, Johnson D, Connors R. Baclofen overdose in two siblings. Pediatr Emerg Care 2001; 17:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/46\">",
"      Perry HE, Wright RO, Shannon MW, Woolf AD. Baclofen overdose: drug experimentation in a group of adolescents. Pediatrics 1998; 101:1045.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/47\">",
"      Jaffee WB, Trucco E, Levy S, Weiss RD. Is this urine really negative? A systematic review of tampering methods in urine drug screening and testing. J Subst Abuse Treat 2007; 33:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/48\">",
"      Levy S, Sherritt L, Vaughan BL, et al. Results of random drug testing in an adolescent substance abuse program. Pediatrics 2007; 119:e843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/49\">",
"      Levy S, Knight JR, Moore T, et al. Acceptability of drug testing in an outpatient substance abuse program for adolescents. J Adolesc Health 2011; 48:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/50\">",
"      Osterwalder JJ. Naloxone--for intoxications with intravenous heroin and heroin mixtures--harmless or hazardous? A prospective clinical study. J Toxicol Clin Toxicol 1996; 34:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/51\">",
"      Chamberlain JM, Klein BL. A comprehensive review of naloxone for the emergency physician. Am J Emerg Med 1994; 12:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/52\">",
"      American Academy of Pediatrics Committee on Drugs: Naloxone dosage and route of administration for infants and children: addendum to emergency drug doses for infants and children. Pediatrics 1990; 86:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/53\">",
"      Kerr D, Kelly AM, Dietze P, et al. Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose. Addiction 2009; 104:2067.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/54\">",
"      Lewis JM, Klein-Schwartz W, Benson BE, et al. Continuous naloxone infusion in pediatric narcotic overdose. Am J Dis Child 1984; 138:944.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/55\">",
"      Leblanc A, Benbrick N, Moreau MH. [Methadone poisoning in a 1-year-old child treated by continuous infusion of naloxone]. Arch Pediatr 2002; 9:694.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/56\">",
"      Goldfrank L, Weisman RS, Errick JK, Lo MW. A dosing nomogram for continuous infusion intravenous naloxone. Ann Emerg Med 1986; 15:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/57\">",
"      Gaddis GM, Watson WA. Naloxone-associated patient violence: an overlooked toxicity? Ann Pharmacother 1992; 26:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/58\">",
"      Cuss FM, Cola&ccedil;o CB, Baron JH. Cardiac arrest after reversal of effects of opiates with naloxone. Br Med J (Clin Res Ed) 1984; 288:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/59\">",
"      Schwartz JA, Koenigsberg MD. Naloxone-induced pulmonary edema. Ann Emerg Med 1987; 16:1294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/60\">",
"      Kaplan JL, Marx JA, Calabro JJ, et al. Double-blind, randomized study of nalmefene and naloxone in emergency department patients with suspected narcotic overdose. Ann Emerg Med 1999; 34:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/61\">",
"      Chumpa A, Kaplan RL, Burns MM, Shannon MW. Nalmefene for elective reversal of procedural sedation in children. Am J Emerg Med 2001; 19:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/62\">",
"      Gonzalez JP, Brogden RN. Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs 1988; 35:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/21/22874/abstract/63\">",
"      Loiselle JM, Baker MD, Templeton JM Jr, et al. Substance abuse in adolescent trauma. Ann Emerg Med 1993; 22:1530.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6504 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-58.240.98.179-1360C6F796-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_21_22874=[""].join("\n");
var outline_f22_21_22874=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H886958\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PHARMACOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20287450\">",
"      Mechanism of action and pharmacokinetics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H886416\">",
"      Morphine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H886423\">",
"      Heroin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Routes of use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H886646\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H886653\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H886660\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H886681\">",
"      ANCILLARY STUDIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Testing for opioids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      MANAGEMENT OF ACUTE TOXICITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Supportive care",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23953471\">",
"      Body packers and stuffers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Gastrointestinal decontamination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Naloxone",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18254225\">",
"      - Dosing and administration",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18254252\">",
"      - Adverse effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18253698\">",
"      - Other opioid antagonists",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H887418\">",
"      Child protection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Disposition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H886898\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7471870\">",
"      ADDITIONAL RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H886958\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H884809\">",
"      Evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H887255\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6504\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6504|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?36/23/37244\" title=\"table 1\">",
"      Classification of opioid agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?10/12/10443\" title=\"table 2\">",
"      Manifestations opioid toxicity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?34/57/35741\" title=\"table 3\">",
"      Opioid intoxication in children and adolescents - Rapid overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/52/3918\" title=\"table 4\">",
"      Drug and toxin induced mental status changes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/41/669\" title=\"table 5\">",
"      Complications IV opioid use",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/7/5245\" title=\"table 6\">",
"      Opioid intoxication in adults - Rapid overview",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/60/22474?source=related_link\">",
"      Approach to the child with occult toxic exposure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/52/11080?source=related_link\">",
"      Benzodiazepine poisoning and withdrawal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/36/37448?source=related_link\">",
"      Botulism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/5/35927?source=related_link\">",
"      Child abuse: Social and medicolegal issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/28/18888?source=related_link\">",
"      Clinical features and complications of status epilepticus in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/50/22313?source=related_link\">",
"      Clonidine and related imidazoline poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/1/37913?source=related_link\">",
"      Decontamination of poisoned children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/47/1784?source=related_link\">",
"      Designer drugs of abuse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/5/2137?source=related_link\">",
"      Ethanol intoxication in children: Clinical features, evaluation, and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/30/28136?source=related_link\">",
"      Evaluation of stupor and coma in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/58/16297?source=related_link\">",
"      Gastrointestinal decontamination of poisoned adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/28/12744?source=related_link\">",
"      Internal concealment of drugs of abuse (body packing)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/20/6470?source=related_link\">",
"      Maintenance fluid therapy in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/57/39833?source=related_link\">",
"      Neonatal opioid withdrawal (Neonatal abstinence syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/46/26346?source=related_link\">",
"      Neonatal resuscitation in the delivery room",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/44/3784?source=related_link\">",
"      Opioid abuse and dependence: Overview and patient evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/51/3897?source=related_link\">",
"      Opioid intoxication in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20103?source=related_link\">",
"      Opioid withdrawal in adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/5/28758?source=related_link\">",
"      Opioid withdrawal in the emergency setting",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/25/33176?source=related_link\">",
"      Organophosphate and carbamate poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/42/40617?source=related_link\">",
"      Peer violence and violence prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/19/24890?source=related_link\">",
"      Physical abuse in children: Diagnostic evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/58/5033?source=related_link\">",
"      Substance use disorders: Principles for recognition and assessment in general medical care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/52/29514?source=related_link\">",
"      Treatment of opioid abuse and dependence",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_21_22875="Infections in residents of LTCF";
var content_f22_21_22875=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F62996&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F62996&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Examples of infections found in residents of long term care facilities",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Community-acquired infections",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Influenza",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Salmonellosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Giardiasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Nosocomial infections",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Methicillin-resistant Staphylococcus aureus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vancomycin resistant Enterococcus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Urinary tract infections",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Skin infections (especially of decubitus ulcers)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Infections associated with aging",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Scabies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Herpes zoster",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pneumonia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Infections associated with crowding",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hepatitis A",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Shigellosis",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_21_22875=[""].join("\n");
var outline_f22_21_22875=null;
var title_f22_21_22876="Rx Ewings sarcoma adults";
var content_f22_21_22876=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F81105&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F81105&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Outcomes of multimodality treatment for adults with localized Ewing's sarcoma family of tumors",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Author, year",
"       </td>",
"       <td class=\"subtitle1\">",
"        n",
"       </td>",
"       <td class=\"subtitle1\">",
"        Age range",
"       </td>",
"       <td class=\"subtitle1\">",
"        Median follow-up",
"       </td>",
"       <td class=\"subtitle1\">",
"        Outcomes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"4\">",
"        Bacci, G; 2007",
"       </td>",
"       <td rowspan=\"4\">",
"        35",
"       </td>",
"       <td rowspan=\"4\">",
"        40 to 60",
"       </td>",
"       <td rowspan=\"4\">",
"        17.8 years",
"       </td>",
"       <td>",
"        43 percent, 5-year EFS",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        35 percent, 10-year EFS",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        46 percent, 5-year OS",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        43 percent, 10-year OS",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Picci, P; 1997",
"       </td>",
"       <td>",
"        56",
"       </td>",
"       <td>",
"        16 to 36",
"       </td>",
"       <td>",
"        7.2 years",
"       </td>",
"       <td>",
"        59 percent, 5-year EFS",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Siegel, R; 1988",
"       </td>",
"       <td>",
"        10*",
"       </td>",
"       <td rowspan=\"2\">",
"        17 to 50",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        <p>",
"         All recurred at a median of 10 months:",
"        </p>",
"        <p>",
"         Two alive at 77 to 103 months post diagnosis",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        6&bull;",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        Five alive from 38 to 125 months post diagnosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sincovics, J; 1980",
"       </td>",
"       <td>",
"        34",
"       </td>",
"       <td>",
"        16 to 36",
"       </td>",
"       <td>",
"        27 months",
"       </td>",
"       <td>",
"        35 percent progression free",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Klassen, R; 1992",
"       </td>",
"       <td>",
"        30",
"       </td>",
"       <td>",
"        15 to 40",
"       </td>",
"       <td>",
"        42 months",
"       </td>",
"       <td>",
"        23 percent, 3-year EFS",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Verrill, MW; 1997",
"       </td>",
"       <td rowspan=\"2\">",
"        24",
"       </td>",
"       <td rowspan=\"2\">",
"        16 to 48",
"       </td>",
"       <td rowspan=\"2\">",
"        NR",
"       </td>",
"       <td>",
"        39 percent, 5-year EFS",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        63 percent, 5-year OS",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     EFS: event-free survival; OS: overall survival; NR: not reported.",
"     <br>",
"      * Extraskeletal or pelvic primary.",
"      <br>",
"       &bull; Non-pelvic skeletal primary site.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_21_22876=[""].join("\n");
var outline_f22_21_22876=null;
var title_f22_21_22877="Rapid overview for hypoglycemia in adults";
var content_f22_21_22877=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F73797&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F73797&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Rapid overview for hypoglycemia in adults, other than significant sulfonylurea overdose",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Clinical features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Any",
"        </strong>",
"        patient with acute change in mental status or coma should undergo rapid assessment of blood glucose as a possible cause",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        All findings of hypoglycemia are nonspecific including the following:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3_start\">",
"        &bull; Autonomic response (tends to occur with blood glucose below 65 mg/dL)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        - Sweating",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        - Weakness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        - Tachycardia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        - Palpitations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        - Tremor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        - Nervousness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        - Hunger",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        - Paresthesias",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3_start\">",
"        &bull; Neuroglycopenia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        - Irritability",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        - Confusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        - Uncharacteristic behavior",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        - Seizure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        - Occasionally, transient focal neurologic deficits",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        - Loss-of-consciousness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        - Visual disturbance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Diagnostic evaluation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist_other_start\">",
"        <ul>",
"         <li>",
"          <strong>",
"           Obtain blood glucose",
"          </strong>",
"          concentration as soon as possible (usually with a meter and strips, if available):",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        For symptomatic patient known to have diabetes and with a low glucose value, &lt;70 mg/dL [3.89 mmol/L], administer treatment. If a glucose test cannot be performed, do not delay. Treat",
"        <strong>",
"         as if",
"        </strong>",
"        hypoglycemia has been confirmed.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent3\">",
"        If the glucose is low (&lt;55 mg/dL) and the patient is a not a diabetic, draw blood for glucose, insulin, C-peptide, and an oral hypoglycemic agent screen and then treat",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist_other_start\">",
"        <ul>",
"         <li>",
"          <strong>",
"           Do not delay",
"          </strong>",
"          treatment if symptomatic hypoglycemia is suspected but rapid blood glucose measurement is not available or blood for diagnostic studies cannot be collected",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Treatment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <ul>",
"         <li>",
"          If the patient is conscious and able to drink and swallow safely (ie, alert enough to do so and with gag reflex intact), administer a rapidly-absorbed carbohydrate (eg, 3 to 4 glucose tablets or a tube of gel with 15 grams, 4 to 6 oz. fruit juice or non-diet soda, or a teaspoon of honey or table sugar)*",
"         </li>",
"         <li>",
"          If the patient has altered mental status, is unable to swallow, or does not respond to oral glucose administration within 15 minutes, give an IV bolus of 12.5 to 25 gm of glucose (25 to 50 mL of 50 percent dextrose)",
"         </li>",
"         <li>",
"          Measure a blood glucose 10 to 15 minutes after the IV bolus. Readminister 12.5 to 25 grams of glucose as needed to maintain the blood glucose above 80 mg/dL.",
"         </li>",
"         <li>",
"          If glucose cannot be given by parenteral or oral routes, give glucagon 1 mg IM or SQ. Response may be transient and should be followed by careful glucose monitoring and oral or intravenous glucose administration.",
"         </li>",
"         <li>",
"          Give additional maintenance glucose by mouth or IV. IV dextrose infusion should ensure delivery of 6 to 9 mg/kg per minute of glucose. Amounts needed vary depending upon the cause and severity of the symptomatic hypoglycemia. Once the patient is able to ingest carbohydrate safely, providing a mixed meal (including carbohydrates, such as a sandwich) is the preferred means of maintaining glucose levels.",
"         </li>",
"         <li>",
"          Measure a blood glucose 10 to 15 minutes after the initial IV bolus and monitor every 30 to 60 minutes thereafter until stable (minimum of 4 hours). The measurement method should provide rapid turnaround, preferably at the point of care.",
"         </li>",
"         <li>",
"          Admit patients with ingestion of a long-acting hypoglycemic agent, recurrent hypoglycemia during observation, and those unable to eat",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     IV: intravenous; IM: intramuscular; SQ: subcutaneous.",
"     <br/>",
"     * Patients taking an alpha-glucosidase inhibitor (eg, acarbose, miglitol, voglibose) with symptomatic hypoglycemia should only receive pure glucose (dextrose) orally because digestion and absorption of other carbohydrates (eg, table sugar [sucrose]) will be delayed by these medications and will be less effective in raising blood glucose levels.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_21_22877=[""].join("\n");
var outline_f22_21_22877=null;
var title_f22_21_22878="Contents: Anxiety disorders";
var content_f22_21_22878=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?23/51/24382\">",
"       Adult Primary Care and Internal Medicine",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Anxiety disorders",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Anxiety disorders",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/32/11782\">",
"           Acute procedure anxiety in adults: Course, screening, assessment, and differential diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/39/9849\">",
"           Acute procedure anxiety in adults: Epidemiology and clinical presentation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/58/7080\">",
"           Acute stress disorder: Epidemiology, clinical manifestations, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/15/10488\">",
"           Agoraphobia in adults: Epidemiology, clinical manifestations and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/42/24232\">",
"           Sedatives and hypnotics abuse and dependence: Pharmacology and epidemiology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/41/38553\">",
"           Comorbid anxiety and depression: Epidemiology, clinical manifestations, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/13/41177\">",
"           Co-occurring anxiety disorders and substance use disorders: Epidemiology, clinical manifestations, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/61/30678\">",
"           Deep brain stimulation for treatment of obsessive-compulsive disorder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/0/32776\">",
"           Generalized anxiety disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/45/36564\">",
"           Obsessive-compulsive disorder: Epidemiology, clinical manifestations, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/37/42582\">",
"           Obsessive-compulsive disorder in pregnant and postpartum women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/42/44713\">",
"           Panic disorder: Epidemiology, clinical manifestations, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/38/2665\">",
"           Pharmacotherapy for generalized anxiety disorder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/0/23561\">",
"           Pharmacotherapy for obsessive-compulsive disorder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/8/7305\">",
"           Pharmacotherapy for panic disorder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/29/33239\">",
"           Pharmacotherapy for posttraumatic stress disorder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/49/27416\">",
"           Pharmacotherapy for social anxiety disorder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/41/6806\">",
"           Pharmacotherapy for specific phobia in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/45/27352\">",
"           Posttraumatic stress disorder: Epidemiology, pathophysiology, clinical manifestations, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/1/20505\">",
"           Psychotherapy for generalized anxiety disorder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/37/34391\">",
"           Psychotherapy for obsessive-compulsive disorder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/22/40297\">",
"           Psychotherapy for panic disorder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/58/5032\">",
"           Psychotherapy for posttraumatic stress disorder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/36/32327\">",
"           Psychotherapy for social anxiety disorder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/59/25527\">",
"           Psychotherapy for specific phobia in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/44/44744\">",
"           Social anxiety disorder: Epidemiology, clinical manifestations, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/24/22921\">",
"           Specific phobia in adults: Epidemiology, clinical manifestations, course and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/0/26632\">",
"           Treatment for specific phobias of medical and dental procedures",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/18/9512\">",
"           Treatment of acute procedure anxiety in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/40/24197\">",
"           Treatment of acute stress disorder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/18/29993\">",
"           Treatment of co-occurring anxiety disorders and substance use disorders",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-0D98F9DB3C-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f22_21_22878=[""].join("\n");
var outline_f22_21_22878=null;
var title_f22_21_22879="CGMS output";
var content_f22_21_22879=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F62355&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F62355&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 555px\">",
"   <div class=\"ttl\">",
"    Accuracy of continuous glucose monitoring: correlation of CGM and simultaneous hemocue",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 535px; height: 423px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Results of continuous glucose monitoring compared with intermittent values checked with a laboratory-quality assay.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dr. David Nathan.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_21_22879=[""].join("\n");
var outline_f22_21_22879=null;
